Sentence,class,file
We suspected that this conserved Article No~e00148 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
The small-RNA Article No~e00148 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
Article No~e00148 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00148 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a2/b9/main.PMC5021778.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/47/79/main.PMC5021780.pdf
"While  the  pseudotumor  itself  is  usually painless,  compression  on  local  structures  and  nerves  can  produce http://dx.doi.org/10.1016/j.ijscr.2016.08.032 2210-2612/© 2016  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/47/79/main.PMC5021780.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/1a/main.PMC5021781.pdf
It  appears  to  arise  from  multipotent  stem http://dx.doi.org/10.1016/j.ijscr.2016.08.037 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/52/1a/main.PMC5021781.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/8c/main.PMC5021783.pdf
"Findings  on  CXR  can  include  pneumoth- orax,  pneumomediastinum,  subcutaneous  emphysema  and  air http://dx.doi.org/10.1016/j.ijscr.2016.08.014 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3c/8c/main.PMC5021783.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC5021784.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.08.019 2049-0801/ ©2016 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.,Non-OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC5021784.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 11 (2016) 26 e28,Non-OADS,/arxiv_data1/oa_pdf/e7/54/main.PMC5021784.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/83/main.PMC5021786.pdf
A  Focused http://dx.doi.org/10.1016/j.ijscr.2015.10.027 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/24/83/main.PMC5021786.pdf
"http://www.uptodate.com/contents/management-of-splenic- injury-in-the-adult-trauma-patient , 2004 (accessed  08.01.14).",Non-OADS,/arxiv_data1/oa_pdf/24/83/main.PMC5021786.pdf
http://www.uptodate.com/contents/ search?search=hepatic+laceration+&x=0&y=0 .,OADS,/arxiv_data1/oa_pdf/24/83/main.PMC5021786.pdf
This  is  an  open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
Celiac  artery  dissection http://dx.doi.org/10.1016/j.ijscr.2016.08.034 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"29  (January  (1))  (2015)  103–138, http://dx.doi.org/10.1016/j.avsg.2014.09.004 .",OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"Cot13  (80)  (2015)  470–472,  http://dx.doi.org/10.12659/PJR.895048 .",Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"Interventional  Imaging  12 (2015),  http://dx.doi.org/10.1016/j.diii.2015.08.004 .",OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"61  (April  (4))  (2015)  972–976,  http://dx.doi.org/10.1016/j.jvs.",OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"20 (August  (4))  (2015)  358–363,  http://dx.doi.org/10.1177/1358863X15581447 .",Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"41  (June  (3))  (2014)  344–345,  http://dx.doi.org/10.14503/THIJ- 13-3404 .",Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"42 (February-March  (1))  (2008)  62–64,  http://dx.doi.org/10.1177/ 1538574407305462 .",Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"31 (June  (6))  (2013)  e3–e5,  http://dx.doi.org/10.1016/j.ajem.2013.02.007  (1000).",OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"128  (January (1))  (2015) 135, http://dx.doi.org/10.4103/0366-6999.147867 .",Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"[15] T.  Zhang,  X.  Zhang,  X.  Zhang,  J.  Jiang,  B.  Zhou,  Endovascular  treatment  of isolated spontaneous  celiac  artery  dissection,  Vascular  20  (April  (2))  (2012) 118–120,  http://dx.doi.org/10.1258/vasc.2011.cr0302 .",Non-OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
"23 (January February  (1))  (2009)  90–94,  http://dx.doi.org/10.1016/j.avsg.2008.",OADS,/arxiv_data1/oa_pdf/84/d1/main.PMC5021788.pdf
These results strongly suggested that DCs processed and degraded exogenousReceived: 18 July 2016 Accepted: 26 August 2016 Heliyon 2 (2016) e00151 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
"Antibodies and reagents The antibodies used in this study were as follows: anti-BiP (rabbit; MBL), anti- calreticulin (for immunoprecipitation: rabbit antibodies from Affinity BioRea- gents, Golden, CO, USA; for western blotting: mouse antibodies from Stressgen, Victoria, British Columbia, Canada), anti-caveolin 1 (mouse; BD Biosciences, San Diego, CA, USA), anti-CHIP (for western blotting: rabbit antibodies as a gift from Dr. K. Tanaka, Tokyo Metropolitan Institute of Medical Science, Tokyo,Japan; and chicken antibodies as a gift from Mr. S. Seki, MBL, Ina, Japan), anti- Flag (mouse; Sigma), anti-GM-130 (m ouse; BD Biosciences), anti-Hsp70 (mouse; Stressgen), anti-KDEL (mouse; Stressgen), anti-LAMP-1 (rat; BD Biosciences), anti-H –2K b(mouse; Serotec), anti-multi-ubiquitin (mouse; MBL), anti-ovalbumin (OVA; rabbit; Polysciences, Warrington, PA, USA), anti-proteindisulfide isomerase (PDI; rabbit; Stressgen), anti-proteasome 20S subunit alpha 5 Article No~e00151 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
"After incubation at 37 °C for 1 h, about 40% of bOVA was still associated with microsomes; however, significant amounts of bOVA were Article No~e00151 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
"After incubation at 37 °C for 2 h with Flag-Ub, bOVA waspolyubiquitinated in purified microsomes in the presence of RLs and Flag-Ub Article No~e00151 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
"Since considerable amounts of bOVA incorporated into microsomes was ubiqutinated before fractionation, we could not distinguish these two kinds of bOVA, one was ubiqutinated beforefractionation and another was ubiqutinated after addition of Flag-Ub both by Article No~e00151 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
"In addition, Article No~e00151 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
"Additional information Supplementary content related to this article has been published online athttp://dx.doi.org/10.1016/j.heliyon.2016.e00151 References [1]C. Janeway, P. Travers, M. Walport, M. Shlomchik, Immunobiology: The Immune System in Health and Disease, 5th edn, Garland Press, New York, 2001 .",Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
Article No~e00151 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00151 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c2/5c/main.PMC5021789.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/cd/main.PMC5021790.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.042 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/77/cd/main.PMC5021790.pdf
The wound closure scratch assay was used to investigate the effect on cell migratory capacity of wild type RON and its variants.Received: 2 August 2016 Accepted: 31 August 2016 Heliyon 2 (2016) e00153 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
No Yes Yes Yes MSP Stimulation Yes Yes Yes Yes Article No~e00153 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
"Variance in cell motility values, if significant, was detected using first an F-test, followed by a Article No~e00153 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
"Research into splicing factors is currently developing, specifically examining the functions of a silencer and enhancer on exon 12 that may regulate aberrant splicing in epithelial cancers [18] or studying the SRSF2 Article No~e00153 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
"Additional information Supplementary content related to this article has been published online athttp://dx.doi.org/10.1016/j.heliyon.2016.e00153 Acknowledgements Dr. Diane Lidke, PhD, University of New Mexico for her generous donation of HEK293 cells.",Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
"Wang, Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluable form of Article No~e00153 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
Article No~e00153 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00153 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/cc/main.PMC5021793.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/59/main.PMC5021796.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.08.016 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/59/main.PMC5021796.pdf
"In contrast, significant15N enrichment was found in lupine and clover and15N was transferred to the associated rapeseed plants (around 6 and 4 mg N plant−1, respectively), which contributed 2 to 3% of the rapeseed total N. Additionally, the data revealed that N 2fixation dominated the N nutrition in lupine despite the high N level provided in the donor compartment,Received: 19 July 2016 Revised: 22 August 2016 Accepted: 26 August 2016 Heliyon 2 (2016) e00150 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
"The percentage of total donor N transferred to the receiver (%N transfer ) was calculated from the ratio between labelled N in the receiver and total labelled N in both the receiver and the donor plant ( Ledgard et al., 1985 ): %Ntransfer ¼15N content receiver=ð15N content receiver þ15N content donorÞx 100 (1) where 15N content ¼ðatom%15N excess x total N Þ=atom%15N excess labelled N (2) with: atom %15N excess labelledN =9 9 atom %15N excess plant= atom %15Nplant−atom %15Ncontrol Then, total amount of N (mg plant−1) transferred from the donor (N transfer ) was calculated as: Article No~e00150 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
(1994) Article No~e00150 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Atom%15N excess RC root DC root Total root Shoot Whole plant Lupine 2.432 a (±0.267)21.084 a (±4.191)14.678 a (±3.306)15.773 a (±2.558)15.584 a (±2.657) Clover 15.497 b (±2.363)62.492 b (±8.735)35.194 ab (±3.028)69.247 b (±7.401)62.349 b (±6.129) Vetch 0.688 a (±0.124)74.448 b (±6.648)58.444 b (±8.069)64.076 b (±9.177)62.647 b (±7.257) Article No~e00150 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
N transfer (%)N transferred (mg N plant−1)Ndft (%) RL 2.17 (±0.64)6.04 (±0.96)3.14 (±0.32) RC 0.88 (±0.44)4.01 (±1.31)2.02 (±0.40) Article No~e00150 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Serrano & Chamber (1990) Article No~e00150 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
Article No~e00150 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00150 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/6b/main.PMC5021797.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 124–135 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2016.05.002 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
http://dx.doi.org/10.4103/0300- 1652.119627 .,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
"Inﬂamm., 8 http://dx.doi.org/10.1155/ 2012/619293 , Hindawi Publishing Corporation.",Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
"JADA 144 (3), http://jada.ada.org .",Non-OADS,/arxiv_data1/oa_pdf/8f/02/main.PMC5021811.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/40/main.PMC5021812.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.005,OADS,/arxiv_data1/oa_pdf/6e/40/main.PMC5021812.pdf
American Cancer Society; 2015 [ http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/6e/40/main.PMC5021812.pdf
http://dx.doi.org/ 10.1002/14651858.CD006017.pub2 .,Non-OADS,/arxiv_data1/oa_pdf/6e/40/main.PMC5021812.pdf
http://dx.doi.org/10.1007/s00330 –015–4168-3 .,Non-OADS,/arxiv_data1/oa_pdf/6e/40/main.PMC5021812.pdf
http://dx.doi.org/10.1148/radiol.14141180:141180 .,Non-OADS,/arxiv_data1/oa_pdf/6e/40/main.PMC5021812.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 118–123 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2016.06.001 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/3e/26/main.PMC5021813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/26/main.PMC5021813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3e/26/main.PMC5021813.pdf
"BMC Oral Health 15, 89. http://dx.doi.org/10.1186/s12903-015-0078-7 .",Non-OADS,/arxiv_data1/oa_pdf/3e/26/main.PMC5021813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/8d/main.PMC5021814.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 142–147 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.12.003 1013-9052 /C2112016 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/2e/8d/main.PMC5021814.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/8d/main.PMC5021814.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
The  lesion  measured  59  ×  64  ×  60  mm http://dx.doi.org/10.1016/j.ijscr.2016.08.044 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"Rep.  5  (1998)  939–944, http://dx.doi.org/10.3892/or.5.4.939 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"21  (1990)  363–381,  http://dx.doi.org/10.1016/0046-8177(90)90198-E .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"15  (1996) 222–229, http://dx.doi.org/10.1097/00004347-199607000-00006 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"61  (2008)  1041–1044,  http://dx.doi.org/10.1136/jcp.",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"121 (2013) 229–232,  http://dx.doi.org/10.1016/j.ijgo.2012.12.015 .",OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"33  (2009) 278–288, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"22 (2009) e45–e51, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"84  (2002)  161–166,  http://dx.doi.org/ 10.1006/gyno.2001.6423 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"52  (2002)  1320–1329,  http://dx.doi.org/10.1016/s0360- 3016(01)02808-5 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"Cancer 14 (2004) 1024–1029,  http://dx.doi.org/10.1111/j.1048-891X.2004.",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"281  (2010)  669–675, http://dx.doi.org/10.1007/s00404-009-1200-3 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"129  (2013)  140–144,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"14  (1995) 223–229, http://dx.doi.org/10.1097/00004347-199507000-00005 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"105 (2007) 256–260, http://dx.doi.org/10.1016/j.ygyno.2006.",OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"21 (2010) 125–128, http://dx.doi.org/ 10.3802/jgo.2010.21.2.125 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"Nardelli,  Cervical mullerian  adenosarcoma  with  heterologous  sarcomatous  overgrowth:  a fourth  case  and  review  of  literature,  BMC  Cancer  11  (2011)  236,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"2012  (2012)  358302,  http://dx.doi.org/10.1155/2012/358302 .",Non-OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"Case  Rep. 9  (2014)  7–10,  http://dx.doi.org/10.1016/j.gynor.2014.04.005 .",OADS,/arxiv_data1/oa_pdf/a5/50/main.PMC5021815.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 109–117 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.09.003 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/99/72/main.PMC5021816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/72/main.PMC5021816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/99/72/main.PMC5021816.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"Mutations in p22phox are associated with a loss of function leading to severe immunode ﬁciency called chronic granulomatous disease (CGD), with inability to clear someContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.08.013 2213-2317/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: CRISPR, Clustered regulatory interspaced short palindromic re- peats; Cas9, CRISPR-associated protein 9; HEK293, human embryonic kidney 293cells; HRP, horseradish peroxidase; Nox4-HEK293, HEK293 cells stably expressingNox4; PMA, phorbol 12-myristate 13-acetate; tetNox4-HEK293, HEK293 cells ex- pressing Nox4 in tetracycline-inducible tet-on vector nCorrespondence to: Institut für Kardiovaskuläre Physiologie, Fachbereich Medizin der Goethe-Universität, Theodor-Stern Kai 7, 60590 Frankfurt am Main,Germany.",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
CRISPR/Cas9 The web interface of CRISPR design ( http://crispr.mit.edu/ )w a s used to develop gRNAs.,OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
Off-target activity was evaluated ad- ditionally with Blastn ( https://blast.ncbi.nlm.nih.gov/Blast.cgi ).,OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
Supplementary information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.08.013 .,OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"279 (2004) 45935 –45941, http://dx.doi.org/ 10.1074/jbc.M406486200 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"28 (7) (2008) 1347 –1354, http://dx.doi.org/10.1161/ATVBAHA.108.164277 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"87 (1) (2007) 245 –313, http://dx.doi.org/10.1152/physrev.00044.2005 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"76 (2014)208 –226, http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.046 .",OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"27 (1) (2007) 42 –48,http://dx.doi.org/10.1161/01.ATV.0000251500.94478.18 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"289 (26) (2014) 18270 –18278, http://dx.doi.org/10.1074/jbc.M114.562249 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"86 (5) (1990) 1729 –1737, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"11 (6) (2009) 1279 –1287, http://dx.doi.org/10.1089/ARS.2008.2383 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"280 (49) (2005) 40813 –40819, http://dx.doi.org/ 10.1074/jbc.M509255200 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"Susan, Simpson, D. Paul, J. Lambeth, David, Nox5 forms a functional oligomer mediated by self-asso-ciation of its dehydrogenase domain, Biochemistry 50 (12) (2011) 2013 –2025, http://dx.doi.org/10.1021/bi1020088 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"Che.m 280 (2005) 31859 –31869, http://dx.doi.org/10.1074/jbc.M501882200 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"283 (50) (2008) 35273 –35282, http://dx.doi.org/ 10.1074/jbc.M804200200 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"30 (4) (2010) 961 –975, http://dx.doi.org/10.1128/MCB.01393-09 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"18 (1) (2006) 69–82,http://dx.doi.org/10.1016/j.cellsig.2005.03.023 .",OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"443 (3) (2014)1060 –1065, http://dx.doi.org/10.1016/j.bbrc.2013.12.086 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"403 (Pt 1) (2007) 97 –108, http://dx.doi.org/10.1042/BJ20060819 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"Invest.118 (3) (2008) 1176 –1185, http://dx.doi.org/10.1172/JCI33835 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"11 (10) (2009) 2399 –2408, http://dx.doi.org/10.1089/ ars.2009.2579 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"291 (13) (2016) 7045 –7059, http://dx.doi.org/10.1074/jbc.M115.710772 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"8(11) (2013) 2281 –2308, http://dx.doi.org/10.1038/nprot.2013.143 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"24 (7) (2016)392 –399, http://dx.doi.org/10.1089/ars.2015.6314 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"110 (9) (2012) 1217 –1225, http://dx.doi.org/ 10.1161/CIRCRESAHA.112.267054 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"Mills, et al., Generation of transgene-free lung disease-speci ﬁc human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette, Stem Cells 28 (10) (2010) 1728 –1740, http://dx.doi.org/10.1002/ stem.495 .",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
"281 (41) (2006) 30336 –30346, http://dx.doi.org/10.1074/jbc.M607191200 .K.-K.",Non-OADS,/arxiv_data1/oa_pdf/46/01/main.PMC5021817.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/1c/main.PMC5021818.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 148–153 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.12.006 1013-9052 /C2112016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/36/1c/main.PMC5021818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/1c/main.PMC5021818.pdf
"( AvaDent Digital Dentures; Global Dental Science ,http://www.avadent.com ;Dentca-CAD/ CAM Denture; Dentca Inc ,http://www.dentca.com ).",Non-OADS,/arxiv_data1/oa_pdf/36/1c/main.PMC5021818.pdf
Available at: <http://www.avadent.com >.,Non-OADS,/arxiv_data1/oa_pdf/36/1c/main.PMC5021818.pdf
http://dx.doi.org/10.11607/ jomi.2014suppl.g2.3 .,OADS,/arxiv_data1/oa_pdf/36/1c/main.PMC5021818.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/main.PMC5021819.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 136–141 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2016.02.001 1013-9052 /C2112016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ee/f6/main.PMC5021819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/f6/main.PMC5021819.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"Production and hosting by ElsevierThe Saudi Dental Journal (2016) 28, 103–108 King Saud University The Saudi Dental Journal www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sdentj.2015.12.005 1013-9052 /C2112016 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"Periodontology 68, 217–269.http://dx.doi.org/10.1111/prd.12080 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/ 10.1111/clr.12155 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1111/j.1600- 051X.2011.01819.x .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.3290/j.qi.a29505 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1002/lsm.20239 .106 F.A.,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1016/j.pdpdt.2012.12.001 .,OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1097/ ID.0b013e3182310d57 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1039/b311900a .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"16, 13– 23.http://dx.doi.org/10.1097/ID.0b013e31803276c8 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1089/pho.2012.3329 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/ 10.1111/j.1365-2842.2008.01895.x .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1097/ ID.0b013e31820867da .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1556/imas.5.2013.3.4 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1039/c3 pp50426c .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"41, 234–241.http://dx.doi.org/10.5051/jpis.2011.41.5.234 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/ 10.1007/s10103-012-1215-z .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"28, 303–309.http://dx.doi.org/10.1007/s10103-012-1148-6 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"6), 95–107.http://dx.doi.org/10.1111/j.1600-0501.2012.02550.x .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"2011, 870364. http://dx.doi.org/10.5402/ 2011/870364 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.11607/ prd.2192 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1902/ jop.2010.090700 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"26, 763–766.http://dx.doi.org/10.1007/s10103-010-0807-8 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"12, 204–208.http://dx.doi.org/10.1016/s1532-3382(12)70038-6 .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1089/pho.2008.2280 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
"22, 282– 288.http://dx.doi.org/10.1097/ID.0b013e3182885fcc .",Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1111/j.1600- 051X.2006.00907.x .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1111/j.1600-051X.2006.00906.x .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1111/j.1600- 0501.2012.02494.x .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1111/ jcpe.12143 .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
http://dx.doi.org/10.1039/c4 pp00083h .,Non-OADS,/arxiv_data1/oa_pdf/5c/e5/main.PMC5021821.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/f7/main.PMC5021848.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.045 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/9a/f7/main.PMC5021848.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.08.005 2213-0071/ ©2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/c6/f7/main.PMC5021849.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 112 e114,Non-OADS,/arxiv_data1/oa_pdf/c6/f7/main.PMC5021849.pdf
http://dx.doi.org/10.1016/j.jcm.2016.04.001,OADS,/arxiv_data1/oa_pdf/be/5a/main.PMC5021899.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Porphyria LPDsPRESSeizures 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/c0/main.PMC5021915.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.08.004 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/c0/main.PMC5021915.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/c0/main.PMC5021915.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Clear cell adenocarcinomaEndometriosisMalignant transformationOvarian cancerBladder cancer 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/84/main.PMC5021916.pdf
Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.08.0052352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/84/main.PMC5021916.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/84/main.PMC5021916.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.018,Non-OADS,/arxiv_data1/oa_pdf/58/09/main.PMC5021918.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 1–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/58/09/main.PMC5021918.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 1–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/58/09/main.PMC5021918.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 1–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/58/09/main.PMC5021918.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 1–35 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/58/09/main.PMC5021918.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 691–701 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.07.003 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/a3/7b/main.PMC5021919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a3/7b/main.PMC5021919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a3/7b/main.PMC5021919.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Mediation analysisIndirect effectsBody mass index Waist circumference Neighborhood environments 1.,Non-OADS,/arxiv_data1/oa_pdf/85/a6/main.PMC5021920.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.06.0122211-3355/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/85/a6/main.PMC5021920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/a6/main.PMC5021920.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/85/a6/main.PMC5021920.pdf
Guidelines for Data Processing and Analysis of the International Physical Activity Questionniare (Ipaq) - Short and Long Forms Website: https://sites.google.com/site/theipaq/ .,Non-OADS,/arxiv_data1/oa_pdf/85/a6/main.PMC5021920.pdf
"http://www.health.gov/paguidelines/pdf/paguide.pdf (Accessed June, 2009).",Non-OADS,/arxiv_data1/oa_pdf/85/a6/main.PMC5021920.pdf
Contents lists available at ScienceDirect Molecular Genetics and Metabolism Reports journal homepage: www.elsevier.com/locate/ymgmr http://dx.doi.org/10.1016/j.ymgmr.2016.09.003 2214-4269/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/f9/e4/main.PMC5021926.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f9/e4/main.PMC5021926.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC5021951.pdf
"Difﬁculties in understanding the me- chanisms of higher brain functions still continue, primarilyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.001 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC5021951.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c9/5e/main.PMC5021951.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC5021952.pdf
We hypothesized that the following day's physical performance for those who took a nap after motor learning would be better on the following day than the perfor-mance of participants who did not nap.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.04.002 1984-0063/ &2016 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC5021952.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/d7/main.PMC5021952.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/7d/main.PMC5021953.pdf
"The aim of this study was to evaluate the association between sleeping habits, Mediterranean Diet pattern, and weight status using bioelectricalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.04.003 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/ab/7d/main.PMC5021953.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/7d/main.PMC5021953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/23/main.PMC5021954.pdf
"Altitude has been shown to increase central apneas even in healthy people and to be associated with higher apnea-hypopneaindex in those with obstructive sleep apnea [3,4]Even more, inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.008 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/7f/23/main.PMC5021954.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).☆This study was sponsored by an educational contribution from Colciencias, Ponti ﬁcia Universidad Javeriana, Hospital Universitario San Ignacio, Instituto del Corazón, which participated in the study design, sample collection, data analysis,and publication.",OADS,/arxiv_data1/oa_pdf/7f/23/main.PMC5021954.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/b4/main.PMC5021955.pdf
Few studies have explored the serum pattern of comple- ment components from the perspective of sleep with varyingContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.04.001 1984-0063/ &2016 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/37/b4/main.PMC5021955.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/b4/main.PMC5021955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/8f/main.PMC5021956.pdf
The validation setup is 3 fold:Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.006 1984-0063/ &2016 Brazilian Association of Sleep.,OADS,/arxiv_data1/oa_pdf/e5/8f/main.PMC5021956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/8f/main.PMC5021956.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/49/main.PMC5021957.pdf
Several studies have replicated theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.005 1984-0063/ &2016 Brazilian Association of Sleep.,OADS,/arxiv_data1/oa_pdf/42/49/main.PMC5021957.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/42/49/main.PMC5021957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC5021958.pdf
"Participants The inclusion criteria were: being an airline pilot on active duty, aged between 20 and 65 years old, and having ﬂown during theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.003 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC5021958.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC5021958.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.slsci.2016.05.003 .,OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC5021958.pdf
(Re- trieved from) 〈http://www.uc.pt/org/ceisuc/RIMAS/Lista/Instrumentos/ESS 〉; 2001.,OADS,/arxiv_data1/oa_pdf/23/a9/main.PMC5021958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/7f/main.PMC5021959.pdf
"Dampened autonomic dysfunction, manifesting as higher resting heart rates with reduced heart rateContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.007 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/02/7f/main.PMC5021959.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/02/7f/main.PMC5021959.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/73/main.PMC5022004.pdf
"Moreover, in the upper airway resistance syn- drome (UARS), the component event could be a respiratory effortContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.06.002 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/f7/73/main.PMC5022004.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/73/main.PMC5022004.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
They suggested that eveningness might explain why the respondents felt they needed more sleep.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.06.003 1984-0063/ &2016 Brazilian Association of Sleep.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Biol Rhythm 2003;18:80 –90.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Sleep Res 2002;11:191 –9.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Genet Psychol 2011;172:302 –8.http://dx.doi.org/10.1080/ 00221325.2010.535225 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.1024/1421-0185/a000121 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2010;27:1259 –70.http://dx.doi.org/10.3109/ 07420528.2010.487624 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.1111/j.1365-2869.2007.00584.x .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2008;25:745 –59.http://dx.doi.org/10.1080/ 07420520802394191 .,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Clin Endocrinol Metab 2015;100:4067 –73.http://dx.doi.org/10.1210/jc.2015 –2775 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Sleep Biol Rhythm 2010;8:267 –73.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Adolesc 2013;36:1025 –33.http://dx.doi.org/10.1016/j.adolescence.2013.08.007 .,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.3109/ 07420528.2014.935786 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Sleep Res 1999;8:291 –5.http://dx.doi.org/10.1046/j.1365-2869.1999.00176.x .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2012;29:311 –7.http://dx.doi.org/10.3109/ 07420528.2012.655870 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.1016/j.smrv.2014.01.002 .,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
J Adolesc Health 1998;23:259 –63.http://dx.doi.org/10.1016/ S1054-139X(98)00037-8 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Al- cohol Alcohol 2008;43:564 –8.http://dx.doi.org/10.1093/alcalc/agn057 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Sleep 1991;14:540 –5.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Pediatrics 2014;134:e921 –32.http://dx.doi.org/ 10.1542/peds.2014-1696 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Pediatrics 2003;111:302 –7.http://dx.doi.org/10.1542/peds.111.2.302 .J.E.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Sleep Health 2015;1:40 –3.http://dx.doi.org/ 10.1016/j.sleh.2014.12.010 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Med 2007;8:602 –12.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2008;25:565 –75.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2015;32:524 –30.http://dx.doi.org/ 10.3109/07420528.2013.790397 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2015;00:1 –10.http://dx.doi.org/10.3109/07420528.2015.1049271 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2005;22:1041 –54.http://dx.doi.org/ 10.1080/07420520500397959 .,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2012;29:502 –8.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
A group socialization theory ofdevelopment Psychol Rev 1995;102:458 –89.http://dx.doi.org/10.1037/ 0033-295X.102.3.458 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/ 10.1016/j.sbspro.2015.01.226 .,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.1371/journal.pone.0111700 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.3109/ 07420528.2013.872121 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.3390/ijerph111111201 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.1016/j.adolescence.2006.07.004 .,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
http://dx.doi.org/10.4414/smw.2014.14061 .,Non-OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
Chronobiol Int 2015;32:37 –42.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/9f/main.PMC5022005.pdf
"On this date, further progressshould be made in relation to medical management againstContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.08.002 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/d3/ed/main.PMC5022006.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/ed/main.PMC5022006.pdf
Lancet Neurol 2014;13(9):904 –12.http://dx.doi.org/10.1016/ S1474-4422(14)70122-X [PMID: 25127232].,OADS,/arxiv_data1/oa_pdf/9a/3d/main.PMC5022007.pdf
Sleep Med 2014;15:111 –5.http://dx.doi.org/10.1016/j.sleep.2013.08.792 [PMID: 24325809].,OADS,/arxiv_data1/oa_pdf/9a/3d/main.PMC5022007.pdf
Sleep Sci 2016;9(1):1 –4.http://dx.doi.org/10.1016/j.slsci.2016.01.003 [PMID: 27217904].,OADS,/arxiv_data1/oa_pdf/9a/3d/main.PMC5022007.pdf
http://dx.doi.org/ 10.1016/j.sleep.2011.12.003 [PMID: 22317945].,OADS,/arxiv_data1/oa_pdf/9a/3d/main.PMC5022007.pdf
"Tomoyuki Kawadan Department of Hygiene and Public Health, Nippon Medical School, Japan E-mail address: kawada@nms.ac.jp Received 22 June 2016; accepted 28 June 2016 Available online 15 July 2016Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.06.005 1984-0063/ &2016 Brazilian Association of Sleep.",OADS,/arxiv_data1/oa_pdf/9a/3d/main.PMC5022007.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/3d/main.PMC5022007.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/8c/main.PMC5022008.pdf
"Both groups of neurons project throughout the central nervous system [4,27].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.010 1984-0063/ &2016 Brazilian Association of Sleep.",OADS,/arxiv_data1/oa_pdf/43/8c/main.PMC5022008.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/8c/main.PMC5022008.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/c9/main.PMC5022045.pdf
"In consideration that ROS has both positive and negative effect, it is conceivable that the different intracellular redox state in different types of cell confer themselves different redox balance, and developed different sen- sitivity to oxidative stress or antioxidant interference, which couldContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.12.001 2213-2317/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/b6/c9/main.PMC5022045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/c9/main.PMC5022045.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2015.12.001 .References [1]L.M.,OADS,/arxiv_data1/oa_pdf/b6/c9/main.PMC5022045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/c9/main.PMC5022046.pdf
Although they were initiallyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2016.04.001 2213-2317/ &2016 The Authors.,OADS,/arxiv_data1/oa_pdf/9f/c9/main.PMC5022046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/c9/main.PMC5022046.pdf
Redﬂuorescence from 20 ﬁelds around the vessel was evaluated using image software imageJ ( http://rsbweb.nih.gov/ij/ )a sp r e v i o u s l y described [33].,OADS,/arxiv_data1/oa_pdf/9f/c9/main.PMC5022046.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/7a/main.PMC5022067.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.04.041 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/39/7a/main.PMC5022067.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/c6/main.PMC5022068.pdf
"Radiological  assessment, including  x-rays  and  computed  tomography  (CT)  scans,  revealed a  complete transphyseal posterior  dislocation  and  a  left  anterior column  fracture  of  the  acetabulum  with  a  displacement  of  less  than http://dx.doi.org/10.1016/j.ijscr.2016.04.038 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/db/c6/main.PMC5022068.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/6a/main.PMC5022069.pdf
"Case report A 44 year old lady  presented  with  severe  generalized  abdominal pain since  two  days  along  with  multiple  episodes  of  non-projectile, http://dx.doi.org/10.1016/j.ijscr.2016.04.025 2210-2612/© 2016  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/05/6a/main.PMC5022069.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/85/main.PMC5022070.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.04.037 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/88/85/main.PMC5022070.pdf
"Madiba,  Cranial  injuries  secondary  to  assault  with  a  machete, Injury  45  (9)  (2014)  1355–1358,  http://dx.doi.org/10.1016/j.injury.2014.04.",Non-OADS,/arxiv_data1/oa_pdf/88/85/main.PMC5022070.pdf
"Trauma Shock  7  (2)  (2014)  77–82,  http://dx.doi.org/10.4103/0974-2700.130875 .",Non-OADS,/arxiv_data1/oa_pdf/88/85/main.PMC5022070.pdf
"18  (4)  (2011)  293–297,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/88/85/main.PMC5022070.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/d5/main.PMC5022071.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.04.042 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/d5/main.PMC5022071.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9f/3d/main.PMC5022073.pdf
Subsequent  MRI  showed  a growing  9  ×  9  ×  5  cm  centrally  necrotic  mass  at  the  level  of  the  11th http://dx.doi.org/10.1016/j.ijscr.2016.04.005 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/3d/main.PMC5022073.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/fb/main.PMC5022074.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.06.001,OADS,/arxiv_data1/oa_pdf/20/fb/main.PMC5022074.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
"Finally, mitochondrial function is reduced andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.04.005 2213-2317/Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2006.01.036 16716900 .,OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1096/fj.09-146308 20040516 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/ 10.1152/ajpregu.00093.2011 21900648 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1096/fj.13-240390 24378874 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1096/fj.13-228130 23729587 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2013.02.026 .,OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
"Epstein, A. Richardson, Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse, Archives of Biochemistry and Bio-physics 363 (1) (1999) 91 –97.http://dx.doi.org/10.1006/abbi.1998.1060 10049502 .",Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1093/gerona/60.7.847 16079206 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1113/jphysiol.1993.,OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/ 10.1111/j.1474-9726.2012.00843.x 22672615 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1111/j.1748-1716.1986.tb07793.x 3953298 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
"[18] L. Larsson, L. Edström, Effects of age on enzyme-histochemical ﬁbre spectra and contractile properties of fast- and slow-twitch skeletal muscles in the rat, Journal of the Neurological Sciences 76 (1) (1986) 69 –89.http://dx.doi.org/ 10.1016/0022-510X(86)90143-7 2946814 .",OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1016/0014-4886(81)90257-0 7308373 .,OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1113/jphysiol.1996.sp021402 8782115 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1038/sj.onc.1208207 15531919 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1002/(SICI)1096-9861(19991011)413:1 o101:: AID-CNE7 43.0.CO;2-L 10464373 .,OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1111/j.1474-9726.2010.00635.x 20883524 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.org/10.1371/journal.pone.0065725 23750273 .,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/c8/main.PMC5022075.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Klotho in human disease MG Pavlatou et al 9 Translational Psychiatry (2016), 1 –9",Non-OADS,/arxiv_data1/oa_pdf/58/11/tp2016135a.PMC5022081.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/88/6e/aps201669a.PMC5022103.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Caspase-1 inhibition reduces development of NASH MC Morrison et al 1423 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/e9/72/ijo201674a.PMC5022108.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Time-of-day-dependent high fat feeding J Joo et al 1451 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/68/35/ijo201680a.PMC5022109.pdf
2010. http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k- tyosa10/4-3.html  (accessed on 14 July 2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/0a/cmw062.PMC5022125.pdf
http://www.mhlw.go.jp/english/policy/ care-welfare/care-welfare-elderly/  (accessed on 14 July 2016)  17.,Non-OADS,/arxiv_data1/oa_pdf/9e/0a/cmw062.PMC5022125.pdf
2013. http://www.mhlw.go.jp/toukei/list/dl/20-21-h25.pdf   (accessed on 14 July 2016).,Non-OADS,/arxiv_data1/oa_pdf/9e/0a/cmw062.PMC5022125.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/3f/ircmj-18-07-27919.PMC5022126.pdf
Available from: http://www.cdc.gov/hrqol/concept.,OADS,/arxiv_data1/oa_pdf/2b/3f/ircmj-18-07-27919.PMC5022126.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © K Znidar et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/d1/mtna201634a.PMC5022127.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/a4/d1/mtna201634a.PMC5022127.pdf
CAGE is available at https://github.com/bm2-lab/cage.,Non-OADS,/arxiv_data1/oa_pdf/86/ab/mtna201635a.PMC5022128.pdf
"BioRxiv, doi: http://dx.doi.org/10.1101/021568.",OADS,/arxiv_data1/oa_pdf/86/ab/mtna201635a.PMC5022128.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © G Chuai et al.",Non-OADS,/arxiv_data1/oa_pdf/86/ab/mtna201635a.PMC5022128.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/86/ab/mtna201635a.PMC5022128.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © ME Gallo et al.",Non-OADS,/arxiv_data1/oa_pdf/5b/b0/mtna201636a.PMC5022129.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/5b/b0/mtna201636a.PMC5022129.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © K Broos et al.",Non-OADS,/arxiv_data1/oa_pdf/36/57/mtna201638a.PMC5022130.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © T Yanagi et al.",Non-OADS,/arxiv_data1/oa_pdf/27/eb/mtna201640a.PMC5022131.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/27/eb/mtna201640a.PMC5022131.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © L Cao et al.",Non-OADS,/arxiv_data1/oa_pdf/84/80/mtna201646a.PMC5022132.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/84/80/mtna201646a.PMC5022132.pdf
"Email: jonhofpt@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc- nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon  in any way.",Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
ORCID Jonathan Hoffman  http://orcid.org/0000-0002-1354-052X C. Philip Gabel  http://orcid.org/0000-0001-8354-4545The exercises The practice of the MMB methods is generally empha- sized in three areas.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.margaretmorrismovement.com/MargaretMorris.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available  from: http://discovery.nationalarchives.gov.uk/details/rd/bdb0366b- f3e1-45d3-a685-887f9f9bc8ac .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: https://www.pilates.com/BBAPP/V/ pilates/origins-of-pilates.html .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://benjamindegenhardt.com/joes-anatomy/ .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://benjamindegenhardt.com/once-upon-a-time/ .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.jillianhessel.com/pilates_ biography.html .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.isofit.com.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.feldenkrais.com/moshe-feldenkrais .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: https://www.gyrotonic.com .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from:  http://gagapeople.com/english/about-gaga/ .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available  from: http://www.pilates.com/BBAPP/V/education/corealign/index.html .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.fffforlife.com/#!human-harmony- training/c66t .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3563510/ 58  Woodman JP, Moore NR.",Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.theatlantic.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://calisthenics.gr/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://hsp.org/sites/ default/files/legacy_files/migrated/findingaid3057progressturnverein.,OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://youtu.be/CxQ5DA6RCHI.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://youtu.be/ KjObalYKTHE.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.olympic.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://www.slate.com/articles/life/ fitness/2011/01/kafkas_calisthenics.html .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from:  http://www.learntomuller.com/j-p-muller-a-danish-sportsman-world- famous-and-forgotten/ .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://pilatesandalexander.com/articles/macy/ .,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
Available from: http://website.lineone.net/~hstjw/p32.htm#i549.,Non-OADS,/arxiv_data1/oa_pdf/29/83/yptr-20-315.PMC5022134.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/6d/ircmj-18-07-22932.PMC5022289.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/44/ircmj-18-07-28050.PMC5022290.pdf
International Programme on Chemical Safety Available from: http://www.who.int/ipcs/assessment/public_health/lead/en /.,Non-OADS,/arxiv_data1/oa_pdf/c0/44/ircmj-18-07-28050.PMC5022290.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs379/en /.,Non-OADS,/arxiv_data1/oa_pdf/c0/44/ircmj-18-07-28050.PMC5022290.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/85/main.PMC5022330.pdf
"When told about this, he did not believe it, but ratherContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssciSleep Science http://dx.doi.org/10.1016/j.slsci.2016.05.009 1984-0063/ &2016 Brazilian Association of Sleep.",Non-OADS,/arxiv_data1/oa_pdf/4c/85/main.PMC5022330.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/85/main.PMC5022330.pdf
Supplementary material related to this article can be found online at http://dx.doi.org/10.1016/j.slsci.2016.05.009 .,Non-OADS,/arxiv_data1/oa_pdf/4c/85/main.PMC5022330.pdf
Clinical Trial Registration:  ChiCTR‑TRC‑12004443; http://www.chictrdb.org.,Non-OADS,/arxiv_data1/oa_pdf/db/74/CMJ-129-2143.PMC5022331.pdf
doi: http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/db/74/CMJ-129-2143.PMC5022331.pdf
"Available  at:http://www.who.int/mediacentre/factsheets/fs297/en,oct 9,2015.",Non-OADS,/arxiv_data1/oa_pdf/6e/43/RPS-11-303.PMC5022378.pdf
"Available at: http://www.cancer.org/en,       oct 12,2015.",Non-OADS,/arxiv_data1/oa_pdf/6e/43/RPS-11-303.PMC5022378.pdf
"17. http://www.google.com/patents/US20120128804,  19/4/2016.",Non-OADS,/arxiv_data1/oa_pdf/bd/69/RPS-11-318.PMC5022380.pdf
http://www.who.int/leishmaniasis  / burden/magnitude/burden_ma gnitude/en/index.,OADS,/arxiv_data1/oa_pdf/da/e4/RPS-11-324.PMC5022381.pdf
http://www.who.int/emc/ diseases/leish/leisgeo1  .html;2003: accessed 15.05.2010.,Non-OADS,/arxiv_data1/oa_pdf/da/e4/RPS-11-324.PMC5022381.pdf
Available at: http://www.cbhidghs.,Non-OADS,/arxiv_data1/oa_pdf/19/b4/JISPCD-6-116.PMC5022387.pdf
5. http://www.hc‑bios.com/en/news_view.php?sn=17.,Non-OADS,/arxiv_data1/oa_pdf/19/b4/JISPCD-6-116.PMC5022387.pdf
Allotment	of	participants	within	the	groups	was	 performed randomly by creating a randomization  list by means of a freeware link (http://www.graphad.,OADS,/arxiv_data1/oa_pdf/98/e5/JISPCD-6-153.PMC5022394.pdf
Available from: http://www.aae.org/publications‑and‑research/ endodontics‑colleagues‑for ‑excellence‑newsletter/cone‑beam‑ computed‑tomography‑in‑endodontics.aspx.,Non-OADS,/arxiv_data1/oa_pdf/83/ff/JISPCD-6-93.PMC5022399.pdf
"8, e1204508 (6 pages)http://dx.doi.org/10.1080/15592324.2016.1204508",Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Plant Cell 2004; 16:3400-12; PMID:15539473; http://dx.doi.org/10.1105/ tpc.104.024315 2.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
CellRes 2008; 18:385-97; PMID:18268542; http://dx.doi.org/10.1038/cr.2008.26 3.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Plant Cell 2010; 22:2219-36;PMID:20675571; http://dx.doi.org/10.1105/tpc.110.074096 4.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Plant Physiol 2015; 167:273-86; PMID:25452667; http://dx.doi.org/10.1104/pp.114.250837 5.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Nucleic Acids Res 2016; 44:D279-85; PMID:26673716; http://dx.doi.org/10.1093/nar/gkv13448.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Chem Rev 1994;94(3):715 – 726; PMID:11539597; http://dx.doi.org/10.1021/cr00027a008 9.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Science 2009; 326:722-6; PMID:19762597; http://dx.doi.org/10.1126/science.1176326 10.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Sci-ence 2009; 326:718-21; PMID:19762596; http://dx.doi.org/10.1126/ science.1176333 11.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
PhysiolRev 2002; 82:373-428; PMID:11917093; http://dx.doi.org/10.1152/ physrev.00027.2001 12.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Plant Physiol 2005; 137:13-30; PMID:15644464; http://dx.doi.org/ 10.1104/pp.104.052423 13.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
PMID:24253678; http://dx.doi.org/10.1038/ncomms3792 15.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Curr Opin Structural Biol 2004; 14:208-16; PMID:15093836; http://dx.doi.org/ 10.1016/j.sbi.2004.03.011 16.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Nucleic Acids Res 2015; 43:D257-60; PMID:25300481; http://dx.doi.org/10.1093/nar/gku949 18.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Cell 2003; 112:779-91; PMID:12654245; http://dx.doi.org/10.1016/S0092-8674(03)00193-4 19.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Cell Cycle 2013; 12:2733-7; PMID:23966173; http://dx.doi.org/10.4161/cc.25785 20.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Plant Cell 2012; 24(10):3921-48;PMID:23043051; http://dx.doi.org/10.1105/tpc.112.102491 21.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
FEMS Microbiol Lett 2008;279:131-45; PMID:18081840; http://dx.doi.org/10.1111/j.1574-6968.2007.01011.x 22.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Biochim Biophys Acta 2012; 1823:1521-30; PMID:22483849; http://dx.doi.org/10.1016/j.bbamcr.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Plant Science 2014; 224:36-43; PMID:24908504; http://dx.doi.org/10.1016/j.plantsci.2014.04.002 24.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
J Biol Chem 2012; 287:7357-65; PMID:22253436; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Nat Struct Mol Biol 2008; 15:1334-42;PMID:19043414; http://dx.doi.org/ http://dx.doi.org/10.1038/nsmb.1521 26.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Nucleic Acids Res 1997; 25:3389-402; PMID:9254694; http://dx.doi.org/10.1093/nar/25.17.3389 27.,Non-OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Nucleic Acids Res 2009; 37:D5-15; PMID:18940862; http://dx.doi.org/10.1093/nar/gkn741 28.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
Nucleic Acids Res 2012; 40:W569-72; PMID:22695796; http://dx.doi.org/10.1093/nar/gks576e1204508-6 A. MATTHIADIS AND T. A.,OADS,/arxiv_data1/oa_pdf/a5/60/kpsb-11-08-1204508.PMC5022407.pdf
"8, e1160189 (6 pages)http://dx.doi.org/10.1080/15592324.2016.1160189",Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Methods Co-expression analysis Genes co-expressing with CB5C were identi ﬁed using the ATTED-II database (http://atted.jp/).35 Plant lines and growth conditions Two T-DNA insertion lines targeting CB5C (AT2G46650) – cb5c-1 (SALK_027748C) and cb5c-2 (cyb5-1 ; SALK_065187) - were acquired from the Nottingham Arabidopsis Stock Center (NASC).,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
J Biochem Mol Toxicol 2002; 16:311-6; PMID:12481306; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Biochem Biophys Res Commun 2005; 338:499-506; PMID:16182240; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
2015; 2532; http://dx.doi.org/10.1080/03602530600570065 4.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Chem ResToxicol [Internet] 2014; Available from: http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
gov/pubmed/25133307; 27:1474-86; PMID:25133307; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Chem Rev 2004; 104:3947- 80; PMID:15352783; http://dx.doi.org/10.1021/cr020443g 6.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Pharma- col Ther 2003; 97:139-52; PMID:12559387; http://dx.doi.org/10.1016/S0163-7258(02)00327-3 7.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.p ubmedcentral.nih.gov/articleren der.fcgi?artid D3073529&tool Dpmcentrez&rendertype Dabstract; PMID:21055385; http://dx.doi.org/10.1016/j.abb.2010.10.023 8.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http: //w ww.pubmedcentral.nih.gov /article render.fcgi?artid D2719124&tool Dpmcentrez&rendertype Dabstract; PMID:19502355; http://dx.doi.org/10.1104/pp.109.141374 10.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
plos.org/10.1371/journal.pone.0031370; PMID:22384013; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://w ww.tandfonline.com/doi/abs/ 10.1080/09168451.2014.877836; PMID:25036477; http://dx.doi.org/ 10.1080/09168451.2014.877836 13.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
gov/articlerender.fcgi?artid D3538417&tool Dpmcentrez&rendertype Dab stract; PMID:23297350; http://dx.doi.org/10.1098/rstb.2012.0426 14.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Biotechnol Appl Biochem 2013; 60:4-8;PMID:23586987; http://dx.doi.org/10.1002/bab.1099 15.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.bioone.org/doi/abs/10.1199/tab.0144; PMID:22303269; http://dx.doi.org/10.1199/tab.0144 16.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.ncbi.nlm.n ih.gov/pubmed/24709279; PMID:24709279; http://dx.doi.org/10.1016/j.pbi.2014.03.004 17.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
"Available from: http://www.ncbi.nlm.nih.gov/ pubmed/25435320 18. de Vetten N, ter Horst J, van Schaik HP, de Boer A, Mol J, Koes R. A cytochrome b5 is required for full activity of ﬂavonoid 3 0,50-hydroxylase, a cytochrome P450 involved in the formation of blue ﬂower colors.",Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http: //www.ncbi.nlm.nih.gov/pubmed/ 23575629; PMID:23575629; http://dx.doi.org/10.1038/nature12051 20.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: h ttp://www.ncbi.nlm.nih.gov/ pubmed/16669764; PMID:16669764; http://dx.doi.org/10.1146/ annurev.arplant.57.032905.105228 21.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
nih.gov/pubmed/20303821; PMID:20303821; http://dx.doi.org/ 10.1016/j.tplants.2010.02.005 22.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artidD3784603&tool Dpmcentrez&rendertype Dabstrac t; PMID:23943862; http://dx.doi.org/10.1105/tpc.113.115139 23.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22311778; PMID:21772031; http://dx.doi.org/10.1093/mp/sss001 24.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Plant Cell Physiol 2008; 49:324-33; PMID:18202003; http://dx.doi.org/10.1093/pcp/pcn007 25.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Planta 2002; 214:562-71; PMID:11925040; http://dx.doi.org/10.1007/s004250100659 26.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Avail- able from: http://www.plantcell.org/content/11/12/2283.full; http://dx.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://w ww.ncbi.nlm.nih.gov/pubmed/ 24431192; PMID:24431192; http://dx.doi.org/10.1093/mp/ssu004 28.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from:http://www.ncbi.nlm.nih.gov/pubmed/11133994; PMID:11133994; http://dx.doi.org/10.1074/jbc.M010123200 29.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://doi.wiley.com/10.1046/j.1365-313X.2003.01679.x; PMID:12609033; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.n cbi.nlm.nih.gov/pubmed/23558912; PMID:23558912; http://dx.doi.org/10.1093/aob/mct067 32.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Plant Physiol 2002; 130:887-94; PMID:12376653; http://dx.doi.org/10.1104/pp.005272 33.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Plant J [Internet] 2009; 58:122-34.Available from: http://www.ncbi.nlm.nih.gov/pubmed/19054355 \nhttp://onlinelibrary.wiley.com/store/10.1111/j.1365-313 X.2008.03765.x/asset/j.1365-313X.2008.03765.x.pdf?v D1&tDhrvnp 91f&sDfdb36bf490c5cd401a654ace5df2fc2a5bd00105;PMID: 19054355; http://dx.doi.org/10.1111/j.1365-313X.2008.03765.x 3 4 .,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Plant J 2014; 77:558-67; PMID:24635651; http://dx.doi.org/10.1111/tpj.1240135.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://pcp.oxfordjournals.org/content/early/2015/11/ 05/pcp.pcv165.abstract; PMID:26546318; PMID:26546318 ; http://dx.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Society 2005; 139:5-17; PMID:16166256; http://dx.doi.org/10.1104/pp.105.063743.1 37.,Non-OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.plantcell.org/cgi/doi/10.1105/tpc.113.110890; PMID:23995084; http:// dx.doi.org/10.1105/tpc.113.110890 38.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
Available from: http://www.pubmedcentral.nih.gov/articleren der.fcgi?artid D4561820&tool Dpmcentrez&rendertype Dabstract; PMID:26442014; http://dx.doi.org/10.3389/fpls.2015.00697e1160189-6 D. VIK ET AL.,OADS,/arxiv_data1/oa_pdf/35/e6/kpsb-11-08-1160189.PMC5022417.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which per- mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"3, e1206171 (11 pages)http://dx.doi.org/10.1080/21624054.2016.1206171",Non-OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Nat Rev MolCell Biol 2008; 9:112-24; PMID:18216768; http://dx.doi.org/10.1038/nrm2330 [2] McIntosh TJ, Simon SA.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Nature 2014; 510:48-57;PMID:24899304; http://dx.doi.org/10.1038/nature13474 [4] Apaja PM, Lukacs GL.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"PLoS ONE 2011; 6:e21343; PMID:21712952;http://dx.doi.org/10.1371/journal.pone.0021343 [6] Svensk E, Sta /C14hlman M, Andersson C-H, Johansson M, Bor/C19en JN, Pilon M. PAQR-2 Regulates Fatty Acid Desa- turation during Cold Adaptation in C. elegans .",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
PLoS Genet 2013; 9:e1003801; PMID:24068966; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"PLoS Genet 2016; 12:e1005982; PMID:27082444; http://dx.doi.org/10.1371/journal.pgen.1005982 [8] Pettitt J, Wood WB, Plasterk RH.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Dev Biol 1999; 207:86-106; PMID:10049567; http://dx.doi.org/10.1006/dbio.1998.9173 [10] Chisholm AD, Hsiao TI.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Wiley Interdiscip Rev Dev Biol 2012; 1:861-78;PMID:23539299; http://dx.doi.org/10.1002/wdev.79 [11] Sulston JE, Albertson DG, Thomson JN.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Dev Biol 1980; 78:542-76; PMID:7409314;http://dx.doi.org/10.101 6/0012-1606(80)90352-8 [12] Morita K, Chow KL, Ueno N. Regulation of body length and male tail ray pattern formation of Caenorhabditis ele- gans by a member of TGF- bfamily.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Dev Growth Differ 2000; 42:69- 77; PMID:10831045; http://dx.doi.org/10.1046/j.1440-169x.2000.00487.x [15] Zori RT, Williams CA.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
Am J Med Genet 1991; 40:248-8; PMID:1897581; http://dx.doi.org/10.1002/ajmg.1320400224e1206171-10 E. SVENSK ET AL.,OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Elife 2013; 2:e00190;PMID:23482940; http://dx.doi.org/10.7554/eLife.00190 [17] Praitis V, Ciccone E, Austin J. SMA-1 spectrin has essen- tial roles in epithelial cell sheet morphogenesis in C. ele- gans.",Non-OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Spectrins: a structural platform for stabilization and activa- tion of membrane channels, receptors and transporters.Biochim Biophys Acta 2014; 1838:620-34; PMID:23673272; http://dx.doi.org/10.101 6/j.bbamem.2013.05.002 [20] Pan C-L, Baum PD, Gu M, Jorgensen EM, Clark SG, Garriga G. C. elegans AP-2 and retromer control Wnt s i g n a l i n gb yr e g u l a t i n g mig-14 /Wntless.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Dev Cell 2008; 14:132-9; PMID:18160346; http://dx.doi.org/10.1016/j.devcel.2007.12.001 [21] Sulston JE, Hodgkin JA.",OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
Curr Biol 1998; 8:1087-90; PMID:9768364; http://dx.doi.org/10.1016/S0960-9822(98)70447-6WORM e1206171-11,OADS,/arxiv_data1/oa_pdf/71/4b/kwrm-05-03-1206171.PMC5022664.pdf
"Curr Biol 2015; 25:3220-4; http://dx.doi.org/10.1016/j.cub.2015.10.055 Commentary to: Nishimura H, et al.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
Curr Biol 2015; 25: 3225 –31; http://dx.doi.org/10.1016/j.cub.2015.10.056 © 2016 Amber R. Krauchunas and Andrew Singson.,OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"3, e1184389 (5 pages)http://dx.doi.org/10.1080/21624054.2016.1184389",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"predicted that C. elegans might also have an Izumo1-like protein that functions during fertilization.However, no Izumo1 orthologs are detectable in the C. elegans genome by BLAST (http://blast.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
J Exp Zool 1914; 16:523-90;http://dx.doi.org/10.1002/jez.1400160404 [2] Yanagimachi R. Mammalian fertilization.,Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
Cell TissueRes 2016; 363:227-35; PMID:26224538; http://dx.doi.org/10.1007/s00441-015-2243-3 [4] Singson A.,OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Dev Biol 2001; 230:101-9; PMID:11161565;http://dx.doi.org/10.1006/dbio.2000.0118 [5] Schultz R, Williams C. Developmental biology: sperm- egg fusion unscrambled.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Nature 2005; 434:152-3; PMID:15758983; http://dx.doi.org/10.1038/434152a [6] Inoue N, Hamada D, Kamikubo H, Hirata K, Kataoka M, Yamamoto M, Ikawa M, Okabe M, Hagihara Y. Molecu-lar dissection of IZUMO1, a sperm protein essential forsperm-egg fusion.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Development 2013; 140:3221-9;PMID:23824580; http://dx.doi.org/10.1242/dev.094854 [7] Inoue N, Ikawa M, Isotani A, Okabe M. The immunoglobu- lin superfamily protein Izumo is required for sperm to fusee1184389-4 A. R. KRAUCHUNAS AND A. SINGSON",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Adv Exp Med Biol 2013; 757:321-50; PMID:22872482; http://dx.doi.org/10.1007/978-1-4614-4015-4_11 [10] Nishimura H, L ’Hernault SW. Spermatogenesis-defective (spe) mutants of the nematode Caenorhabditis elegansprovide clues to solve the puzzle of male germline func-tions during reproduction.",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Reproduction 2004; 127:409-16; PMID:15047931; http://dx.doi.org/10.1530/rep.1.00009 [12] Nishimura H, Tajima T, Comstra HS, Gleason EJ, L ’Her- n a u l tS W .T h eI m m u n o g l o b u l i n - l i k eG e n es p e - 4 5A c t sd u r -ing Fertilization in Caenorhabditis elegans like the MouseIzumo1 Gene.",Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Curr Biol 2015; 25:3225-31; PMID:26671669;http://dx.doi.org/10.1016/j.cub.2015.10.056 [13] Singaravelu G, Rahimi S, Krauchunas A, Rizvi A, Dharia S, Shakes D, Smith H, Golden A, Singson A.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Curr Biol 2015; 25:3220-4; PMID:26671668;http://dx.doi.org/10.1016/j.cub.2015.10.055 [14] Ellis RE, Stan ﬁeld GM.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Semin Cell Dev Biol 2014; 29:17-30; PMID:24718317; http://dx.doi.org/ 10.1016/j.semcdb.2014.04.005 [15] Letunic I, Doerks T, Bork P. SMART: recent updates, new developments and status in 2015.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Nucleic Acids Res2015; 43:D257-60; PMID:25300481; http://dx.doi.org/ 10.1093/nar/gku949 [16] Reinke V, Gil IS, Ward S, Kazmer K. Genome-wide germline-enriched and sex-biased expression pro ﬁles in Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Development 2004; 131:311-23;PMID:14668411; http://dx.doi.org/10.1242/dev.00914 [17] Swanson WJ, Vacquier VD.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Nat Rev Genet 2002; 3:137-44; PMID:11836507; http://dx.doi.org/10.1038/nrg733 [18] Ellerman DA, Pei J, Gupta S, Snell WJ, Myles D, Primak- off P. Izumo is part of a multiprotein family whose mem-bers form large complexes on mammalian sperm.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"MolReprod Dev 2009; 76:1188-99; PMID:19658160; http://dx.doi.org/10.1002/mrd.21092 [19] Inoue N, Hagihara Y, Wright D, Suzuki T, Wada I. Oocyte- triggered dimerization of sperm IZUMO1 promotes sperm- egg fusion in mice.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
"Nat Commun 2015; 6:8858;PMID:26568141; http://dx.doi.org/10.1038/ncomms9858 [20] Bianchi E, Doe B, Goulding D, Wright GJ.",OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
Nature 2014; 508:483-7; PMID:24739963; http://dx.doi.org/10.1038/nature13203 [21] Barclay AN.,Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
Annu Rev Neurosci 2007; 30:451-74;PMID:17600523; http://dx.doi.org/10.1146/annurev.neuro.29.051605.113034 [23] Grayson P. Izumo1 and Juno: the evolutionary origins and coevolution of essential sperm-egg binding partners.R Soc Open Sci 2015; 2:150296; PMID:27019721; http://dx.doi.org/10.1098/rsos.150296WORM e1184389-5,Non-OADS,/arxiv_data1/oa_pdf/c4/3c/kwrm-05-03-1184389.PMC5022665.pdf
Nat Commun 2015; 6:8782; http://dx.doi.org/ 10.1038/ncomms9782.,Non-OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"3, e1184390 (7 pages)http://dx.doi.org/10.1080/21624054.2016.1184390",Non-OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
NatChem Biol 2011; 7:504-11; PMID:21769097; http://dx.doi.org/10.1038/nchembio.607 [2] Finkel T. Signal transduction by reactive oxygen species.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
J Cell Biol 2011; 194:7-15; PMID:21746850; http://dx.doi.org/10.1083/jcb.201102095 [3] Finkel T. Oxidant signals and oxidative stress.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
Curr Opin Cell Biol 2003; 15:247-54; PMID:12648682; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Nat Rev Mol Cell Biol 2007; 8:813-24;PMID:17848967; http://dx.doi.org/10.1038/nrm2256 [5] Halliwell B, Gutteridge J.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Antioxid Redox Signal 2011; 15:147-51;PMID:21375475; http://dx.doi.org/10.1089/ars.2011.3968 [7] Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular sig-naling.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Cell Signal 2012; 24:981-90; PMID:22286106;http://dx.doi.org/10.1016/j.cellsig.2012.01.008 [8] Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Nature1999; 401:79-82; PMID:10485709; http://dx.doi.org/10.1038/43459 [9] Lambeth JD, Neish AS.",Non-OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Annu RevPathol 2014; 9:119-45; PMID:24050626; http://dx.doi.org/10.1146/annurev-pathol-012513-104651 [10] Geiszt M, Kopp JB, V /C19arnai P, Leto TL.",Non-OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
Curr Biol 2010; 20:2131-6;PMID:21093262; http://dx.doi.org/10.1016/j.cub.2010.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
J CellBiol 2001; 154:879-91; PMID:11514595; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
AntioxidRedox Signal 2009; 11:1289-99; PMID:18999986; http://dx.doi.org/10.1089/ars.2008.2333 [16] Ushio-Fukai M. Localizing NADPH oxidase-derived ROS.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Nat Commun 2015; 6:8782;PMID:26621324; http://dx.doi.org/10.1038/ncomms9782 [18] Miller EW, Dickinson BC, Chang CJ.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Dev Biol 2010; 342:96-107; PMID:20380830;http://dx.doi.org/10.1016/j.ydbio.2010.03.026 [20] Yee C, Yang W, Hekimi S. The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Cell 2014; 157:897-909; PMID:24813612;http://dx.doi.org/10.1016/j.cell.2014.02.055 [21] Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, McKinney R, Poole LB, Fukai T, Ushio-Fukai M. Extra-cellular SOD-derived H2O2 promotes VEGF signaling incaveolae/lipid rafts and post-ischemic angiogenesis inmice.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"AntioxidRedox Signal 2011; 15:1583-606; PMID:21473702; http://dx.doi.org/10.1089/ars.2011.3999 [23] Madesh M, Hawkins BJ, Milovanova T, Bhanumathy CD, Joseph SK, Ramachandrarao SP, Sharma K, Kurosaki T,Fisher AB.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"J Cell Biol 2005; 170:1079-90; PMID:16186254;http://dx.doi.org/10.1083/jcb.200505022 [24] Bienert GP, Møller AL, Kristiansen KA, Schulz A, Møller IM, Schjoerring JK, Jahn TP.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"J Biol Chem 2007; 282:1183-92; PMID:17105724;http://dx.doi.org/10.1074/jbc.M603761200 [25] Dynowski M, Schaaf G, Loque D, Moran O, Ludewig U.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
Gene 2007; 398:132-42; PMID:17540514; http://dx.doi.org/10.1016/j.gene.2007.02.041e1184390-6 S. DE HENAU AND B. P. BRAECKMAN,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"PLoS One 2011; 6:e20478;PMID:21674044; http://dx.doi.org/10.1371/journal.pone.0020478 [28] Vinogradov SN, Moens L. Diversity of globin function: enzymatic, transport, storage, and sensing.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"J Biol Chem2008; 283:8773-7; PMID:18211906; http://dx.doi.org/10.1074/jbc.R700029200 [29] Hankeln T, Ebner B, Fuchs C, Gerlach F, Haberkamp M, Laufs TL, Roesner A, Schmidt M, Weich B, Wystub S,et al.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
J Inorg Biochem 2005; 99:110-9; PMID:15598495; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"AntioxidRedox Signal 2010; 13:1087-123; PMID:20170402; http://dx.doi.org/10.1089/ars.2009.2974 [33] Hoogewijs D, Geuens E, Dewilde S, Moens L, Vierstraete A, Vinogradov S, Van ﬂeteren J. Genome-wide analysis of the globin gene family of C. elegans.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"IUBMB Life 2004; 56:697-702; PMID:15804834; http://dx.doi.org/10.1080/ 15216540500037562 [34] Tilleman L, De Henau S, Pauwels M, Nagy N, Pintelon I, Braeckman BP, De Wael K, Van Doorslaer S, AdriaensenD, Timmermans JP, et al.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"PLoS One 2012;7:e48768; PMID:23251335; http://dx.doi.org/10.1371/ journal.pone.0048768 [35] Yoon J, Herzik MA, Jr., Winter MB, Tran R, Olea C, Jr., Marletta MA.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Biochemistry2010; 49:5662-70; PMID:20518498; http://dx.doi.org/10.1021/bi100710a [36] Tilleman L, Germani F, De Henau S, Geuens E, Hoogewijs D, Braeckman BP, Van ﬂeteren JR, Moens L, Dewilde S. Glo- bins in Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"IUBMB Life 2011; 63:166-74; PMID:21445847; http://dx.doi.org/10.1002/iub.443 [37] Hoogewijs D, De Henau S, Dewilde S, Moens L, Couv- reur M, Borgonie G, Vinogradov SN, Roy SW, Van ﬂete- ren JR.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"PLoS One 2011; 6:e25292; PMID:21949889; http://dx.doi.org/10.1371/journal.pone.0025292 [39] Hoffmann FG, Opazo JC, Hoogewijs D, Hankeln T, Ebner B, Vinogradov SN, Bailly X, Storz JF.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"Mol Biol Evol 2012; 29:1735-45; PMID:22319164; http://dx.doi.org/10.1093/molbev/mss018 [40] Ertas B, Kiger L, Blank M, Marden MC, Burmester T. A membrane-bound hemoglobin from gills of the greenshore crab Carcinus maenas.",OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
J Biol Chem 2011; 286: 3185-93; PMID:21118803; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"M110.160341 [41] Blank M, Burmester T. Widespread occurrence of N-ter- minal acylation in animal globins and possible origin ofrespiratory globins from a membrane-bound ancestor.Mol Biol Evol 2012; 29:3553-61; PMID:22718912; http://dx.doi.org/10.1093/molbev/mss164WORM e1184390-7",Non-OADS,/arxiv_data1/oa_pdf/3e/cf/kwrm-05-03-1184390.PMC5022669.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/9c/aww045.PMC5022671.pdf
"In a recent landmark clinical pilot study, NeuroVista and a team of Australian researchers implantedthis device in 15 patients with drug-resistant epilepsy (http://ClinicalTrials.gov, study NCT01043406), and achieved seizure forecasting sensitivity of 65–100% in 11patients during algorithm training, and eight patients pro-spectively after 4 months.",Non-OADS,/arxiv_data1/oa_pdf/71/9c/aww045.PMC5022671.pdf
"Data used in this competition as well as the source code for the top performing algorithms are freely available on theInternational IEEG Portal (http://ieeg.org), and the MayoSystems Electrophysiology Lab ftp site (http://msel.mayo.edu/data.html).",OADS,/arxiv_data1/oa_pdf/71/9c/aww045.PMC5022671.pdf
The algorithm was implemented in python using the scikit-learn toolkit (http://scikit-learn.org/stable/modules/svm.html.),OADS,/arxiv_data1/oa_pdf/71/9c/aww045.PMC5022671.pdf
Algorithms were coded in R (http://www.R-project.org) and used the APRIL-ANN machine learn- ing toolkit (.https://github.com/pakozm/april-ann).,OADS,/arxiv_data1/oa_pdf/71/9c/aww045.PMC5022671.pdf
"Making the data and algorithm source code from thepresent study freely available (http://ieeg.org and http://msel.mayo.edu/data.html), facilitates reproducibility and provides a benchmark for future algorithm development.",OADS,/arxiv_data1/oa_pdf/71/9c/aww045.PMC5022671.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s)(2016)",Non-OADS,/arxiv_data1/oa_pdf/c6/de/mtm201659.PMC5022796.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/ed/4e/mtm201660.PMC5022869.pdf
"First, we conducted a search of the  Kaplan-Meier plotter database (http://kmplot.com/analysis/) to systematically assess the expression level of the GPBAR1  gene  in gastric, breast, lung and ovarian cancer patients (21-23).",OADS,/arxiv_data1/oa_pdf/1b/da/or-36-04-1997.PMC5022870.pdf
"Second, a PrognoScan database (http://www.abren.net/PrognoScan/) analysis was conducted.",OADS,/arxiv_data1/oa_pdf/1b/da/or-36-04-1997.PMC5022870.pdf
The data were obtained from the Kaplan-Meier plotter database  (http://kmplot.com/analysis/).,OADS,/arxiv_data1/oa_pdf/1b/da/or-36-04-1997.PMC5022870.pdf
"Globocan 2012: Estimated Cancer Incidence, Mortality  and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.",Non-OADS,/arxiv_data1/oa_pdf/2b/55/or-36-04-1819.PMC5022899.pdf
2014.  http://www.accessdata.fda.gov/cdrh_docs/pdf12/P120020b.pdf.,OADS,/arxiv_data1/oa_pdf/8d/f9/10.1177_1526602816650206.PMC5023034.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/67/dc/10.1177_2325967116665589.PMC5023046.pdf
http://www.livestrong.com/article/70583-urinary-infection-can-cause-diarrhea/.,Non-OADS,/arxiv_data1/oa_pdf/56/2e/10.1177_2333794X16667175.PMC5023094.pdf
"Bimodality was assessed with Hartigan ’sd i pt e s t( 18), using an implementation of the algorithm downloaded from http://ringachlab.net/lab/Data.html.",OADS,/arxiv_data1/oa_pdf/28/fd/1600797.PMC5023317.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1600797/DC1 fig.,Non-OADS,/arxiv_data1/oa_pdf/28/fd/1600797.PMC5023317.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1600803/DC1Supplementary Textfig.,Non-OADS,/arxiv_data1/oa_pdf/ae/29/1600803.PMC5023319.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1501623/DC1 section S1.,Non-OADS,/arxiv_data1/oa_pdf/d8/c3/1501623.PMC5023320.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/   by-nc-sa/4.0/ © X Li et al.",Non-OADS,/arxiv_data1/oa_pdf/1c/f4/mt2016104a.PMC5023377.pdf
http://clinicaltrials.gov/show/NCT02312011.,Non-OADS,/arxiv_data1/oa_pdf/ce/24/mt2016111a.PMC5023379.pdf
17. http://www.gene-tools.com.,OADS,/arxiv_data1/oa_pdf/ce/24/mt2016111a.PMC5023379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/   by-nc-sa/4.0/ © J CJ Chen et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/24/mt2016111a.PMC5023379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © DD.",Non-OADS,/arxiv_data1/oa_pdf/33/7a/mt201693a.PMC5023384.pdf
http://ftp.jrc.es/EURdoc/  7.,Non-OADS,/arxiv_data1/oa_pdf/99/30/mt2016115a.PMC5023392.pdf
http://www.ondrugdelivery.com/publications/diabetes.pdf.,Non-OADS,/arxiv_data1/oa_pdf/99/30/mt2016115a.PMC5023392.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © CK Kwon and  and H Daniell (2016) 1350 www.moleculartherapy.org vol.",Non-OADS,/arxiv_data1/oa_pdf/99/30/mt2016115a.PMC5023392.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © S Downs-Canner et al.",Non-OADS,/arxiv_data1/oa_pdf/7f/0a/mt2016101a.PMC5023393.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © M Wang et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/4f/mtna201651a.PMC5023397.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/d0/4f/mtna201651a.PMC5023397.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © CF Bjurström et al.",Non-OADS,/arxiv_data1/oa_pdf/01/07/mtna201652a.PMC5023398.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/01/07/mtna201652a.PMC5023398.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © WH Thiel (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/3c/fb/mtna201654a.PMC5023399.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © T Khan et al.",Non-OADS,/arxiv_data1/oa_pdf/aa/13/mtna201655a.PMC5023400.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/aa/13/mtna201655a.PMC5023400.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © GS Romano et al.",Non-OADS,/arxiv_data1/oa_pdf/39/f5/mtna201656a.PMC5023401.pdf
(2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna),Non-OADS,/arxiv_data1/oa_pdf/39/f5/mtna201656a.PMC5023401.pdf
"We mapped the clean reads to the latest mouse reference  genome (ftp://ftp.Ensemble.org/pub/release-81/gtf/mus_musculus/), and the mapping rate was 70.72% and 83.55% in SAMP8 and SAMR1 mice, respectively.",OADS,/arxiv_data1/oa_pdf/c4/06/mtna201657a.PMC5023402.pdf
Paired-end  clean reads were mapped to the mouse genome sequence  (ftp://ftp.ensembl.org/pub/release-81/gtf/mus_musculus/) with TopHat v2.0.9.,OADS,/arxiv_data1/oa_pdf/c4/06/mtna201657a.PMC5023402.pdf
http://www.ninds.nih.gov/disorders/dementias/detail_ dementia.htm  6.,Non-OADS,/arxiv_data1/oa_pdf/c4/06/mtna201657a.PMC5023402.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/c4/06/mtna201657a.PMC5023402.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/90/06/mtna201658a.PMC5023403.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/18/a8/mtna201660a.PMC5023404.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/98/65/mtna201661a.PMC5023405.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/0e/50/mtna201662a.PMC5023406.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/a6/00/mtna201663a.PMC5023407.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/0f/95/mtna201665a.PMC5023408.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/a5/14/mtna201670a.PMC5023409.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/88/bd/mtna201672a.PMC5023410.pdf
"Analogous to the ‘reference case’ approach proposed by the US panel on cost-effectiveness on health and medicine[8], standardization can ensure the comparability of dif- ferent studies and therefore consistent decision making.Among currently available protocols, those developed by the EuroQol Group ( http://www.euroqol.org ) are the most widely studied and utilized.",Non-OADS,/arxiv_data1/oa_pdf/a7/13/40273_2016_Article_404.PMC5023738.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a7/13/40273_2016_Article_404.PMC5023738.pdf
http://www.euroqol.org/ uploads/media/EQ14-CH01_Shah.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a7/13/40273_2016_Article_404.PMC5023738.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/7b/a0/10029_2016_Article_1504.PMC5023741.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d3/0f/10029_2016_Article_1493.PMC5023748.pdf
http://cochrane-handbook.org 10.,OADS,/arxiv_data1/oa_pdf/d3/0f/10029_2016_Article_1493.PMC5023748.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), whichpermits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ab/5d/12630_2016_Article_706.PMC5023754.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published April 2013. http://www.nice.org.uk/article/pmg9/chapter/foreword .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published 2008. http://www.ispor.org/ PEguidelines/source/Australia-Guidelines-for-preparing-submissions-to-the-Pharmaceutical-Beneﬁts-Advisory-Committee-2008.,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
"Presented at ISPOR 18th Annual European Congress,Milan, Italy, November, 2015. http://www.ispor.org/Event/ GetReleasedPresentation/450 .",Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
"Publishedat ISPOR 18th Annual European Congress, Milan, Italy,November, 2015. http://www.ispor.org/research_pdfs/51/pdfﬁles/ PHP275.pdf .",Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published 2006. http://www.ispor.org/PEguidelines/ source/HTAGuidelinesfortheEconomicEvaluationofHealthTechnologies-Canada.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published Oct 2012. http://www.has-sante.fr/portail/ upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_evaluation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published Dec 2015. https://kce.fgov.be/sites/default/ﬁles/page_documents/KCE_183_economic_evaluations_ second_edition_Report3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published Sept 2007. https://kce.fgov.be/sites/default/ ﬁles/page_documents/kce_process_notes_hta.pdf .,OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published May 2003. http://www.tlv.se/ Upload/English/Guidelines-for-economic-evaluations-LFNAR-2003-2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Pub- lished Dec 2014. https://www.evidem.org/docs/2015/EVIDEM-v2- 4-Decision-criteria-conceptual-background-deﬁnitions-and-instructions-Dec-2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
2013. http://apps.who.int/medicinedocs/documents/ s21368en/s21368en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
http://www.england.nhs.,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Appendix E. https://www.google.,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
2016. https://www.nice.org.uk/ news/article/faster-access-to-effective-cancer-treatments-through- new-cancer-drugs-fund .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Revised Sept 2010. http://www.hqontario.ca/en/mas/tech/pdfs/ 2011/guide_decision.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Published Mar 2014. http://www.has- sante.fr/portail/upload/docs/application/pdf/2014-03/pricing_reimbursement_of_drugs_and_hta_policies_in_france.pdf .,Non-OADS,/arxiv_data1/oa_pdf/89/5f/40273_2016_Article_427.PMC5023755.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Association of germline-somatic variants in BRCA 760 www.bjcancer.com | DOI:10.1038/bjc.2016.223,Non-OADS,/arxiv_data1/oa_pdf/ed/7b/bjc2016223a.PMC5023771.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Urinary miRNAs in prostate cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.233 715,Non-OADS,/arxiv_data1/oa_pdf/33/c5/bjc2016233a.PMC5023772.pdf
TCGA Research Network (http://cancergenome.nih.gov/) is acknowledged for providing access to their data.,OADS,/arxiv_data1/oa_pdf/85/c9/bjc2016234a.PMC5023773.pdf
Available from http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/a6/3b/bjc2016237a.PMC5023776.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Genome-wide measures of DNA methylation and risk of UCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.237 673,Non-OADS,/arxiv_data1/oa_pdf/a6/3b/bjc2016237a.PMC5023776.pdf
The inhibition of mTOR kinase activity at 10 mMATP was measured by TR-FRET according to the manufacturer’s instructions (http://tools.invitrogen.com/Content/SFS/lanthascreen/ PV4753%20FRAP1%20Assay%20Validation.pdf).,OADS,/arxiv_data1/oa_pdf/dd/60/bjc2016238a.PMC5023777.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Dual PI3K/CDK2 inhibition enhances antitumour activity 690 www.bjcancer.com | DOI:10.1038/bjc.2016.238,Non-OADS,/arxiv_data1/oa_pdf/dd/60/bjc2016238a.PMC5023777.pdf
These analyses were conducted according to the protocol provided by KeyGen Biotech (http://www.keygentec.com.cn).,OADS,/arxiv_data1/oa_pdf/8a/7a/bjc2016244a.PMC5023779.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER miR-23a regulates the IKK a-NF-kB and ST7L-WNT/MAPK pathways 740 www.bjcancer.com | DOI:10.1038/bjc.2016.244,Non-OADS,/arxiv_data1/oa_pdf/8a/7a/bjc2016244a.PMC5023779.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Loss of SLCO1B3 drives taxane resistance BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.251 681,Non-OADS,/arxiv_data1/oa_pdf/22/26/bjc2016251a.PMC5023781.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Nodal regression in gastric cancer patients BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.252 663,Non-OADS,/arxiv_data1/oa_pdf/da/9b/bjc2016252a.PMC5023782.pdf
Available from: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/98/38/bjc2016254a.PMC5023783.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Fertility preservation in epithelial ovarian cancer patients 648 www.bjcancer.com | DOI:10.1038/bjc.2016.254,Non-OADS,/arxiv_data1/oa_pdf/98/38/bjc2016254a.PMC5023783.pdf
The figures were created using images provided by pubchem and Servier Medical Art (http://www.servier.co.uk/content/servier-medical-art).,Non-OADS,/arxiv_data1/oa_pdf/c2/6e/bjc2016256a.PMC5023784.pdf
"To screen multiple EDS genes and otherknown disease-associated genes, we ﬁrst performed TES for the proband by using a TruSight One Sequencing Panel (Illumina, San Diego, CA, USA) and MiSeq benchtop sequencer (Illumina) with our pipeline for NGS data analysis, as described previously.9,10To identify presumably pathogenic single-nucleotide variants, weexcluded minor sequence variants with relatively high-allele frequencies, i.e., 40.01, included in the 1000 Genomes Project database (http://www.1000genomes.org/), NHLBI GO ExomeSequencing Project (ESP6500, http://evs.gs.washington.edu/EVS/),Human Genetic Variation Database 11(HGVD, http://www.genome.",OADS,/arxiv_data1/oa_pdf/b9/13/hgv201630.PMC5023785.pdf
"med.kyoto-u.ac.jp/SnpDB/) and Integrative Japanese Genome Variation Database12(iJGVD, https://ijgvd.megabank.tohoku.ac.jp/).",OADS,/arxiv_data1/oa_pdf/b9/13/hgv201630.PMC5023785.pdf
"This mutation is not present in human genome variation databases, such as dbSNP138, 1000 Genomes Project, ESP6500, HGVD and iJGVD, or in disease-causing mutation databases, suchas the Human Gene Mutation Database Professional 2016.1(HGMD, http://www.hgmd.org/), Leiden Open Variation Database (LOVD, https://eds.gene.le.ac.uk/home.php?select_db = COL5A2) and ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/).",Non-OADS,/arxiv_data1/oa_pdf/b9/13/hgv201630.PMC5023785.pdf
"Through in silico analysis using LJB23 databases for non-synonymous variant annotation in ANNOVAR(http://annovar.openbioinformatics.org/en/latest/), this mutation was predicted to damage protein function, i.e., SIFT score = 0,PolyPhen-2 score = 1 and MutationTaster score = 1.",OADS,/arxiv_data1/oa_pdf/b9/13/hgv201630.PMC5023785.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/b9/13/hgv201630.PMC5023785.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2016Novel COL5A2 mutation in Ehlers –Danlos syndrome M Watanabe et al 3 Ofﬁcial journal of the Japan Society of Human Genetics Human Genome Variation (2016) 16030",Non-OADS,/arxiv_data1/oa_pdf/b9/13/hgv201630.PMC5023785.pdf
"c.830G 4A was not registered in the healthy control database in dbSNP (http://www.ncbi.nlm.nih.gov/snp), the Human Genetic Variation Database (http://www.genome.med.kyoto-u.ac.jp/SnpDB/) or ExAC(http://exac.broadinstitute.org/).",Non-OADS,/arxiv_data1/oa_pdf/4c/b6/hgv201629.PMC5023786.pdf
"Moreover, p.Arg277His was foundto be a pathogenic amino-acid change through use of the functionalprediction websites PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/), SIFT (http://sift.jcvi.org/) and Mutation Taster (http://www.mutationtaster.org/).",OADS,/arxiv_data1/oa_pdf/4c/b6/hgv201629.PMC5023786.pdf
"Although one healthy control sample (nsv826262) in the database of genomic variants (http://dgv.tcag.ca/dgv/app/home)9carried a small deletionincluding GRIN2B exon 4, we concluded that the GRIN2B mutations have a central role in the phenotype of this patient.",Non-OADS,/arxiv_data1/oa_pdf/4c/b6/hgv201629.PMC5023786.pdf
HGV DATABASE The relevant data from this Data Report are hosted at the Human Genome Variation Database at http://dx.doi.org/10.6084/m9.,OADS,/arxiv_data1/oa_pdf/4c/b6/hgv201629.PMC5023786.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Vitamin D in early spontaneous pregnancy loss W Hou et al 1008 European Journal of Clinical Nutrition (2016) 1004 –1008 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/8c/43/ejcn201683a.PMC5023787.pdf
Medicine (2016) 95:36(e4345)Received: 4 April 2016 / Received in ﬁnal form: 23 June 2016 / Accepted: 25 June 2016 http://dx.doi.org/10.1097/MD.0000000000004345Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e5/97/medi-95-e4345.PMC5023856.pdf
Medicine (2016) 95:36(e4357)Received: 29 February 2016 / Received in ﬁnal form: 4 July 2016 / Accepted: 4 July 2016 http://dx.doi.org/10.1097/MD.0000000000004357Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7d/c6/medi-95-e4357.PMC5023857.pdf
Medicine (2016) 95:36(e4393)Received: 9 May 2016 / Received in ﬁnal form: 6 July 2016 / Accepted: 6 July 2016 http://dx.doi.org/10.1097/MD.0000000000004393Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/bf/8f/medi-95-e4393.PMC5023858.pdf
Medicine (2016) 95:36(e4522)Received: 2 March 2016 / Received in ﬁnal form: 14 July 2016 / Accepted: 14 July 2016 http://dx.doi.org/10.1097/MD.0000000000004522Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/39/27/medi-95-e4522.PMC5023864.pdf
Medicine (2016) 95:36(e4526)Received: 24 October 2015 / Received in ﬁnal form: 10 June 2016 / Accepted: 15 July 2016 http://dx.doi.org/10.1097/MD.0000000000004526Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fe/90/medi-95-e4526.PMC5023865.pdf
Medicine (2016) 95:36(e4542)Received: 29 April 2016 / Received in ﬁnal form: 5 July 2016 / Accepted: 14 July 2016 http://dx.doi.org/10.1097/MD.0000000000004542Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/23/94/medi-95-e4542.PMC5023866.pdf
"The duration of CRRT (3.94 [3.21 –5.18] vs 3.91 [1.81 –8.99], P=0.003) and hospital stay (34.53 [19.40 –70.16] vs 6.20 [2.33 –19.74], P<0.001) were signi ﬁcant- ly longer in survivors than in nonsurvivors (SupplementaryTable 1, http://links.lww.com/MD/B261).",Non-OADS,/arxiv_data1/oa_pdf/23/94/medi-95-e4542.PMC5023866.pdf
"In addition, the serum levels of these parameters at 0hour did not differ between survivors andnonsurvivors (Supplementary Table 3, http://links.lww.com/MD/ B261).",Non-OADS,/arxiv_data1/oa_pdf/23/94/medi-95-e4542.PMC5023866.pdf
"This pattern was consistent when analyzed by using phosphate levels at 24hours(3.42±1.37mg/dL vs 4.21 ±1.84mg/dL, P=0.01) (Supplementary Table 3, http://links.lww.com/MD/B 261).",OADS,/arxiv_data1/oa_pdf/23/94/medi-95-e4542.PMC5023866.pdf
"Most baseline characteristics were comparable between groups before CRRT initiation (Supplementary Table 5, http://links.lww.com/MD/B261).",OADS,/arxiv_data1/oa_pdf/23/94/medi-95-e4542.PMC5023866.pdf
"Next, patients were classi ﬁed into 3 groups according to deﬁcient, normal, and excess phosphate levels at 24hours after CRRT (Supplementary Table 6, http://links.lww.com/MD/B261).The hyperphosphatemic group was younger ( P=0.18), had higher BMI ( P=0.01) and SOFA score ( P<0.001), and had lower MAP (P=0.002).",Non-OADS,/arxiv_data1/oa_pdf/23/94/medi-95-e4542.PMC5023866.pdf
Medicine (2016) 95:36(e4546)Received: 10 January 2016 / Received in ﬁnal form: 20 June 2016 / Accepted: 15 July 2016 http://dx.doi.org/10.1097/MD.0000000000004546Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/08/b9/medi-95-e4546.PMC5023867.pdf
Medicine (2016) 95:36(e4557)Received: 29 June 2016 / Received in ﬁnal form: 14 July 2016 / Accepted: 15 July 2016 http://dx.doi.org/10.1097/MD.0000000000004557Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2d/7d/medi-95-e4557.PMC5023868.pdf
"2006, Aug 9. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf.",Non-OADS,/arxiv_data1/oa_pdf/2d/7d/medi-95-e4557.PMC5023868.pdf
Medicine (2016) 95:36(e4585)Received: 8 November 2015 / Received in ﬁnal form: 8 March 2016 / Accepted: 21 July 2016 http://dx.doi.org/10.1097/MD.0000000000004585Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5d/6a/medi-95-e4585.PMC5023870.pdf
Medicine (2016) 95:36(e4603)Received: 7 May 2016 / Received in ﬁnal form: 3 July 2016 / Accepted: 20 July 2016 http://dx.doi.org/10.1097/MD.0000000000004603Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/77/51/medi-95-e4603.PMC5023872.pdf
Medicine (2016) 95:36(e4604)Received: 28 March 2016 / Received in ﬁnal form: 9 July 2016 / Accepted: 21 July 2016 http://dx.doi.org/10.1097/MD.0000000000004604Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/medi-95-e4604.PMC5023873.pdf
Medicine (2016) 95:36(e4625)Received: 23 May 2016 / Received in ﬁnal form: 21 July 2016 / Accepted: 27 July 2016 http://dx.doi.org/10.1097/MD.0000000000004625Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/b1/medi-95-e4625.PMC5023875.pdf
This correction was conﬁned within the brain gray matter and determined by the Monte Carlo simulations performed by the AlphaSim program in the REST toolkit (http://sourceforge.net/projects/resting-fmri).,OADS,/arxiv_data1/oa_pdf/ae/b1/medi-95-e4625.PMC5023875.pdf
Medicine (2016) 95:36(e4628)Received: 8 January 2016 / Received in ﬁnal form: 11 July 2016 / Accepted: 28 July 2016 http://dx.doi.org/10.1097/MD.0000000000004628Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a1/90/medi-95-e4628.PMC5023876.pdf
Medicine (2016) 95:36(e4639)Received: 18 September 2015 / Received in ﬁnal form: 28 July 2016 / Accepted: 1 August 2016 http://dx.doi.org/10.1097/MD.0000000000004639Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/81/9a/medi-95-e4639.PMC5023877.pdf
Medicine (2016) 95:36(e4655)Received: 29 October 2015 / Received in ﬁnal form: 20 July 2016 / Accepted: 23 July 2016 http://dx.doi.org/10.1097/MD.0000000000004655Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/73/84/medi-95-e4655.PMC5023880.pdf
Medicine (2016) 95:36(e4663)Received: 16 February 2016 / Received in ﬁnal form: 11 May 2016 / Accepted: 1 August 2016 http://dx.doi.org/10.1097/MD.0000000000004663Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f2/00/medi-95-e4663.PMC5023881.pdf
Medicine (2016) 95:36(e4685)Received: 10 March 2016 / Received in ﬁnal form: 8 July 2016 / Accepted: 3 August 2016 http://dx.doi.org/10.1097/MD.0000000000004685Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a3/e5/medi-95-e4685.PMC5023884.pdf
Medicine (2016) 95:36(e4697)Received: 26 April 2016 / Received in ﬁnal form: 10 July 2016 / Accepted: 2 August 2016 http://dx.doi.org/10.1097/MD.0000000000004697Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/33/3e/medi-95-e4697.PMC5023887.pdf
Medicine (2016) 95:36(e4710)Received: 29 May 2016 / Received in ﬁnal form: 23 July 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004710Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cb/27/medi-95-e4710.PMC5023888.pdf
Medicine (2016) 95:36(e4712)Received: 11 December 2015 / Received in ﬁnal form: 19 July 2016 / Accepted: 4 August 2016 http://dx.doi.org/10.1097/MD.0000000000004712Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/eb/40/medi-95-e4712.PMC5023889.pdf
Medicine (2016) 95:36(e4732)Received: 30 June 2016 / Received in ﬁnal form: 5 August 2016 / Accepted: 8 August 2016 http://dx.doi.org/10.1097/MD.0000000000004732Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b1/19/medi-95-e4732.PMC5023892.pdf
Available from: http://www.sdu.dk/om_sdu/institutter_centre/ klinisk_institut/forskning/forskningsenheder/open.,Non-OADS,/arxiv_data1/oa_pdf/b1/19/medi-95-e4732.PMC5023892.pdf
Available from: http://dccg.dk/retningslinjer/august2014/2014_screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/19/medi-95-e4732.PMC5023892.pdf
Medicine (2016) 95:36(e4733)Received: 11 April 2016 / Received in ﬁnal form: 29 June 2016 / Accepted: 7 August 2016 http://dx.doi.org/10.1097/MD.0000000000004733Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e4/54/medi-95-e4733.PMC5023893.pdf
Medicine (2016) 95:36(e4741)Received: 11 May 2016 / Received in ﬁnal form: 4 August 2016 / Accepted: 6 August 2016 http://dx.doi.org/10.1097/MD.0000000000004741Diagnostic Accuracy Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/08/23/medi-95-e4741.PMC5023894.pdf
Medicine (2016) 95:36(e4755)Received: 3 May 2016 / Received in ﬁnal form: 29 July 2016 / Accepted: 9 August 2016 http://dx.doi.org/10.1097/MD.0000000000004755Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/c0/ec/medi-95-e4755.PMC5023895.pdf
Medicine (2016) 95:36(e4758)Received: 24 February 2016 / Received in ﬁnal form: 4 August 2016 / Accepted: 9 August 2016 http://dx.doi.org/10.1097/MD.0000000000004758Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
"The Supplemental Table (Supplemental Content 2,http://links.lww.com/MD/B251) shows participant character- istics by hypertension awareness, treatment, and control.",Non-OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
"This means that approximately 69,000 residents of Luxembourg, aged 25 to 64 years, may be unawarethat they are suffering from hypertension or are not suf ﬁciently controlled (see Figure, Supplemental Content 3, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
Available at: http://www.who.int/nmh/publications/ncd-status-report-2014/en/.,Non-OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
Available at: http://www.sante.public.lu/fr/publications/s/statistiques-causes-deces-2013/index.html.,Non-OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
Available at: http://www.who.int/countries/lux/en/.,Non-OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
"[25] Belitz C, Brezger A, Kneib T, Lang S. BayesX Software for Bayesian Inference in Structured Additive Regression Models Version 2.0.1, 2012.Available at: http://www.stat.uni-muenchen.de/ ∼bayesx/manual/meth odology_manual.pdf.",OADS,/arxiv_data1/oa_pdf/04/44/medi-95-e4758.PMC5023897.pdf
Medicine (2016) 95:36(e4759)Received: 24 March 2016 / Received in ﬁnal form: 24 July 2016 / Accepted: 8 August 2016 http://dx.doi.org/10.1097/MD.0000000000004759Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/dd/e3/medi-95-e4759.PMC5023898.pdf
Medicine (2016) 95:36(e4771)Received: 11 July 2016 / Received in ﬁnal form: 9 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004771Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/01/e6/medi-95-e4771.PMC5023899.pdf
†Opioid Conversion Ratios —Guide to Practice 2010 http://www.medicalcriteria.com/site/en/criteria/ 67-oncology/259-oncop.html.Table 1 Patient characteristics and hospital stay after operation.,Non-OADS,/arxiv_data1/oa_pdf/01/e6/medi-95-e4771.PMC5023899.pdf
Medicine (2016) 95:36(e4780)Received: 20 November 2015 / Received in ﬁnal form: 3 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004780Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b1/0a/medi-95-e4780.PMC5023903.pdf
Medicine (2016) 95:36(e4782)Received: 3 March 2016 / Received in ﬁnal form: 9 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004782Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0d/e4/medi-95-e4782.PMC5023904.pdf
Medicine (2016) 95:36(e4784)Received: 29 May 2016 / Received in ﬁnal form: 10 August 2016 / Accepted: 11 August 2016 http://dx.doi.org/10.1097/MD.0000000000004784Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b3/37/medi-95-e4784.PMC5023905.pdf
Available at: http://hcupnet.ahrq.gov/HCUPnet.jsp.,OADS,/arxiv_data1/oa_pdf/b3/37/medi-95-e4784.PMC5023905.pdf
Availableat: http://innovation.cms.gov/initiatives/bundled-payments/.,OADS,/arxiv_data1/oa_pdf/b3/37/medi-95-e4784.PMC5023905.pdf
Availableat: https://www.federalregister.gov/articles/2015/07/14/2015-17190/medicare-program-comprehensive-care-for-joint-replacement-payment- model-for-acute-care-hospitals.,Non-OADS,/arxiv_data1/oa_pdf/b3/37/medi-95-e4784.PMC5023905.pdf
"Available at: http://kaiserhealthnews.org/news/medicare-readmissions-penalties-2015/.Accessed October 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b3/37/medi-95-e4784.PMC5023905.pdf
Medicine (2016) 95:36(e4787)Received: 1 September 2015 / Received in ﬁnal form: 7 August 2016 / Accepted: 13 August 2016 http://dx.doi.org/10.1097/MD.0000000000004787Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a8/13/medi-95-e4787.PMC5023906.pdf
Medicine (2016) 95:36(e4791)Received: 29 March 2016 / Received in ﬁnal form: 30 July 2016 / Accepted: 12 August 2016 http://dx.doi.org/10.1097/MD.0000000000004791Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/95/56/medi-95-e4791.PMC5023907.pdf
Available: http://wwwn.cdc.gov/nchs/nhanes/search/nhanes99_00.aspx.,OADS,/arxiv_data1/oa_pdf/95/56/medi-95-e4791.PMC5023907.pdf
Available: http://wwwn.cdc.gov/nchs/nhanes/search/nhanes01_02.aspx.,OADS,/arxiv_data1/oa_pdf/95/56/medi-95-e4791.PMC5023907.pdf
Medicine (2016) 95:36(e4799)Received: 30 June 2016 / Received in ﬁnal form: 5 August 2016 / Accepted: 15 August 2016 http://dx.doi.org/10.1097/MD.0000000000004799Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f1/6b/medi-95-e4799.PMC5023912.pdf
Medicine (2016) 95:36(e4800)Received: 18 May 2016 / Received in ﬁnal form: 5 August 2016 / Accepted: 15 August 2016 http://dx.doi.org/10.1097/MD.0000000000004800Meta-Analysis of Observational Studies in Epidemiology Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/34/ab/medi-95-e4800.PMC5023913.pdf
Medicine (2016) 95:36(e4802)Received: 13 May 2016 / Received in ﬁnal form: 11 August 2016 / Accepted: 12 August 2016 http://dx.doi.org/10.1097/MD.0000000000004802Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a9/29/medi-95-e4802.PMC5023914.pdf
"Available at: http://www.va.gov/health/docs/HospitalReportCard2010.pdf AccessedAugust 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/a9/29/medi-95-e4802.PMC5023914.pdf
"Available at: http://www.wehonorveterans.org/va-veteran-organizations/about-va/healthcare-working-va. Accessed August 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/a9/29/medi-95-e4802.PMC5023914.pdf
Medicine (2016) 95:36(e4803)Received: 22 March 2016 / Received in ﬁnal form: 5 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004803Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b6/2a/medi-95-e4803.PMC5023915.pdf
The study is registered at http://www.clinicaltrials.gov with identi ﬁer NCT01705210.,Non-OADS,/arxiv_data1/oa_pdf/b6/2a/medi-95-e4803.PMC5023915.pdf
Medicine (2016) 95:36(e4804)Received: 13 April 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004804Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1d/8c/medi-95-e4804.PMC5023916.pdf
Medicine (2016) 95:36(e4806)Received: 29 April 2016 / Received in ﬁnal form: 30 July 2016 / Accepted: 11 August 2016 http://dx.doi.org/10.1097/MD.0000000000004806Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ee/9e/medi-95-e4806.PMC5023917.pdf
"The relationship between subjectsdeﬁned with MetS compared to the 3 non-MetS subgroups was also analyzed using a Kruskal –Wallis test (Supplemental Digital Content 1, http://links.lww.com/MD/B253).",OADS,/arxiv_data1/oa_pdf/ee/9e/medi-95-e4806.PMC5023917.pdf
Medicine (2016) 95:36(e4807)Received: 26 July 2016 / Received in ﬁnal form: 10 August 2016 / Accepted: 11 August 2016 http://dx.doi.org/10.1097/MD.0000000000004807Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9a/e6/medi-95-e4807.PMC5023918.pdf
Medicine (2016) 95:36(e4817)Received: 22 March 2016 / Received in ﬁnal form: 16 August 2016 / Accepted: 17 August 2016 http://dx.doi.org/10.1097/MD.0000000000004817Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/71/61/medi-95-e4817.PMC5023920.pdf
Medicine (2016) 95:36(e4828)Received: 20 May 2016 / Received in ﬁnal form: 3 August 2016 / Accepted: 18 August 2016 http://dx.doi.org/10.1097/MD.0000000000004828Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b1/33/medi-95-e4828.PMC5023921.pdf
Medicine (2016) 95:36(e4829)Received: 5 May 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 18 August 2016 http://dx.doi.org/10.1097/MD.0000000000004829Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5a/59/medi-95-e4829.PMC5023922.pdf
Medicine (2016) 95:36(e4832)Received: 1 May 2016 / Received in ﬁnal form: 27 July 2016 / Accepted: 16 August 2016 http://dx.doi.org/10.1097/MD.0000000000004832Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/85/e9/medi-95-e4832.PMC5023923.pdf
Medicine (2016) 95:36(e4838)Received: 21 April 2016 / Received in ﬁnal form: 4 August 2016 / Accepted: 11 August 2016 http://dx.doi.org/10.1097/MD.0000000000004838Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ee/01/medi-95-e4838.PMC5023924.pdf
Medicine (2016) 95:36(e4844)Received: 13 April 2016 / Received in ﬁnal form: 9 August 2016 / Accepted: 10 August 2016 http://dx.doi.org/10.1097/MD.0000000000004844Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/cf/42/medi-95-e4844.PMC5023926.pdf
"In Cox proportional hazards analysis, the NC value was a signi ﬁcant risk factor for incident CKD events in the female sex group (per 1cm increase, hazard ratio[HR]=1.159, con ﬁdence interval [CI] =1.024 –1.310, P=0.019) even after adjusting for confounding factors, whereas the relationship between the NC value and incident CKD eventswas not signi ﬁcant in male subjects (per 1cm increase, HR =0.989, CI=0.887 –1.103, P=0.841) (Table 3, Supplementary Tables 1 and 2, http://links.lww.com/MD/B258).",OADS,/arxiv_data1/oa_pdf/cf/42/medi-95-e4844.PMC5023926.pdf
Medicine (2016) 95:36(e4845)Received: 25 April 2016 / Received in ﬁnal form: 12 August 2016 / Accepted: 17 August 2016 http://dx.doi.org/10.1097/MD.0000000000004845Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/5c/af/medi-95-e4845.PMC5023927.pdf
Available at: http://hand-book.cochrane.org/Accessed January 2016.,Non-OADS,/arxiv_data1/oa_pdf/5c/af/medi-95-e4845.PMC5023927.pdf
Availableat: http://hand-book.cochrane.org/Accessed January 2016.,Non-OADS,/arxiv_data1/oa_pdf/5c/af/medi-95-e4845.PMC5023927.pdf
synonymous muta- tions) (see http://snpeff.sourceforge.net for details).,Non-OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
"Because TOMJPE6018_1 indeed possesses abnor- mal leaf morphology (http://tomatoma.nbrp.jp/strainDetail Action.do?mutantNo=982), the Solyc08g065910 gene is a highly likely candidate gene for this mutant phenotype.",Non-OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
"To facilitate mutant studies of Micro-Tom, the polymorphism data from this study, as well as the induced mutation data for the mutant lines, were released in the Kazusa Tomato Genomic DataBase (KaTomicsDB: http://www.kazusa.or.jp/tomato).",OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
photographs of the lines are available at the TOMATOMA database (http://tomatoma.nbrp.jp).,Non-OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
"Identiﬁcation of SNVs and CNVs The sequence reads were trimmed with fastq_quality_ﬁlter (-q 10 -p 10), fastq_quality_trimmer (-t 10 -l 250 for the MiSeq reads or101 for the HiSeq reads), fastx_artifacts_ﬁlter, and fastx_clipper (-a AGATCGGAAGAGC -l 250 or 101 -M 10 -n) in FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit; version 0.10.1), and the ﬁltered reads were mapped onto the tomato reference genomesequence (SL2.40) with Bowtie 2 (Langmead and Salzberg, 2012; version 2.1.0; parameters of --minins 100 --no-mixed -k 2).",OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
", 2012: http://plants.ensembl.org) were used.",OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
", 2014; DRR000741, ERR340383 and ERR340384) were obtained from the DDBJ Sequence Read Archive (http://trace.ddbj.nig.ac.jp/dra), and the data were pro-cessed using the same methods described above.",OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
", 2013; http://www.kazusa.or.jp/tomato) and Sol Genom- ics Network (Mueller et al.",OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
", 2005; http://www.sgn.cornell.edu).",Non-OADS,/arxiv_data1/oa_pdf/9c/3e/PBI-14-51.PMC5023996.pdf
Available at: http://www.sigmaaldrich.com/content/dam/ sigma-aldrich/docs/Sigma/Product_Information_Sheet/1/p5188pis.pdf.,OADS,/arxiv_data1/oa_pdf/e4/16/JBM-104-67.PMC5024005.pdf
Available at: http://www.juntadeand- alucia.es/servicioandaluzdesalud/principal/documentosacc.,Non-OADS,/arxiv_data1/oa_pdf/34/4b/ANE-132-111.PMC5024007.pdf
Available at: http://www.ine.es/inebm-enu/mnu_cifraspob.htm (accessed 19 December 2012).,Non-OADS,/arxiv_data1/oa_pdf/34/4b/ANE-132-111.PMC5024007.pdf
Available at: https://www.pharma.us.novar- tis.com/product/pi/pdf/neoral.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/8d/AJT-15-1313.PMC5024008.pdf
Available at: http://www.rxabbvie.com/pdf/ norvirtab_pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/8d/AJT-15-1313.PMC5024008.pdf
Available at:http://www.informedhorizons.com/hepdart2009/pdf/AbstractBook_ HEPDART09_sent.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/8d/AJT-15-1313.PMC5024008.pdf
Details onthe clinical characteristics of the patients are available athttp://discovery.ucl.ac.uk/1456634/.,Non-OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
"No signifi- cant difference between CD73 surface and total (surfaceplus intracellular) protein expression on SF CD8 /H11001 T cells was observed, showing that protein retentioninside the cell does not explain the reduced CD73expression on JIA synovial lymphocytes (representativeresults from fluorescence-activated cell sorter analysisand summary data are available at http://discovery.ucl.ac.uk/1456634/).",OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
CD26 expressionwas also reduced on SFMCs from JIA patients com-pared to paired PBMCs from JIA patients and PBMCsfrom healthy controls (results available at http://discovery.ucl.ac.uk/1456634/).,Non-OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
"In addition, low frequencies of CD19 /H11001B cells were found in SF samples compared to paired PBsamples from JIA patients (results available at http://discovery.ucl.ac.uk/1456634/).The difference in expression of CD73 on SF CD8/H11001T cells and SF CD19 /H11001B cells between patients with persistent oligoarticular JIA and those with ex-tended oligoarticular JIA was not simply due to thelonger disease duration of those with the more severedisease.",Non-OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
"Neither granulocytes(CD66B /H11001) nor monocytes (CD14 /H11001) were found to express CD73 in these samples, although both CD3 /H11001 and CD19 /H11001lymphocytes isolated from the inflamed SF showed a reduction in CD73 expression when comparedto that in the PB (results available at http://discovery.ucl.ac.uk/1456634/).",Non-OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
"Furthermore, CD73 expression was de-creased when PBMCs were cultured with anti-CD3 mAbalone, showing that costimulation was not required toachieve this down-regulation (results available at http://discovery.ucl.ac.uk/1456634/).",Non-OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
"Contrary to the findings inmurine Treg cells (15), human Treg cells from healthydonor PB and JIA patient PB or SF did not coexpressCD39 and CD73 (results available at http://discovery.ucl.ac.uk/1456634/).",Non-OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
All of these results are available athttp://discovery.ucl.ac.uk/1456634/.,OADS,/arxiv_data1/oa_pdf/82/b5/ART-67-545.PMC5024010.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000332/WC500026149.pdf [15 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/b6/56/PDS-24-414.PMC5024014.pdf
Registration number: NCT00149266 (https://www.clinicaltrials.gov).,Non-OADS,/arxiv_data1/oa_pdf/c8/cf/BJS-102-341.PMC5024022.pdf
"http://www.who int/ features/factﬁles/diabetes/facts/en/index7.html(accessed February 18, 2014).",Non-OADS,/arxiv_data1/oa_pdf/25/bf/IJCP-69-292.PMC5024024.pdf
http://bit.ly/Diabetes0412.,Non-OADS,/arxiv_data1/oa_pdf/25/bf/IJCP-69-292.PMC5024024.pdf
Available at: https://usatrade.census.gov (Achived at: http://www .webcitation.org/6Vse6sZN7 on 26 January 2015).59.,OADS,/arxiv_data1/oa_pdf/59/21/ADD-110-805.PMC5024027.pdf
Available at: http:// www.emcdda.europa.eu/stats12#display:/stats12/szrtab10a(Achived at: http://www.webcitation.org/6Vo6RU74V on 23 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/59/21/ADD-110-805.PMC5024027.pdf
Gen-eReviewsTM [Internet] http://www.ncbi.nlm.nih.gov/books/NBK1434/.,Non-OADS,/arxiv_data1/oa_pdf/46/f8/DNEU-75-1219.PMC5024031.pdf
"Hereditary Hearing Loss Homepage, http://hereditaryhearingloss.org/.",Non-OADS,/arxiv_data1/oa_pdf/46/f8/DNEU-75-1219.PMC5024031.pdf
"Adverse events (AEs) were graded according to the National Cancer Insti-tute’s Common Terminology Criteria for AEs version 4 /C10 (http://evs.nci.nih.gov/ftp1/CTCAE/Archive/CTCAE_4.02_2009-09-15_QuickReference_8.5x11.pdf), and were sum- marized according to the Medical Dictionary for Regulatory Activities System Organ Class and preferred terms.",OADS,/arxiv_data1/oa_pdf/54/00/BJH-169-672.PMC5024033.pdf
include a widely accessed online multimedia tool designed for neonatal EEG application and monitoring(http://www.nemo-europe.com/ en/educational-tools-for- clinicians-and-health-care-professionals.php).,Non-OADS,/arxiv_data1/oa_pdf/50/45/APA-104-152.PMC5024034.pdf
"The Bayesian inference programme MrBayes 3.2.0 (http://mrbayes.sourceforge.net/ index.php) was used togenerate the phylogenetic tree using Markov chainMonte Carlo coupling (MCMC; Ronquist, 2012).",OADS,/arxiv_data1/oa_pdf/fe/1d/JMP-44-125.PMC5024038.pdf
"Institute of Evolutionary Biology, University ofEdinburgh, 2009; http://tree.bio.ed.ac.uk/software/ﬁgtree/.",Non-OADS,/arxiv_data1/oa_pdf/fe/1d/JMP-44-125.PMC5024038.pdf
Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000012.pub4/full.,Non-OADS,/arxiv_data1/oa_pdf/7a/4a/BIRT-42-141.PMC5024040.pdf
"Accessed December 12, 2014.Available at: https://www.rcm.org.uk/sites/default/ ﬁles/FMU%20Trends %20-%20Web%20Final.pdf Trends - Web Final.pdf 20.",Non-OADS,/arxiv_data1/oa_pdf/7a/4a/BIRT-42-141.PMC5024040.pdf
Available at: http://www.parliament.uk/brief-ing-papers/POST-PN-184/caesarean-sections-october-2002 27.,Non-OADS,/arxiv_data1/oa_pdf/7a/4a/BIRT-42-141.PMC5024040.pdf
"Accessed December 12, 2014.Available at: http://www.qsrinternational.com/products_previous-products_nvivo8.aspx.",Non-OADS,/arxiv_data1/oa_pdf/7a/4a/BIRT-42-141.PMC5024040.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/18394766.,Non-OADS,/arxiv_data1/oa_pdf/7a/4a/BIRT-42-141.PMC5024040.pdf
Available at: http://www.imi-protect.eu/wp3.shtml [25 Nov 2012].,Non-OADS,/arxiv_data1/oa_pdf/f2/86/PDS-24-486.PMC5024044.pdf
GI Motility Online 2006. http://www.nature.com/gimo/contents/pt1/full/ gimo2.html (accessed 09/26/2014).,OADS,/arxiv_data1/oa_pdf/37/ca/ENE-22-1260.PMC5024045.pdf
http://ir.cyberon- ics.com/annuals.cfm (accessed 03/05/2014).,OADS,/arxiv_data1/oa_pdf/37/ca/ENE-22-1260.PMC5024045.pdf
"Houston, TX: Cyberonics Inc., 2013. http://dynamic.cyberonics.com/ manuals/ (accessed 01/05/2015).",Non-OADS,/arxiv_data1/oa_pdf/37/ca/ENE-22-1260.PMC5024045.pdf
http://www.biocontrol-medical.com/health_pros.php?ID=23 (accessed 02/10/2014).,Non-OADS,/arxiv_data1/oa_pdf/37/ca/ENE-22-1260.PMC5024045.pdf
http://cerbomed.com/upload/Brochure_Epi- lepsy_Patients_EN.pdf (accessed 01/29/2014).,Non-OADS,/arxiv_data1/oa_pdf/37/ca/ENE-22-1260.PMC5024045.pdf
"2015, 9, 342–347 343 Correspondence concerning this and other Viewpoint articles can be accessed on the journals’ home page at: http://viewpoint.clinical.proteomics- journal.com Correspondence for posting on these pages is welcome and can also be submitted at this site.",Non-OADS,/arxiv_data1/oa_pdf/ef/04/PRCA-9-342.PMC5024047.pdf
"Constructions for ROI All ROIs were constructed using the WFU PickAtlas Tool (http://www.fmri.wfubmc.edu/cms/software#Pick-Atlas) [ Maldjian et al ., 2003, 2004].",OADS,/arxiv_data1/oa_pdf/ee/a9/HBM-36-1808.PMC5024049.pdf
URL http://www.amgen.ca/Enbrel_PM.pdf (lastaccessed 22 September 2014).,OADS,/arxiv_data1/oa_pdf/6c/e7/JDV-29-1555.PMC5024053.pdf
"In macaques, polymorphism for the DRA gene has been described, and manyDRAalleles havebeenreportedforcynomolgus,rhesus, and pigtailed macaques (http://www.ebi.ac.uk/ipd/mhc/nhp/)(5).",Non-OADS,/arxiv_data1/oa_pdf/3e/63/TAN-85-146.PMC5024057.pdf
"Candidate pep- tides can be selected from databases such as the PeptideAt- las (www.peptideatlas.org/), PRIDE (www.ebi.ac.uk/pride/), Human Proteinpedia (www.humanproteinpedia.org), and the Global Proteome Machine (http://gpmdb.thegpm.org/), which contain sets of tryptic peptides that are frequently ob- served in global proteomics experiments.",OADS,/arxiv_data1/oa_pdf/49/25/PMIC-15-862.PMC5024058.pdf
The digital images on X-Omat ﬁlm wereprocessed using Adobe Photoshop 7.0 (http://www.adobe.com/).,OADS,/arxiv_data1/oa_pdf/1e/cd/MC-55-182.PMC5024070.pdf
"Expression changes of rice grain- ﬁlling-related genes in response to Ustilaginoidea virens (Uv) infection Gene IDaGene descriptionLog 2-fold change (Os-Inf/Os-CK)bFDRc Seed storage protein Os02t0248800-01 Similar to glutelin type-B2 precursor 2.67 0.00E þ00 Os02t0453600-01 Similar to glutelin 2.60 0.00E þ00 Os03t0427300-01 Glutelin type-A III precursor 2.54 0.00E þ00 Os02t0249000-01 Glutelin, seed storage protein 2.49 0.00E þ00 Os02t0268100-01 Similar to glutelin (fragment) 2.17 0.00E þ00 Os02t0268300-00 Similar to glutelin (fragment) 2.11 0.00E þ00 Os10t0400200-01 Glutelin type II precursor 2.06 0.00E þ00 Os01t0761800-00 Similar to glutelin type-A3 1.92 2.50E /C001 Os02t0242600-01 Similar to glutelin 1.88 0.00E þ00 Os02t0249600-01 Similar to glutelin 1.73 8.22E /C065 Os01t0762500-00 Glutelin subunit mRNA 1.68 0.00E þ00 Os02t0456100-01 Similar to glutelin 1.30 6.39E /C029 Os03t0188500-01 Glutelin family protein 1.27 2.51E /C081 Os12t0472500-01 Glutelin family protein 1.16 1.71E /C002 Os07t0219300-01 Prolamin precursor (13 kDa prolamin) 9.79 5.20E /C002 Os05t0332000-01 Similar to prolamin precursor 4.94 1.32E /C038 Os05t0331532-01 Similar to prolamin 3.98 0.00E þ00 Os05t0329200-00 Similar to prolamin 3.92 2.93E /C004 Os05t0330600-00 Similar to prolamin 3.62 0.00E þ00 Os05t0331800-01 Similar to prolamin 2.98 2.53E /C0136 Os05t0331366-00 Similar to prolamin 2.85 0.00E þ00 Os05t0328466-00 Similar to prolamin 2.66 2.52E /C002 Os05t0328800-00 Prolamin 7 2.66 1.09E /C003 Os05t0328333-00 Similar to prolamin 2.51 2.25E /C009 Os06t0507100-01 Similar to prolamin 2.00 2.56E /C043 Os07t0206400-01 13 kDa prolamin precursor 1.84 0.00E þ00 Os07t0220000-01 Similar to prolamin 1.76 0.00E þ00 Os07t0219400-01 Prolamin precursor 1.74 0.00E þ00 Os07t0206500-00 13 kDa prolamin precursor 1.53 0.00E þ00 Os12t0269200-01 Similar to prolamin precursor 1.13 0.00E þ00 Os03t0336100-01 11-S plant seed storage protein family protein 1.39 1.21E /C0208 Os05t0499100-01 26 kDa globulin (alpha-globulin) 1.14 0.00E þ00 Starch metabolismd Os01t0633100-01 AGPase large subunit 1.03 0.00E þ00 Os08t0345800-01 AGPase small subunit 2.32 5.55E /C0210 Os06t0160700-01 Starch synthase I /C00.26 4.02E /C002 Os06t0229800-01 Starch synthase IIa 1.73 6.39E /C086 Os08t0191433-00 Starch synthase IIIa 1.46 8.23E /C0173 Os06t0726400-01 Branching enzyme I 1.17 3.24E /C075 Os02t0528200-01 Branching enzyme IIb 1.10 0.00E þ00 Os08t0520900-00 Isoamylase1 0.91 2.78E /C0163 Os06t0133000-01 Granule-bound starch synthase I 1.88 0.00E þ00 Transcription factor Os07t0182000-01 bZIP transcription factor 1.29 6.47E /C060 Os02t0252400-01 DOF zinc finger transcription factor 1.29 1.90E /C082 Genes selected for quantitative real-time polymerase chain reaction analysis are underlined and presented in Figure 4 .aGene accession number for rice gene in the Rice Annotation Project Database ( http://rapdb.dna.affrc.go.jp/ ).bThe log 2-fold change of gene expression in Uv-infected rice spikelets versus mock-inoculated rice samples from RNA-Seq experiment.cFalse discovery rate (FDR) as calculated according to Benjamini and Yekutieli ( 2001 ).dThese starch metabolism genes have been implicated in grain ﬁlling during rice endosperm development ( Zhou et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/5c/JIPB-57-577.PMC5024071.pdf
"Expression changes of rice defense/stress-related genes in response to Ustilaginoidea virens (Uv) infection Gene IDaHomolog name Gene descriptionLog 2-fold change (Os-Inf/Os-CK)bFDRc Plant –pathogen interaction Os01t0194300-01 NPR1 Similar to NPR1 /C01.96 (/C00.73/C60.11) 1.04E-79 Os11t0141900-00 NPR1 Ankyrin domain containing protein /C01.58 4.12E-04 Os05t0595000-01 PR1 Allergen V5/Tpx-1 related family protein /C07.78 (/C05.64/C60.38) 0.00E þ00 Os12t0633400-01 PR1 Similar to Pathogenesis-related protein PR-1 precursor/C06.11 (/C05.07/C60.54) 1.02E-121 Os01t0382400-01 PR1 Similar to Pathogenesis-related protein PRB1-2 precursor/C01.88 (/C00.82/C60.28) 5.05E-157 Os10t0191300-01 PR1 Similar to PR-1a pathogenesis related protein (Hv-1a) precursor1.43 4.75E-05 Os01t0382000-01 PR1 Similar to Pathogenesis-related protein PRB1-2 precursor2.77 (2.45 /C60.37) 1.36E-32 Os03t0646300-01 CNGC Similar to Cyclic nucleotide-gated channel A (Fragment)/C010.30 2.88E-04 Os06t0250600-01 CNGC Ankyrin domain containing protein /C01.78 (/C01.02/C60.10) 1.96E-71 Os01t0788500-01 CNGC Disease resistance protein domain containing protein/C01.06 7.02E-04 Os03t0265500-01 COI1 Similar to Coronatine-insensitive 1 /C02.30 (/C02.54/C60.14) 4.55E-08 Os05t0449500-01 COI1 Similar to Coronatine-insensitive 1 /C01.48 1.08E-79 Os01t0853400-01 COI1 Coronatine-insensitive 1 /C01.07 1.62E-28 Os10t0391400-01 JAZ Tify domain containing protein 3.47 (3.95 /C60.15) 2.98E-15 Os04t0117300-01 MIN7 Similar to H0207B04.10 protein /C02.52 (/C02.08/C60.26) 8.54E-05 Os07t0564750-00 MIN7 Conserved hypothetical protein /C02.10 3.82E-05 Os04t0620600-01 RIN4 Similar to NOI protein /C04.47 (/C03.68/C60.28) 1.25E-61 Os06t0636100-00 RIN4 Hypothetical conserved gene /C03.66 8.67E-14 Induced systemic resistanceOs03t0243900-01 TLP Similar to Thaumatin-like protein /C01.83 1.90E-27 Os05t0586200-01 GH3-5/JAR1 GH3 auxin-responsive promoter family protein /C01.29 1.13E-46 Symbiont immune response Os05t0156500-01 DnaJ Similar to Apobec-1 binding protein 2 1.07 (1.18 /C60.30) 1.23E-22 Os08t0278900-01 SDF2-like Stromal-derived factor-2, MIR domain containing protein1.08 3.09E-07 Os08t0440500-01 SDF2-like Stromal-derived factor-2, MIR domain containing protein1.29 (1.40 /C60.31) 1.36E-26 Os05t0156401-00 Unknown Hypothetical gene 1.17 1.40E-08 Dehydration-responsive-element-binding proteinOs01t0885900-00 TINY Similar to transcriptional factor TINY 12.41 1.32E /C009 Os02t0676800-01 DREB1E Similar to dehydration-responsive-element- binding protein 1E6.25 (8.03 /C60.43) 1.50E /C0131 Os06t0127100-01 DREB1C Dehydration-responsive-element-binding protein 1C5.43 9.07E /C070 Os08t0545500-00 DREB1J Similar to dehydration-responsive-element- binding protein 1J5.38 1.14E /C012 Os09t0522100-00 DREB1H Similar to dehydration-responsive-element- binding protein 1H3.41 7.23E /C023 Os09t0522000-01 DREB1B Similar to dehydration-responsive-element- binding protein 1B2.58 2.66E /C030 Os08t0521600-01 DREB2C Similar to dehydration-responsive-element- binding protein 2C2.29 5.61E /C0112 Os02t0797100-00 DREB2B Similar to dehydration-responsive-element- binding protein 2B/C01.31 4.16E /C008 Genes selected for quantitative real-time polymerase chain reaction (PCR) analysis are underlined.aGene accession number for rice gene in the Rice Annotation Project Database ( http://rapdb.dna.affrc.go.jp/ ).bThe log 2-fold change of gene expression in Uv- infected rice spikelets versus mock-inoculated rice samples from RNA-Seq experiment.",Non-OADS,/arxiv_data1/oa_pdf/9d/5c/JIPB-57-577.PMC5024071.pdf
"After removing adaptor sequences and ﬁltering low-quality sequences, clean reads from rice samples were mapped to therice reference genome ( http://rapdb.dna.affrc.go.jp/down- load/irgsp1.html ) using SOAPaligner/SOAP2 ( Li et al.",OADS,/arxiv_data1/oa_pdf/9d/5c/JIPB-57-577.PMC5024071.pdf
Conserved motifs are underlinedbased on BLASTP analysis in NCBI ( http://blast.st-va.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/9d/5c/JIPB-57-577.PMC5024071.pdf
Expression pro ﬁling of rice grain- ﬁlling-related genes in various tissues/organs and at different stages of reproduc-tive developmentGlobal expression data for the grain- ﬁlling-related genes listed in Table 1 were retrieved from Affymetrix microarray experi-ments in the RicePLEX database ( http://www.plexdb.org/ modules/PD_browse/experiment_browser.php ).,OADS,/arxiv_data1/oa_pdf/9d/5c/JIPB-57-577.PMC5024071.pdf
"Available at: http:// www.ncsi.org.uk/wp-content/uploads/ Living-with-and-beyond-2013.pdf NICE (2008) Guidelines on Supportive and Palliative Care in Cancer Services .Available at: http://www.nice.org.uk/ nicemedia/live/10893/28820/28820.pdf O’Brien R., Rose P., Campbell C., Weller D., Neal R.D., Wilkinson C., McIntosh H. & Watson E. (2010) Experiences of follow-up after treatment in patients with prostate cancer: a qualitative study.",Non-OADS,/arxiv_data1/oa_pdf/ed/0a/ECC-24-618.PMC5024073.pdf
Available at: http://www.ncbi.nlm.nih .gov/pmc/articles/PMC2478656/ Wallace M. & Storms S. (2007) The needs of men with prostate cancer: results of a focus group study.,Non-OADS,/arxiv_data1/oa_pdf/ed/0a/ECC-24-618.PMC5024073.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Myocardial infarctionHDL-cholesterolAgedAged, 80 and over 1.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.09.001 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Bureau, Projections of the Population by Sex and Age for the United States: 2015 to 2060, 2015 ( http://www.census.gov/population/projections/data/national/ 2014/summarytables.html ).",OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Nations, World Population Ageing, 2015, 2013 ( http://www.un.org/en/develop- ment/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Mortality, C, Causes of Death, Global, regional, and national age-sex speci ﬁc all-cause and cause-speci ﬁc mortality for 240 causes of death, 1990 –2013: a sys- tematic analysis for the Global Burden of Disease Study 2013, Lancet 385 (2015) 117–171, http://dx.doi.org/10.1016/S0140-6736(14)61682-2 .Table 4 Attributable risk of independent risk markers.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Global Utilization of Streptokinase and TPA for occluded coronary arteries trial, Circulation 94 (1996) 1826 –1833 ( http://www.ncbi.nlm.nih.gov/pubmed/ 8873656 ).",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"[6] ClinicalTrials.gov, Brasilia Heart Study (BHS), 2016, https://clinicaltrials.gov/ct2/ show/NCT02062554 2014.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
56 (2006) 11 –50http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"of Helsinki, Recommendations guiding physicians in biomedical research involving human subjects, JAMA 277 (1997) 925 –926 ( http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"J. Geriatr.Psychiatry 21 (2006) 633 –644, http://dx.doi.org/10.1002/gps.1538 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"51 (2008) 1440 –1445, http://dx.doi.org/10.1016/j.jacc.2007.11.075 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
130 (1999) 461 –470 ( http://www.ncbi.nlm.nih.gov/pubmed/10075613 ).,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"32 (2009) E46 –E51, http://dx.doi.org/ 10.1002/clc.20354 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"148 (2011) 300 –304, http://dx.doi.org/10.1016/j.ijcard.2009.11.009 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
Okayama 65 (2011) 379 –385 ( http://www.ncbi.nlm.nih.gov/pubmed/ 22189478 ).,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"163 (2003) 1549 –1554, http://dx.doi.org/10.1001/archinte.163.13.1549 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"[18] C. Prospective Studies, S. Lewington, G. Whitlock, R. Clarke, P. Sherliker, J. Emberson, J. Halsey, N. Qizilbash, R. Peto, R. Collins, Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet 370 (2007) 1829 –1839, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"27 (2014) 61 –67,http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"American Heart Association Councils on Kidney in Cardiovascular Disease, Epidemiology, Prevention, Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Re- search, Clinical Cardiology, and Epidemiology and Prevention, Circulation 108 (2003) 2154 –2169, http://dx.doi.org/10.1161/01.CIR.0000095676.90936.80 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
120 (2009) 419 –428 ( http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"72 (2007) 632 –637, http://dx.doi.org/10.1038/sj.ki.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Wiviott, T. Acute Coronary, Registry intervention outcomes net- work, use of evidence-based therapies in short-term outcomes of ST-segment eleva- tion myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National CardiovascularData Acute Coronary, Circulation 121 (2010) 357 –365, http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.865352 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Newman, Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular HealthStudy, Atherosclerosis 237 (2014) 336 –342, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"5 (2014) 138, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Sun, Aging, arterial stiffness, and hypertension, Hypertension 65 (2015) 252 –256, http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.03617 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"319 (1988) 1365 –1369, http://dx.doi.org/ 10.1056/NEJM198811243192101 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"J. Psychiatry 165 (2008) 515 –523, http://dx.doi.org/10.1176/appi.ajp.2007.07061018 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"25 (2015) 614 –622, http://dx.doi.org/10.1016/j.tcm.2015.02.002 .",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
"Psychiatry 27 (2012) 262 –270, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
111 (1986) 383 –390http://www.ncbi.nlm.nih.gov/pubmed/3946178 .112 A.M. Campos et al.,Non-OADS,/arxiv_data1/oa_pdf/55/e9/main.PMC5024138.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
"Introduction In the United States, acetaminophen is the medicine that is most commonly associated with overdose and the leading cause of overdose-related hepatotoxicity leading to acute liver failure.1 Approximately half of overdose-related deaths are due to productscontaining acetaminophen in combination with other drugs.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2016.06.001 0011-393X/ &2016.",Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
Available at: http://www.fda.gov/ohrms/dockets/ac/03/brief ing/3995B1_07_GFI-BioAvail-BioEquiv.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
Available at: http://www.foodafacto ﬂife.org.uk/sheet.aspx?siteId =20&sectionId =85& contentId =329.,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/main.PMC5024139.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/7c/main.PMC5024141.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.08.018 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7c/main.PMC5024141.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.017,Non-OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC5024142.pdf
The MALDI-TOF spectrum of ‘Urinacoccus massiliensis ’strain FC2T is available at: http://mediterranee-infection.com/article.php?,Non-OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC5024142.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 6 –37 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5b/41/main.PMC5024142.pdf
http://dx.doi.org/10.1016/j.ymgmr.2016.09.002 2214-4269/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/46/main.PMC5024143.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/46/main.PMC5024143.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Curcuma longaSuvarna RNA-seq Transcriptome Speci ﬁcation Organism/cell line/tissueTurmeric ( Curcuma longa cv.,Non-OADS,/arxiv_data1/oa_pdf/c1/47/main.PMC5024144.pdf
http://dx.doi.org/10.1016/j.gdata.2016.09.001 2213-5960/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/c1/47/main.PMC5024144.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/47/main.PMC5024144.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/84/5f/main.PMC5024145.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.08.002 2213-2244/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/84/5f/main.PMC5024145.pdf
This is an open access article under the CC BY-NC-ND li cense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).International Journal for Parasitology: Parasites and Wildlife 5 (2016) 258 e262,Non-OADS,/arxiv_data1/oa_pdf/84/5f/main.PMC5024145.pdf
"This is an open access article under the CC BY-NC- ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: MangosteenFruitTranscriptomeRNA-SeqIon Proton Speci ﬁcations Organism/cell line/tissue Garcinia mangostana L./rind and aril Sex NA Sequencer or array type Ion Proton System ™ Data format Raw data :FASTQ ﬁle Experimental factors De novo transcriptome assembly of twotissues from Garcinia mangostana L. Experimental features Aril and Rind of Garcinia mangostana L. fruit were collected for RNA isolation,de novo transcriptome assemblyand annotations Consent N/A Sample source location Bogor, West Java, Indonesia, S6° 36 ′30.6 ″E106° 47 ′03.0 ″ 1.",OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC5024146.pdf
"Direct link to deposited data The dataset of RNA-seq was deposited at DDBJ Sequence Read Ar- chive (DRA) under with the accession number of DRA005014, and canbe accessed at http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc= DRA005014 .",OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC5024146.pdf
http://dx.doi.org/10.1016/j.gdata.2016.09.003 2213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC5024146.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/04/main.PMC5024146.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Cyclin G2 disrupts Wnt –β-catenin signaling S Bernaudo et al 4827 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/54/f9/onc201615a.PMC5024152.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: West SyndromeInfantile spasms Epileptic spasms EpilepsyCPP-115 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/c6/main.PMC5024311.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.08.002 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/c6/main.PMC5024311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/c6/main.PMC5024311.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/main.PMC5024312.pdf
http://dx.doi.org/10.1016/j.ebcr.2016.01.007 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/main.PMC5024312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/fa/main.PMC5024312.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: YawningSeizureFrontal lobe epilepsy Ictal VEEGMEG-CSI 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/8b/main.PMC5024315.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.08.005 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/8b/main.PMC5024315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9c/8b/main.PMC5024315.pdf
"Cortical thickness of the brain was evaluated based on the T1- weighted magnetic resonance images (MRI), acquired on a 1.5T Philips healthcare scanner and processed using the FreeSurfer software (version 5.3.0; http://www.surfer.nmr.mgh.harvard.edu ).",OADS,/arxiv_data1/oa_pdf/9c/8b/main.PMC5024315.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Neurostimulation EpilepsyMirtazapineSafetyMedicationTherapy 1.,Non-OADS,/arxiv_data1/oa_pdf/2e/08/main.PMC5024316.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2016.06.002 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/08/main.PMC5024316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/08/main.PMC5024316.pdf
[Available from: http://tinyurl.com/ zvokx6a ].,Non-OADS,/arxiv_data1/oa_pdf/2e/08/main.PMC5024316.pdf
dRoute of administration in CKD study was not speciﬁed.eCKD group included subjects with GFR of 7.5 to 77.1.fSubjects in moderate to severe CKD subjects were com- bined in one group.gRenal function estimated with creatinine clearance but calculation method not speciﬁed.hEstimation method of renal function not speciﬁed.iRenal function estimated with Cockcroft and Gault equation.jUnbound fraction data were obtained from summary of original submission ﬁle in PMDA website (http://www.info.,OADS,/arxiv_data1/oa_pdf/d4/e5/CPT-100-75.PMC5024330.pdf
"It is also important to note that the(c) CYP3A4/5 model drugs with AUCR liver<3 or whose F aFgand F gwere not calculated due to nonlinearity or insufficient clinical pharmacokinetic data Drugs f m,CYP3A4/5 1-fm,CYP3A4/5 fe,urinebDDI with maximum AUCR F aFgor F g References AUCR AUCR liver Inhibitors Value Method aliskiren —a—a0.075 6.33 0.18 itraconazole 0.029 IV/PO (100)k anacetrapib 0.513 0.487 <0.001c4.58 2.05 ketoconazole 0.448 Hisaka (101, 102) atorvastatin 0.165 0.835 <0.1 4.43 1.20 mibefradilh0.270 IV/PO (103, 104), NDA 020702 bosentan — — <0.03c3.73 —gclarithromycin —g—j colchicine 0.400 0.600 0.27 3.39 1.67 clarithromycin 0.491 IV/PO (105—107)l ebastine 0.917 0.083 0.001c42.50 — ketoconazole — — (108)i erythromycin 0.297 0.703 0.12 3.69 1.42 troleandomycin 0.386 IV/PO (69, 109—111) loratadine 0.312 0.688 0c4.46 — ketoconazole — — (108)i maraviroc 0.504 0.496 0.23 5.00 2.01 ketoconazole 0.403 IV/PO (112, 113) mirodenaﬁl 0.449 0.551 — 4.89 — ketoconazole — — (114) nisoldipine 0.647 0.353 0c25.28 2.83 ketoconazole 0.112 IV/PO (115—117)l quetiapine 0.665 0.335 <0.01c6.20 — ketoconazole — — (118, 119) ranolazine — — <0.05c3.64 —gketoconazole —g—j saxagliptin 0.570 0.430 0.24c3.67 2.33 ketoconazole 0.635 Hisaka NDA 022350 silodosin 0.154 0.846 0.069 3.09 1.18 ketoconazole 0.383 IV/PO NDA 022206 simeprevir — — <0.01c6.54 —gerythromycin —g—j voclosporin 0.620 0.380 0.0025c18.14 2.63 ketoconazole 0.145 Hisaka (120, 121) drug C <0.667 /C210.333 — — — — — — — drug D <0.667 /C210.333 — — — — — — — drug E <0.667 /C210.333 — — — — — — — References after 51 can be found in the Supplementary Text S5 online.aNot calculated because AUCR liverwas less than one.bfe,urine after intravenous administration or fe,urine after oral administration divided by absolute bioavailability, if not indicated otherwise.cfe,urine after oral administration.dfe,urine after nasal administration.efe,urine after intramuscular administration.fAUC5AUCR liverbecause clinical DDI study was conducted after the intravenous administration of victim drugs.gNot calculated because of nonlinearity.hDDI reports with cyclosporine A and clarithromycin were not used as these are known inhibitor of OATPs-mediated hepatic uptake.iData obtained from interview forms from PMDA.jData obtained from product labels.kData obtained from summary of original submission ﬁle in PMDA website (http://www.info.pmda.go.",Non-OADS,/arxiv_data1/oa_pdf/d4/e5/CPT-100-75.PMC5024330.pdf
"Pharmacokinetics in Patientswith Impaired Renal Function — Study Design, Data Analysis, andImpact on Dosing and Labeling .<http://www.fda.gov/downloads/ Drugs/Guidances/UCM204959.pdf, http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm064982.htm >(2010).",Non-OADS,/arxiv_data1/oa_pdf/d4/e5/CPT-100-75.PMC5024330.pdf
Draft guideline on the evaluation of the pharmacokinetics of medicinal products in patients with decreasedrenal function .<http://www.ema.europa.eu/docs/en_GB/ document_library/Scientiﬁc_guideline/2014/02/WC500162133.pdf>(2014).,Non-OADS,/arxiv_data1/oa_pdf/d4/e5/CPT-100-75.PMC5024330.pdf
"Drug Interaction Studies—Study Design, Data Analysis, Implications for Dosing, and LabelingRecommendations .<http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM292362.pdf >(2012).",OADS,/arxiv_data1/oa_pdf/d4/e5/CPT-100-75.PMC5024330.pdf
"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).Drug Development and Drug Interactions: Table of Substrates,Inhibitors and Inducers .<http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ucm093664.htm >.",OADS,/arxiv_data1/oa_pdf/d4/e5/CPT-100-75.PMC5024330.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Halorubrum sp.,Non-OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
"Resource table Name of resource Halorubrum species strain SAH-A6 Institution This strain is available from Korean Collection for Type Cultures (KCTC) with the accession number KCTC 43215 Person who created resourceAshagrie Gibtan, Mingyeong Woo, Dokyung Oh,Kyounghee Park, Han-Seung Lee, Jae Hak Sohn,Dong-Woo Lee, Jung-Kue Shin, Sang-Jae Lee ,⁎ Contact person and email Sang-Jae Lee, sans76@silla.ac.kr Date archived/stock date June 2, 2016Type of resource Whole genome sequence dataLink to directly related literature thatemployed/validatedthis resourcehttp://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
gov/genome/14537?genome_ assembly_id=263668 Information in public databaseshttp://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
Strain SAH-A6 Sequencer or array type PacBio RS IIData format AnalyzedExperimental factors Archaea strain http://dx.doi.org/10.1016/j.gdata.2016.08.0142213-5960/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
"The open reading frames of the assembled genome were predicted and an-notated using the hierarchical genome-assembly process (HGAP) [7] protocol RS HGAP Assembly 2 in SMRT analysis version 2.3.0 (Paci ﬁc Biosciences; https://github.com/Paci ﬁcBiosciences/SMRT-Analysis ), IMG-ER [8],N C B IC O Gf u n c t i o n [9], Pfam information [10], and EzTaxon [11] database.",OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/genome/14537?genome_assembly_ id=263668 Supplementary data to this article can be found online at http://dx.,OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC5024332.pdf
http://dx.doi.org/10.1016/j.pmedr.2016.09.002 2211-3355/© 2016 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
"118, 746 –750http://www.acog.",Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
http://www.bat.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
"Feb 20, https://www.youtube.com/watch?v=FaZ6abK2RrQ (Accessed July, 2016).",Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM331925.pdf Accessed April.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
http://www.internationalvaporgroup.com/ about-us/why-e-cigs.html Accessed April.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
http://rjrvapor.com/Pages/ TransformingTobacco.aspx Accessed April.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
Prop- osition 65 List of Chemicals http://oehha.ca.gov/media/downloads/proposition-65// p65single080516.pdf Accessed April.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
http://www.vapourart.com/en/faq-item/which-are-bene ﬁts-electronic  -cigarettes- over-tobacco-cigarettes Accessed April.485 L.J.,Non-OADS,/arxiv_data1/oa_pdf/95/b7/main.PMC5024333.pdf
Acknowledgments We acknowledge the director of St. Stephen's Hospital and the hospital management for allowing us to publish this work.Epilepsy & Behavior Case Reports 6 (2016) 64 –66 http://dx.doi.org/10.1016/j.ebcr.2016.08.006 2213-3232/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/ca/main.PMC5024334.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/ca/main.PMC5024334.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/d2/main.PMC5024335.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.07.003,OADS,/arxiv_data1/oa_pdf/ca/d2/main.PMC5024335.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.07.010,Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Chromas Pro 1.34 software (Technelysium, Tewantin, Australia) was used to correct sequences, and BLASTn searches were performed at the National Center forBiotechnology Information (NCBI) website ( http://blast.ncbi.",OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
The scripts also remove species that are not found on the List of Prokaryotic Names With Standing in Nomenclature (LPSN) website ( http://www.bacterio.net/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
Acknowledgements The authors thank the Xegen Company ( http://www.xegen.fr/ ) for automating the genomic annotation process and K. Grif ﬁths for English-language review.,Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,3 8–48 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/5c/14/main.PMC5024336.pdf
Global Ecology and Biogeography published by John Wiley & Sons LtdDOI: 10.1111/geb.12438 http://wileyonlinelibrary.com/journal/geb 1 VC2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/01/GEB-25-575.PMC5024350.pdf
"Global Ecology and Biogeography published by John Wiley & Sons LtdDOI: 10.1111/geb.12438 http://wileyonlinelibrary.com/journal/geb 575Global Ecology and Biogeography, (Global Ecol.",Non-OADS,/arxiv_data1/oa_pdf/ab/01/GEB-25-575.PMC5024350.pdf
Available at: http://ctfs.arnarb.harvard.edu/webatlas/datasets/bci (accessed 17June 2014).,OADS,/arxiv_data1/oa_pdf/ab/01/GEB-25-575.PMC5024350.pdf
"Appendix S1 Detailed description of the CONFETTI model and the parameter estimation approach.Appendix S2 Supplementary ﬁgures on parameter estimates and model predictions.Appendix S3 Point pattern theory and the link between the distance decay, species abundance and aggregation.BIOSKETCH The involved authors are researchers within the Euro- pean Research Council (ERC) ERC-funded researchproject ‘Spatiodiversity’ (http://www.thorsten-wiegand.de/towi_ERC.html) that aims to understandthe relative importance of processes and factors thatgovern the composition and dynamics of species-richcommunities.",Non-OADS,/arxiv_data1/oa_pdf/ab/01/GEB-25-575.PMC5024350.pdf
[Available at https://software.ecmwf.int/wiki/display/IFS/CY41R1 1Ofﬁcial1IFS1 Documentation#CY41R1OfﬁcialIFSDocumentation-IV.Physicalprocesses.],Non-OADS,/arxiv_data1/oa_pdf/7f/02/JAME-8-196.PMC5024354.pdf
"(2015), WGNE drag project: An inter-model comparison of surface stresses, technical report [Available at http://collaboration.cmc.",Non-OADS,/arxiv_data1/oa_pdf/7f/02/JAME-8-196.PMC5024354.pdf
", 2008; Beszczynska-Möller and Dye , 2013; http://ocean.ices.dk/iroc/] would be consistent with a higher transport of western subtropical waters,thathighertransportdoesnotaccountforthedropin nutrientconcentrationintheeasternsubpolarNorth Atlantic (Rockall Trough, Figure 1) observed from 2007 onward [ Johnson et al.",Non-OADS,/arxiv_data1/oa_pdf/44/4c/GRL-43-2059.PMC5024355.pdf
"Hydrographic measurements (salinity,temperature, and pressure from CTDdata) from the Santander section used in this study are available on request at http://indamar.ieo.es and thosefrom the Greenland Sea are freelyavailable from the Pangaea database (www.pangaea.de).",OADS,/arxiv_data1/oa_pdf/44/4c/GRL-43-2059.PMC5024355.pdf
"We conclude that MIDAS is suitable for automatic generation of velocity estimates and uncertainties for publication and for automated operational analysis, for example, on our web pages at http://geodesy.unr.",Non-OADS,/arxiv_data1/oa_pdf/3b/29/JGRB-121-2054.PMC5024356.pdf
[Available at http://pubs.usgs.gov/twri/ twri4a3/pdf/twri4a3-new.pdf.],Non-OADS,/arxiv_data1/oa_pdf/3b/29/JGRB-121-2054.PMC5024356.pdf
Time series used for testing MIDAS were obtained through the Nevada GeodeticLaboratory web portal http://geodesy.unr.edu.,OADS,/arxiv_data1/oa_pdf/3b/29/JGRB-121-2054.PMC5024356.pdf
"Modeling the photosynthetic rates as a function of the product of chl aand surface irradiance produced a much more accurate and realistic description of the data, but the OLS continued to beReceived: 24 August 2016 Accepted: 7 September 2016 Heliyon 2 (2016) e00156 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
The multi-decadal dataset available from those studies ( http://hahana.soest.,OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
"In the present study, we focused on the relationship between in situ photosynthetic rates measured by the 14C method [9]and chl aconcentrations at Station ALOHA Article No~e00156 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
"Because errors in the dependent variable create scatter but no bias, the implication is that during months 5 –7 errors in the Article No~e00156 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
"Finally, we now recognize that oligotrophic ocean gyres are dynamic, non-steady-state ecosystems, where stochastic physical processes can lead to a decoupling of the Article No~e00156 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Additional information Data associated with this study has been deposited at http://hahana.soest.hawaii.,OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
Article No~e00156 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00156 2405-8440/© 2016 Published by Elsevier Ltd.,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/25/ac/main.PMC5024501.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/2e/main.PMC5024502.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.com/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.08.010 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/main.PMC5024502.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 115 e117,Non-OADS,/arxiv_data1/oa_pdf/86/2e/main.PMC5024502.pdf
(b ) Quantitation of uptake of  fluorescent label into LNCaP tumor tissues was performed using  ImageJ (n  = 5) (http://rsb.info.nih.gov/ij/); *P < 0.05; **P < 0.01.,OADS,/arxiv_data1/oa_pdf/de/19/mtna201643a.PMC5024509.pdf
"The pKa values of these carboxylic acid groups are predicted to be 3.11, 3.69, and 3.99 (Marvin, ChemAxon, http://www.chemaxon.com/products/marvin/), indicating that this PSMA-targeting ligand will possess a strong negative  charge at physiological pH.",Non-OADS,/arxiv_data1/oa_pdf/de/19/mtna201643a.PMC5024509.pdf
"LNP fluorescence was quantified using  Image J (v1.50b, https://imagej.nih.gov/).",OADS,/arxiv_data1/oa_pdf/de/19/mtna201643a.PMC5024509.pdf
"To view a copy of this   license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/de/19/mtna201643a.PMC5024509.pdf
[62] http://europa.eu/rapid/press-release_IP-05-1687_en.htm.,Non-OADS,/arxiv_data1/oa_pdf/d7/b7/CAC-12-303.PMC5024650.pdf
[63] http://www.vmd.defra.,Non-OADS,/arxiv_data1/oa_pdf/d7/b7/CAC-12-303.PMC5024650.pdf
[74] http://www.sigmaaldrich.com/content/dam/sigma- aldrich/docs/Supelco/Product_Information_Shee t/t709074.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d7/b7/CAC-12-303.PMC5024650.pdf
"The coverslips were imaged using ﬂuorescent microscope (Nikon Corp.) and analyzed using ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the NationalInstitutes of Health, Bethesda, MD, USA) to quantify the number of internalized DiI-ox-LDL particles.",OADS,/arxiv_data1/oa_pdf/9e/fe/i1552-5783-57-11-4704.PMC5024668.pdf
"Induction ofASAP in HUVECs was dependent on reactive oxygen [Keywords : tumor microenvironment; chemoresistance; paracrine; senescence; endothelial cell; SASP]Corresponding author: jesus.gil@csc.mrc.ac.ukArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.288571.116.© 2016 Georgilis and Gil This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (Attri-bution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/4a/09/1791.PMC5024677.pdf
"Theydemonstrate that adipose-specific deletion of LSD1 ele-vates WAT-selective gene expression, increases fat mass, [Keywords : LSD1; PRDM16; HSD11B1; brown adipose tissue; thermogenesis; mitochondria]Corresponding authors: sfarmer@bu.edu, jeanlin@bu.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.288720.116.© 2016 Lin and Farmer This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/85/7b/1793.PMC5024678.pdf
The [Keywords : fluorescence; single molecule; splicing; transcription] Corresponding author: dan.larson@nih.govArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.281725.116.This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (seehttp://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9a/d7/1796.PMC5024679.pdf
"After six months, it isavailable under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/9a/d7/1796.PMC5024679.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.284851.116.© 2016 Bent et al.,Non-OADS,/arxiv_data1/oa_pdf/51/18/1811.PMC5024680.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/51/18/1811.PMC5024680.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/51/18/1811.PMC5024680.pdf
Concentrations were deter- mined with a four-parameter logistic regression using a standard curve on ReaderFit.com or http://www.elisaanalysis.com.,OADS,/arxiv_data1/oa_pdf/51/18/1811.PMC5024680.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.285312.116.© 2016 Zeng et al.,OADS,/arxiv_data1/oa_pdf/5d/b6/1822.PMC5024681.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5d/b6/1822.PMC5024681.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5d/b6/1822.PMC5024681.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.287235.116.© 2016 Reid et al.,OADS,/arxiv_data1/oa_pdf/3e/c6/1837.PMC5024682.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3e/c6/1837.PMC5024682.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3e/c6/1837.PMC5024682.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.284729.116.© 2016 Bechard et al.,Non-OADS,/arxiv_data1/oa_pdf/5f/cf/1852.PMC5024683.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5f/cf/1852.PMC5024683.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.286278.116.© 2016 Penke et al.,Non-OADS,/arxiv_data1/oa_pdf/5d/70/1866.PMC5024684.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/5d/70/1866.PMC5024684.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5d/70/1866.PMC5024684.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.282194.116.© 2016 Ryu et al.,OADS,/arxiv_data1/oa_pdf/4c/b0/1881.PMC5024685.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4c/b0/1881.PMC5024685.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/4c/b0/1881.PMC5024685.pdf
"713 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/68/saw043.PMC5024707.pdf
"For example, the Cornell Lab ofOrnithology’s YardMap program (http://yardmap.org) recommends reducing lawns because of the reputation of chemically treated lawns as nonhabitat for wildlife ( Bormann et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/68/saw043.PMC5024707.pdf
"Accessed from: https://www.whitehouse.gov/sites/default/ﬁles/microsites/ostp/Pollinator%20Research%20Action%20Plan%202015.pdf, Last accessed 14 June 2016.",Non-OADS,/arxiv_data1/oa_pdf/a2/68/saw043.PMC5024707.pdf
Available  from: http://www.envivopharma.com/news-item.php?id=45  [110]  NCT01716975.,Non-OADS,/arxiv_data1/oa_pdf/5f/ab/CPD-21-3797.PMC5024727.pdf
The transcripts were BLASTed against the NONCODE v3.0  database (http://www.noncode.org/NONCODERv3/) to identify already known non-coding RNAs (identity >0.9 and coverage >0.8 as the selection criteria).,OADS,/arxiv_data1/oa_pdf/c3/3d/or-36-04-1861.PMC5024742.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ad/cf/10.1177_2325967116665595.PMC5024745.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 279–283International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 279 CASE SERIES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S111349Three cases of ocular syphilis and the resurgence  of the disease in Queensland Sergio A Sara Andrew S McAllister Department of Ophthalmology, Gold  Coast University Hospital (GCUH),  Southport, QLD, AustraliaAbstract:  The past few years has seen a resurgence of syphilis.",Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
"1,5,7Correspondence: Sergio A Sara Department of Ophthalmology, Gold Coast University Hospital (GCUH), 1 Hospital Blvd, Southport, QLD 4215, AustraliaEmail sergio.sara@health.qld.gov.auJournal name: International Medical Case Reports Journal Article Designation: CASE SERIESY ear: 2016V olume: 9Running head verso: Sara and McAllisterRunning head recto: Resurgence of ocular syphilis in QueenslandDOI: http://dx.doi.org/10.2147/IMCRJ.S111349",Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdi3904-1.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
Available from: https://kirby.unsw.edu.au/surveillance/2015-annual-surveillance-report-hiv-   viral-hepatitis-stis.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 283 Resurgence of ocular syphilis in Queensland  8.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
Available from: http://www.cdc.gov/std/syphilis/clinicaladvisoryos2015.htm.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
Available from: http://www.cdc.gov/std/tg2015/syphilis.htm.,Non-OADS,/arxiv_data1/oa_pdf/47/cb/imcrj-9-279.PMC5024761.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/1a/fnw195.PMC5024762.pdf
"Sequence analyses The analysis of sequencing results was performed with BioEdit software version 7.2.0 ( http://www.mbio.ncsu.edu/ bioedit/bioedit.html ).Iftheinsertwassequencedusingmultiple primers, the sequences were assembled with CAP contig func- tion within the software (Huang 1992).",OADS,/arxiv_data1/oa_pdf/f1/1a/fnw195.PMC5024762.pdf
The vector sequences were initially trimmed from the sequences by using VecScreen analysis tool ( http://www.ncbi.nlm.nih.gov/tools/vecscreen ) and identified for the primer binding sites.,OADS,/arxiv_data1/oa_pdf/f1/1a/fnw195.PMC5024762.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/81/8c/ott-9-5587.PMC5024763.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5587–5595OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5587Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10687 1 role of postmastectomy radiation therapy in  breast cancer patients with T1–2 and 1–3 positive  lymph nodes Yasemin Benderli cihan1 Talha sarigoz2 1Department of radiation Oncology,   2Department of general surgery,   Kayseri Training and research  hospital, Kayseri, T urkeyObjective:  To evaluate the role of radiotherapy (RT) in overall survival (OS) and disease-free  survival in postmastectomy breast cancer patients with tumor size ,5 cm, with 1–3 involved  axillary lymph nodes (T1–2N1).",Non-OADS,/arxiv_data1/oa_pdf/81/8c/ott-9-5587.PMC5024763.pdf
"The most commonly used surgical method is modified radical correspondence: Yasemin Benderli cihan Department of radiation Oncology,  Kayseri Training and research hospital,  sanayi District, ataturk Boulevard,  hastane street, no 78, 38010 Kocasinan,  Kayseri, Turkey Tel +90 352 336 8884 Fax +90 352 320 7313 email cihany@erciyes.edu.t r Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Cihan and Sarigoz Running head recto: Role of postmastectomy radiation therapy DOI: http://dx.doi.org/10.2147/OTT.S106871",Non-OADS,/arxiv_data1/oa_pdf/81/8c/ott-9-5587.PMC5024763.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/81/8c/ott-9-5587.PMC5024763.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/8c/ott-9-5587.PMC5024763.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d4/25/ott-9-5603.PMC5024764.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5603–5609OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5603Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10489 0 Polymorphisms in the MTHFR  gene are associated  with recurrence risk in lymph node-positive  breast cancer patients ali suner1 hakan Buyukhatipoglu1 gokmen aktas1 T ulay Kus1 Mustafa Ulaslı2 serdar Oztuzcu2 Mehmet emin Kalender1 alper sevinc1 seval Kul3 celaletdin camci1 1Division of Medical Oncology,   Department of internal Medicine,   gaziantep Oncology hospital,   University of gaziantep, gaziantep,   T urkey; 2Department of Medical  Biology, Faculty of Medicine,   University of gaziantep, gaziantep,   T urkey; 3Department of Biostatistics,   Faculty of Medicine, University of  gaziantep, gaziantep, T urkeyPurpose:  The aim of this study is to clarify the relationship between recurrence risk of breast  cancer and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms.",Non-OADS,/arxiv_data1/oa_pdf/d4/25/ott-9-5603.PMC5024764.pdf
"Traditional parameters such as stage accord - ing to the pathological tumor–node–metastasis (TNM) system, the number of metastatic  lymph nodes, the extent of metastases in the lymph nodes, histological type and grade of  the tumor, resection margins including the location and minimum distance of the margin,  vascular invasion, and expression of estrogen receptor (ER), progesterone receptor (PR),  human epidermal growth factor receptor 2 (HER-2), and Ki-67 are used to decide the  adjuvant treatment choice and also to predict breast cancer recurrence and survival.1 In  addition, there have been untraditional markers predicting breast cancer recurrence.correspondence: ali suner Division of Medical Oncology,  Department of internal Medicine,  gaziantep Oncology hospital,  University of gaziantep, Bestepe District,  Onkoloji street, number 15, sahinbey/ gaziantep, Tr-27310, Turkey email dralisuner@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Suner et al Running head recto: Association of MTHFR polymorphisms with recurrence risk DOI: http://dx.doi.org/10.2147/OTT.S104890",Non-OADS,/arxiv_data1/oa_pdf/d4/25/ott-9-5603.PMC5024764.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d4/25/ott-9-5603.PMC5024764.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/25/ott-9-5603.PMC5024764.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/a2/ott-9-5597.PMC5024765.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5597–5602OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5597Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11064 6 correlation of PDK1 expression with  clinicopathologic features and prognosis of  hepatocellular carcinoma Junrong Wang Fenqin liu Peiran ao Xianneng li haixiao Zheng Di Wu nina Zhang Junping she Junhui Yuan Xiuying Wu Department of laboratory Medicine,   Wenling Maternal and child health  care hospital, Wenling, Zhejiang  Province, People’s republic of chinaObjective:  To explore the clinical significance of 3-phosphoinositide-dependent protein  kinase-1 (PDK1) expression in hepatocellular carcinoma (HCC) and its association with clini - copathologic features and prognosis in HCC patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/a2/ott-9-5597.PMC5024765.pdf
"3-Phosphoinositide-dependent kinase-1 (PDK1)  is a 63 kD serine/threonine kinase, which can be divided into the kinase domain and the correspondence: Xiuying Wu Department of laboratory Medicine,  Wenling Maternal and child health care  hospital, Wenling, Zhejiang Province,  People’s republic of china Tel +86 576 8616 8016 Fax +86 576 8616 8022 email x iuyingw@139.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: PDK1 expression is correlated with prognosis of HCC DOI: http://dx.doi.org/10.2147/OTT.S110646",Non-OADS,/arxiv_data1/oa_pdf/a2/a2/ott-9-5597.PMC5024765.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/a2/ott-9-5597.PMC5024765.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/a2/ott-9-5597.PMC5024765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 319–324International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 319 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S109452Clinical usefulness of red cell distribution width  to angiographic severity and coronary stent  thrombosis Aysun Erdem1  Ufuk Sadik Ceylan1  Aycan Esen1  Ertugrul Zencirci2  Birol T opcu3  Kivilcim Ozden1  Selcuk Yazici1  Sait T erzi1  Ayse Emre1  Kemal Yesilcimen1 1Department of Cardiology, Siyami  Ersek Thoracic and Cardiovascular  Surgery Training and Research Hospital, Istanbul, T urkey;   2Department of Cardiology, Acibadem  Hospital Maslak, Istanbul, T urkey;   3Department of Biostatistics, Faculty  of Medicine, Namik Kemal University,  T ekirdag, T urkeyBackground: Red cell distribution width (RDW) is a quantitative measurement and shows  heterogeneity of red blood cell size in peripheral blood.",Non-OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
"High RDW val-ues were also shown to be associated with increased mortality with coronary artery Correspondence: Aysun Erdem   Rıhtım Caddesi, Nemlizade Sok, No 9/5,  Kadikoy, Istanbul, Turkey   Tel +90 53 3325 2733   Fax +90 21 2285 9314   Email erdemaysun@yahoo.comJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Erdem et alRunning head recto: RDW for angiographic severity and coronary stent thrombosisDOI: http://dx.doi.org/10.2147/IJGM.S109452",Non-OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 324 Erdem et al  14.,Non-OADS,/arxiv_data1/oa_pdf/6c/94/ijgm-9-319.PMC5024766.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/07/dddt-10-2869.PMC5024769.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2869–2879Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2869Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10832 7 synthesis, solubility, plasma stability, and  pharmacological evaluation of novel  sulfonylhydrazones designed as anti-diabetic agents gisele Zapata-sudo1,2 isabelle Karine da costa  nunes2 Josenildo segundo chaves  araujo1,2 Jaqueline soares da silva2 Margarete Manhães  Trachez2,3 Tiago Fernandes da silva1 Filipe P da costa2 roberto Takashi sudo1,2 eliezer J Barreiro1,2 lídia Moreira lima1,2 1national institute of science and  T echnology on Drugs and Medicines,   Federal University of rio de Janeiro,   laboratory of evaluation and  synthesis of Bioactive compounds,   center of health sciences, rio de  Janeiro, Brazil; 2Program of research  in Drug Development, institute  of Biomedical sciences, Federal  University of rio de Janeiro, rio  de Janeiro, Brazil; 3Department of  anesthesiology, Fluminense Federal  University, rio de Janeiro, BrazilAbstract:  Neuropathy is a serious complication of diabetes that has a significant socioeconomic  impact, since it frequently demands high levels of health care consumption and compromises labor  productivity.",Non-OADS,/arxiv_data1/oa_pdf/f4/07/dddt-10-2869.PMC5024769.pdf
"However, safety concerns including increased plasma creatinine and homocysteine,  signs of myopathy and rhabdomyolysis, fluid retention, peripheral edema, weight  gain, and a potential increased risk of cardiac failure, bring into question the safety of  these drugs.12 Zapata-Sudo et al identified new synthetic PPAR γ agonists, described as  sulfonylhydrazone derivatives; long-term administration (20 mg/kg, intraperitoneally  [ip], for 7 days) of compound 3 ′-[(E)-[2-[(6-methyl-1,3-benzodioxol-5-yl)sulfonyl] hydrazinylidene]methyl]benzoic acid (3, LASSBio-1471) improved oral glucose  tolerance, reduced blood glucose levels, and reduced neuropathic pain in a murine  streptozotocin (STZ)-induced diabetes model.13 This work describes the design, synthesis, solubility, plasma stability, and pharma - cological evaluation of novel sulfonylhydrazones (referred to herein as compounds 4–9), correspondence: lídia Moreira lima Federal University of rio de Janeiro,  ccs, Bloco B, sala 14, PO Box 68024,  rio de Janeiro, rJ, 21941-971, Brazil Tel/fax +55 21 3938 6503 email lidia@lassbio.icb.ufrj.b rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Zapata-Sudo et al Running head recto: Novel sulfonylhydrazones designed as anti-diabetic agents DOI: http://dx.doi.org/10.2147/DDDT.S108327",Non-OADS,/arxiv_data1/oa_pdf/f4/07/dddt-10-2869.PMC5024769.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f4/07/dddt-10-2869.PMC5024769.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/07/dddt-10-2869.PMC5024769.pdf
Or use: http://youtu.be/ZWz9AltFnw UVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/f4/07/dddt-10-2869.PMC5024769.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/32/ba/ott-9-5619.PMC5024770.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5619–5627OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5619Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9351 7 eribulin in the management of inoperable soft- tissue sarcoma: patient selection and survival Colin Thomas Sujana Movva Department of Hematology/ Oncology, Fox Chase Cancer  Center, Philadelphia, PA, USAAbstract:  Patients diagnosed with metastatic soft-tissue sarcoma (STS) have a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/32/ba/ott-9-5619.PMC5024770.pdf
"Because of the Correspondence: Sujana Movva Department of Hematology/Oncology,  Fox Chase Cancer Center, 333 Cottman  Avenue, Philadelphia, PA 19111, USA email sujana.movva@fccc.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Thomas and Movva Running head recto: Eribulin in soft-tissue sarcoma DOI: http://dx.doi.org/10.2147/OTT.S93517",Non-OADS,/arxiv_data1/oa_pdf/32/ba/ott-9-5619.PMC5024770.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/32/ba/ott-9-5619.PMC5024770.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/ba/ott-9-5619.PMC5024770.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 215–219Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 215 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S114770Lyme disease: the promise of Big Data, companion  diagnostics and precision medicine Raphael B Stricker1 Lorraine Johnson2 1International Lyme and Associated  Diseases Society, Bethesda, MD,   2LymeDisease.org, Chico, CA, USAAbstract:  Lyme disease caused by the spirochete Borrelia burgdorferi has become a major  worldwide epidemic.",Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
"10 The study concluded that Lyme  disease patients frequently endure extensive delays in obtaining an initial diagnosis, Correspondence: Raphael B Stricker Union Square Medical Associates, 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USATel +1 415 399 1035Fax +1 415 399 1057Email rstricker@usmamed.comJournal name: Infection and Drug Resistance  Article Designation: PERSPECTIVESY ear: 2016V olume: 9Running head verso: Stricker and JohnsonRunning head recto: Lyme diseaseDOI: http://dx.doi.org/10.2147/IDR.S114770 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
Or use: http://youtu.be/hMJAjvVoysQ,Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
Available from: http://www.cdc.gov/media/releases/2013/p0819-lyme-disease.html.,Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
Available  from: http://www.cdc.gov/lyme/diagnosistesting/labtest/twostep/index.html.,OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 219 Lyme disease  44.,Non-OADS,/arxiv_data1/oa_pdf/b1/dc/idr-9-215.PMC5024771.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/d6/ott-9-5611.PMC5024772.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5611–5617OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5611Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11059 5 Prostate cancer patients may have an increased  risk of coexisting advanced colorectal neoplasms sun-hye Ko1,2 Myong Ki Baeg2,3 Woong Jin Bae4 Pumsoo Kim3 Myung-gyu choi2 1Department of internal Medicine,   asan Medical center, University of  Ulsan college of Medicine, seoul,   south Korea; 2Department of internal  Medicine, college of Medicine,   The catholic University of Korea,   seoul, south Korea; 3Department of  internal Medicine, international st  Mary’s hospital, catholic Kwandong  University, incheon, south Korea;   4Department of Urology, college of  Medicine, The catholic University of  Korea, seoul, south KoreaBackground/aims:  Patients being treated for prostate cancer (PCa) have an increased risk of  developing colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/72/d6/ott-9-5611.PMC5024772.pdf
"Keywords:  colorectal neoplasms, prostate cancer, colonoscopy, colorectal adenoma and  carcinoma Introduction With the introduction of prostate-specific antigen (PSA) screening in clinical practice,  the number of patients with prostate cancer (PCa) has rapidly increased.1 PSA screen - ing, combined with improvements in therapeutic modalities, has led to an increase in  long-term survival.2 The long-term survival of PCa patients, older age at diagnosis,  and increased cancer risk associated with PCa therapy has led to a focus on secondary  primary malignancies (SPMs).3–8 One sixth of PCa patients have been reported to have an SPM.9 Among the various  types of SPMs reported in PCa patients, colorectal cancer is clinically significant as its  risk can be increased by PCa treatment.5–8 This becomes even more important when  considering that colorectal cancer and PCa have been reported to confer increased  risks to each other.9–12 This increase in risk may be due to shared risk factors between correspondence: Myong Ki Baeg catholic Kwandong University,  international st Mary’s hospital,  simgokro 100gil 25 seo-gu, incheon  22711, south Korea Tel +82 32 290 2923  email baegmk@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ko et al Running head recto: Prostate cancer and colorectal neoplasms DOI: http://dx.doi.org/10.2147/OTT.S110595",Non-OADS,/arxiv_data1/oa_pdf/72/d6/ott-9-5611.PMC5024772.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/72/d6/ott-9-5611.PMC5024772.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/d6/ott-9-5611.PMC5024772.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5577–5586OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5577Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10855 9 Proton therapy for early stage prostate cancer:  is there a case?",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"However, mixed opinions derived from results reported by nonrandomized  studies,5–7 the lack of randomized data comparing PBT to modern photon-based therapy  in the treatment of early stage prostate cancer, and the increased cost compared to other  forms of treatment have resulted in PBT becoming a source of controversy.8–10 Therefore, this article aims to compare the basics of PBT with EBRT, review  the evidence for and against PBT, and inquire about PBT’s future in the treatment Correspondence: Tabitha Y Chan Department of Radiation Oncology,  National University Cancer  institute, 5 Lower Kent Ridge Road,  Singapore 119074 Tel +65 6772 8381 Fax +65 6734 2986 email tabitha_chan@nuhs.edu.s g Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Chan et al Running head recto: Proton therapy for early stage prostate cancer DOI: http://dx.doi.org/10.2147/OTT.S108559",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"Avail - able from: http://emedicine.medscape.com/article/454283-overvie w.  Accessed March 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"Available from:  http://www.cancer.org/treatment/treatmentsandsideeffects/treatment - types/radiation/radiationtherapyprinciples/radiation-therapy-principles- how-is-radiation-given-external-beam-ra d. Accessed March 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"Available from:  http://www.proton-cancer-treatment.com/proton-therapy/principles-of- proton-therap y. Accessed March 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"Available from: http://www.radiotherapie.nl/research/research- projects/mri-guided-radiotherapy/mri-guided-proton-therap y. Accessed  March 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"Available from: https://www.mdanderson.org/patients-family/diagno - sis-treatment/care-centers-clinics/proton-therapy-center/conditions-we- treat/prostate-cancer.htm l. Accessed March 9, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0123086 6.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT0195035 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/ott-9-5577.PMC5024773.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Pharmacology: Advances and Applications 2016:8 117–125Clinical Pharmacology: Advances and Applications Dovepress submit your manuscript | www.dovepress.com Dovepress  117 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S111867Exposure-response analysis to assess the  concentration–QTc relationship of CC-122 Yan Li   Leonidas N  Carayannopoulos   Michael Thomas   Maria Palmisano   Simon Zhou Translational Development and  Clinical Pharmacology, Celgene Corporation, Summit, NJ, USAAbstract:  CC-122 hydrochloride is a novel pleiotropic pathway modifier compound that binds  cereblon, a substrate receptor of the Cullin 4 RING E3 ubiquitin ligase complex.",Non-OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
"1 As per the regulatory guidance and industrial best practice, novel pharmaceuti- cal agents shall undergo rigorous evaluation for their potential to delay cardiac Correspondence: Simon Zhou   Translational Development and Clinical  Pharmacology, Celgene Corporation, 86 Morris Avenue, Summit, NJ 07920, USA   Tel +1 908 673 9284   Fax +1 908 673 2842   Email szhou@celgene.comJournal name: Clinical Pharmacology: Advances and Applications Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Li et alRunning head recto: Potential concentration–QTc relationshipDOI: http://dx.doi.org/10.2147/CPAA.S111867",Non-OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
"Clinical Pharmacology: Advances and Applications 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-pharmacology-advances-and-applications-journalClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 125 Potential concentration–QTc relationship References  1.,Non-OADS,/arxiv_data1/oa_pdf/d5/74/cpaa-8-117.PMC5024774.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 253–262Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 253 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S112421 Grappling with the issue of homosexuality:  perceptions, attitudes, and beliefs among high  school students in Kenya Winnie Mucherah1  Elizabeth Owino2  Kaleigh McCoy1 1Department of Educational  Psychology, Ball State University,   Muncie, IN, USA, 2Department  of Educational Psychology, Moi University, Eldoret, KenyaAbstract: While the past decade has seen an improvement in attitudes toward homosexuality,  negative attitudes are still prevalent in many parts of the world.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
"Savin-Williams concluded that Correspondence: Winnie Mucherah   Department of Educational Psychology,  Ball State University, Muncie, IN 47306, USA Tel +1 765 285 8500 Fax +1 765 285 3653   Email wmucherah@bsu.eduJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Mucherah et alRunning head recto: Grappling with homosexualityDOI: http://dx.doi.org/10.2147/PRBM.S112421",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
Available from: http://www.amnesty.org.uk/lgbti-lgbt-gay-human-rights-law-africa-uganda-kenya-nigeria-cameroon#.U4x_YfldWS8.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
Available from: http://www.bbc.com/news/health-18913497.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
Available from: http://www.bbc.com/news/world-africa-23464694.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
Available  from: http://www.pewglobal.org/2014/04/15/global-morality/table/ homosexuality/.,Non-OADS,/arxiv_data1/oa_pdf/8c/f6/prbm-9-253.PMC5024775.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 425–433Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 425 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S113898Development of the parental needs scale for rare  diseases: a tool for measuring the supportive care  needs of parents caring for a child with a rare  disease Lemuel J Pelentsov1  Andrea L Fielder2,3  Thomas A Laws4  Adrian J Esterman1,2,5 1School of Nursing and Midwifery,   2Sansom Institute for Health  Research, 3School of Pharmacy and  Medical Sciences, University of South  Australia, Adelaide, SA, Australia;   4School of Nursing and Midwifery,   Faculty of Health, Keele University,  Staffordshire, UK;  5Australian Institute  for Health and Tropical Medicine,  James Cook University, Cairns, QLD,  AustraliaBackground: Children and families affected by rare diseases have received scant consideration  from the medical, scientific, and political communities, with parents’ needs especially having  received little attention.",Non-OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
"3,4 Notably, the definition of a rare disease differs between Correspondence: Lemuel J Pelentsov School of Nursing and Midwifery, Division of Health Sciences, University of South Australia, City East Campus, GPO Box 2471, Adelaide, SA 5001, AustraliaPh: +61 8302 1038 Fax: +61 8302 2168Email lemuel.pelentsov@unisa.edu.auJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Pelentsov et alRunning head recto: Development of the parental needs scale for rare diseasesDOI: http://dx.doi.org/10.2147/JMDH.S113898",Non-OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 433 Development of the parental needs scale for rare diseases SECTION 4: Emotional issues Rate each of the following based on how you have been feeling  in the last week:I never feel this wayI always feel this way  9.,Non-OADS,/arxiv_data1/oa_pdf/14/17/jmdh-9-425.PMC5024776.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 205–221International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 205 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S105124 The potential use of biomarkers in predicting  contrast-induced acute kidney injury Michele Andreucci1  T eresa Faga1  Eleonora Riccio2  Massimo Sabbatini2  Antonio Pisani2  Ashour Michael1 1Department of Health Sciences,   University “Magna Graecia” of  Catanzaro, Catanzaro, 2Department  of Public Health, University of Naples Federico II, Naples, ItalyAbstract:  Contrast-induced acute kidney injury (CI-AKI) is a problem associated with the  use of iodinated contrast media, causing kidney dysfunction in patients with preexisting renal  failure.",Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
"2–8  CI-AKI Correspondence: Michele Andreucci   Viale Europa, Località Germaneto,  Campus “Salvatore Venuta”, University “Magna Graecia” of Catanzaro, I-88100 Catanzaro, Italy   Tel +39 0961 364 7573 Email andreucci@unicz.itJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Andreucci et alRunning head recto: Biomarkers in predicting CI-AKIDOI: http://dx.doi.org/10.2147/IJNRD.S105124",Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
Available from: http://circ.ahajournals.org/con-tent/132/Suppl_3/A12855.,Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 221 Biomarkers in predicting CI-AKI  184.,Non-OADS,/arxiv_data1/oa_pdf/3b/76/ijnrd-9-205.PMC5024777.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/f7/dddt-10-2771.PMC5024778.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2771–2777Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2771Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9137 4 Efficacy and safety of monoclonal antibodies  targeting interleukin-17 pathway for inflammatory  arthritis: a meta-analysis of randomized controlled  clinical trials Min Wei1 Dongmei Duan2 1Department of Orthopedics,   2Department of Traditional chinese  Medicine, People’s Liberation  army general hospital, Beijing,   People’s Republic of ChinaAbstract:  T-helper 17 (Th17) pathway plays an important and distinct role in autoimmunity  and inflammation.",Non-OADS,/arxiv_data1/oa_pdf/76/f7/dddt-10-2771.PMC5024778.pdf
"These IL-17-producing cells are mainly a subset of cluster  of differentiation 4 (CD4 +) T-cells, a type of CD4 + “helper” lymphocytes named Th17  cells.5,6 IL-17 levels are extremely low or undetectable in normal human peripheral blood,  while the levels are elevated in peripheral blood or synovial fluid in RA patients.7–10 correspondence: Min Wei Department of Orthopedics, People’s  Liberation Army General Hospital,  28 Fuxing road, Beijing 100853,  People’s Republic of China Tel +86 10 6693 8206 email minwei57@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wei and Duan Running head recto: Efficacy of MAbs targeting IL-17 pathway in inflammatory arthritis DOI: http://dx.doi.org/10.2147/DDDT.S91374",Non-OADS,/arxiv_data1/oa_pdf/76/f7/dddt-10-2771.PMC5024778.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/76/f7/dddt-10-2771.PMC5024778.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/f7/dddt-10-2771.PMC5024778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 517–518Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 517 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S114753 The transition from high school to university: a  medical student’s perspective Fatema Zehra Juma  Tamkin Abas  Shiria Banu Manchester Medical School,   The University of Manchester,  Manchester,  UKDear editor As medical students from the University of Manchester, we read the study by Siri et al1  with great interest.",Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
"Correspondence: Tamkin Abas Manchester Medical School, The University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK   Tel +44 161 306 0460   Email tamkin.abas@student.manchester.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Juma et alRunning head recto: The transition from high school to universityDOI: http://dx.doi.org/10.2147/AMEP .S114753",Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 518 Juma et al As discussed earlier, it is undeniably important for students  to be prepared for the transition; however, it is also crucial  that once at university a smooth transition is maintained and continued support is available, thereby reducing dropout rates.",Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
Manchester Access Programme (MAP); 2016; Available from: http://www.manchester.ac.uk/connect/teachers/students/post-16/manchester-access-programme/.,Non-OADS,/arxiv_data1/oa_pdf/91/71/amep-7-517.PMC5025003.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2159–2166International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2159OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10409 7 The association of renin–angiotensin system  blockades and pneumonia requiring admission in  patients with COPD Junghyun Kim1 Jung-Kyu lee2 eun Y oung heo2 hee soon Chung2 Deog Kyeom Kim2 1Department of Internal Medicine,   Division of Pulmonary and Critical  Care Medicine, seoul national  University hospital, 2Department  of Internal Medicine, Division  of Pulmonary and Critical Care  Medicine, seoul Metropolitan  government- seoul national  University Boramae Medical Center,   seoul, KoreaBackground:  The hallmark of COPD is chronic airway inflammation, which may be  mediated by renin–angiotensin system.",Non-OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
"Keywords:  angiotensin-converting enzyme inhibitors, angiotensin receptor antagonist, COPD,  pneumonia Introduction COPD is an increasing cause of chronic morbidity and mortality worldwide.1,2 As  the general populations age, the incidence and prevalence of COPD increase.3,4  Recently, the incidence of COPD in adults $40 years of age was estimated to be Correspondence: Deog Kyeom Kim seoul Metropolitan government- seoul national University Boramae  Medical Center, Boramae-ro 5-gil 20,  Dongjak-gu, seoul 07061, Korea Tel +82 2 870 2228 Fax +82 2 831 2826 email kimdkmd@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim et al Running head recto: ACEi/ARB and pneumonia in COPD DOI: http://dx.doi.org/10.2147/COPD.S104097",Non-OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
"Available from: http://www.goldcopd.or g.  Accessed January 1, 2015.",OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
"Available from: http://ginaasthma.or g. Accessed  January 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/09/42/copd-11-2159.PMC5025004.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1231–1237Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1231RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11375 8 Use of the Internet as a prevention tool against  cognitive decline in normal aging Blanka Klimova Department of Applied Linguistics,   Faculty of Informatics and  Management, University of Hradec  Kralove, Hradec Kralove, Czech  RepublicAbstract:  Recent demographic trends indicate that older people appear to be one of the fastest  growing population groups worldwide.",Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
"In fact, it can be even enhanced with advancing age at a rate of 0.02–0.003 SDs  per year at the age of 60 years and 70 years.6 In contrast, fluid intelligence, which  usually starts in middle age, significantly influences the cognitive functions because  this intelligence requires speed processing, problem-solving skills, working memory,  abstract reasoning, and learning.7 This ability usually declines at a rate of −0.02 per year Correspondence: Blanka Klimova Department of Applied Linguistics,  Faculty of Informatics and Management,  University of Hradec Kralove,  Rokitanskeho 62, 50003, Hradec Kralove,  Czech Republic Tel +420 737 928 745 email blanka.klimova@uhk.c z Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Klimova Running head recto: Use of the Internet as a prevention tool DOI: http://dx.doi.org/10.2147/CIA.S113758",Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
Available from http://www.vda.virginia.,Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
Available from: http://www.pewinternet.org/2014/04/03/older- adults-and-technology-use /.,Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
Available  from: http://kff.org/medicare/poll-finding/e-health-and-the-elderly- how-seniors/.,Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/a9/9b/cia-11-1231.PMC5025005.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/55/cia-11-1221.PMC5025006.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1221–1229Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1221RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11176 1 Pseudophakic cystoid macular edema: update 2016 Andrzej Grzybowski1,2 Bartosz L Sikorski3 Francisco J Ascaso4,5 valentín Huerva6,7 1Department of Ophthalmology,   University of warmia and Mazury,   Olsztyn, Poland; 2Department of  Ophthalmology, Poznań City Hospital,   Poznań, Poland; 3Department of  Ophthalmology, Nicolaus Copernicus  University, Bydgoszcz, Poland;   4Department of Ophthalmology,   Hospital Clínico Universitario  “Lozano Blesa”, Zaragoza, Spain;   5Instituto de Investigación Sanitaria  Aragón (IIS Aragón), Zaragoza, Spain;   6Department of Ophthalmology,   Universitary Hospital Arnau de  vilanova, Lleida, Spain; 7IRB Lleida,   Lleida, SpainAbstract:  Pseudophakic cystoid macular edema (PCME) is the most common complication  of cataract surgery, leading in some cases to a decrease in vision.",Non-OADS,/arxiv_data1/oa_pdf/b9/55/cia-11-1221.PMC5025006.pdf
"Various factors have been  implicated in its development, including, but not limited to, inflammation, vascular  instability, vitreomacular tractions, and light toxicity.12–14 Most researchers agree that Correspondence: Andrzej Grzybowski Department of Ophthalmology, Poznań  City Hospital, Szwajcarska 3, Poznań  61-285, Poland email ae.grzybowski@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Grzybowski et al Running head recto: Pseudophakic cystoid macular edema: update 2016 DOI: http://dx.doi.org/10.2147/CIA.S111761",Non-OADS,/arxiv_data1/oa_pdf/b9/55/cia-11-1221.PMC5025006.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b9/55/cia-11-1221.PMC5025006.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b9/55/cia-11-1221.PMC5025006.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d5/05/cia-11-1193.PMC5025007.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1193–1198Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1193OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11424 4 Atypical antipsychotics as add-on treatment  in late-life depression sibel Cakir1 Zeynep senkal2 1Department of Psychiatry, Mood  Disorders, geriatric Psychiatry Unit,   Istanbul Medical school, Istanbul  University, 2Department of Psychiatry,   Marmara University, Istanbul, T urkeyBackground:  Second-generation antipsychotics (SGAs) have been used in the augmentation of  treatment-resistant depression.",Non-OADS,/arxiv_data1/oa_pdf/d5/05/cia-11-1193.PMC5025007.pdf
"Keywords:  treatment resistance, aripiprazole, quetiapine, olanzapine, elderly Introduction Major depression is common in the elderly and results in increased mortality, disability,  and suicide.1,2 It is estimated that in 2020 late-life depression (LLD) will be a sig - nificant public health problem and the second greatest cause of overall disability  following heart disease.3,4 However, the response to initial first-line pharmacologic  treatment of LLD is ,50%.5–7 Currently, treatment resistance is defined by the  following parameters: failure to achieve remission with one antidepressant trial and  failure with two trials of adequate dose and duration.8 Randomized controlled trials in  LLD exhibit treatment resistance rates up to 77% when selective serotonin reuptake  inhibitors (SSRIs) are applied, which varies between 55% and 81% with serotonin/ norepinephrine reuptake inhibitors.8 Despite the fact that there is growing evidence  from the Sequenced Treatment Alternatives to Relieve Depression study regarding  the treatment-resistant depression (TRD) in the general population, evidence-based  guidelines for the elderly are lacking.3,9 Impaired executive functions in LLD and  magnetic resonance imaging white matter hyperintensities are more frequently known Correspondence: sibel Cakir Department of Psychiatry, Mood  Disorders, geriatric Psychiatry Unit,  Istanbul Medical school, Istanbul  University, Millet Cad 34390 Çapa/Fatih,  Istanbul, Turkey Fax +90 212 635 1204 email drsibelcakir@yahoo.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Cakir and Senbal Running head recto: Atypical antipsychotics as add-on treatment in late-life depression DOI: http://dx.doi.org/10.2147/CIA.S114244",Non-OADS,/arxiv_data1/oa_pdf/d5/05/cia-11-1193.PMC5025007.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d5/05/cia-11-1193.PMC5025007.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d5/05/cia-11-1193.PMC5025007.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/51/ce/copd-11-2179.PMC5025008.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2179–2189International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2179OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11037 3 The disease burden of chronic obstructive  pulmonary disease in greece georgia Kourlaba1 georgios hillas2 Theodoros Vassilakopoulos2 nikos Maniadakis3 1evroston lP , 2Department of  Critical Care of evangelismos  hospital, Medical school of  national & Kapodistrian University  of athens, 3Department of  health services Organization and  Management, national school of  Public health, athens, greeceBackground:  The objective of the study was to estimate the self-reported prevalence of chronic  obstructive pulmonary disease (COPD) in Greece and to quantify its burden on patients’ daily  activities, productivity, and psychological status.",Non-OADS,/arxiv_data1/oa_pdf/51/ce/copd-11-2179.PMC5025008.pdf
"COPD was the third most frequent cause of  death in 2012 as per the World Health Organization2 report and by 2020 it is predicted  to become the fifth most common cause of disability.3 COPD is characterized by a progressive decline in lung function and health-related  quality of life.4 Many studies have reported that COPD imposes a significant burden on  individuals, the society, and the economy.5–8 In particular, there is abundant evidence Correspondence: georgia Kourlaba eVrOsTOn lP, Chatzigianni Mexi 5,  115 28, athens, greece Tel +30 21 6900 1701 Fax +30 21 6900 1702 email g.kourlaba@evroston.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kourlaba et al Running head recto: COPD burden DOI: http://dx.doi.org/10.2147/COPD.S110373",Non-OADS,/arxiv_data1/oa_pdf/51/ce/copd-11-2179.PMC5025008.pdf
Available from: http://www.goldcopd.org / 19.,Non-OADS,/arxiv_data1/oa_pdf/51/ce/copd-11-2179.PMC5025008.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/51/ce/copd-11-2179.PMC5025008.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/ce/copd-11-2179.PMC5025008.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2171–2178International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2171OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11425 6 scabies increased the risk and severity of COPD:  a nationwide population-based study Jung-Yueh Chen1,* Jui-Ming liu2,* Fung-Wei Chang3 hung Chang4,5 Kuan-Chen Cheng6,7 Chia-lun Yeh2 Yu-Feng Wei1 ren-Jun hsu8–10 1Division of Chest Medicine,   Department of Internal Medicine,   e-Da hospital, I-shou University,   Kaohsiung, 2Division of Urology,   Department of surgery, Taoyuan  general hospital, Ministry of health  and Welfare, Taoyuan, 3Department  of Obstetrics & gynecology, Tri- service general hospital, national  Defense Medical Center, Taipei,   4Division of Thoracic surgery,   Department of surgery, Taichung  armed Forces general hospital,   Taichung, 5Department of Physiology,   national Defense Medical Center,   6graduate Institute of Food science  and Technology, national Taiwan  University, 7Institute of Biotechnology,   national Taiwan University, 8graduate  Institute of life sciences, national  Defense Medical Center, 9Department  of Pathology, graduate Institute  of Pathology and Parasitology, Tri- service general hospital, national  Defense Medical Center, 10Biobank  Management Center, Tri- service  general hospital, national Defense  Medical Center, Taipei, Taiwan *These authors contributed equally  to this workBackground:  Scabies is a common parasitic infectious disease, and COPD is a major pulmonary  disease.",Non-OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
"There are many factors that affect the spread  of scabies, including age, overcrowding, hygiene, socioeconomic status, and season.5 Correspondence: ren-Jun hsu Tri-service general hospital, national  Defense Medical Center, number  161, section 6, Minquan east road,  neihu District, Taipei 114, Taiwan Tel +886 2 8792 3311 ext 16738 Fax +886 2 6600 0309 email hsurnai@gmail.co mJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chen et al Running head recto: Increased risk of COPD following scabies infection DOI: http://dx.doi.org/10.2147/COPD.S114256",Non-OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
Available from: http://nhird.nhri.org.tw/en/Data_Subsets.,OADS,/arxiv_data1/oa_pdf/60/13/copd-11-2171.PMC5025009.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/copd-11-2167.PMC5025010.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2167–2170International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2167Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S11621 4 Lost in interpretation: should the highest VC value  be used to calculate the FeV1/VC ratio?",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/copd-11-2167.PMC5025010.pdf
"Although the postbronchodilator  FEV1/FVC ,0.7 is likely inferior to the FEV1/FVC , LLN criterion6,7 to diagnose Correspondence: Spyridon Fortis Pulmonary and Critical Care, University  of Iowa Hospitals and Clinics, 200  Hawkins Drive – C33 GH, Iowa City,  IA 52242, USA tel +1 319 356 4418 Fax +1 319 353 6406 email spyridon-fortis@uiowa.ed u Journal name: International Journal of COPD Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Fortis Running head recto: Vital capacity value to calculate FEV1/VC ratio DOI: http://dx.doi.org/10.2147/COPD.S116214",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/copd-11-2167.PMC5025010.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ec/a2/copd-11-2167.PMC5025010.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/a2/copd-11-2167.PMC5025010.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/52/main.PMC5025260.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.05.006,OADS,/arxiv_data1/oa_pdf/d4/52/main.PMC5025260.pdf
"The first is to identify  This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License ( http://creativecommons.org/licenses/by-nc/4.0/ ), permitting all non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/f0/nihms-811010.PMC5025263.pdf
"Adv Mod Oncol Res 2016; 2(4): XX-XX; http://dx.doi.org/10.18282/amor.v2.i4.141 Conflict of interest The authors declare no potential conflict of interest with respect to the research, authorship, and/or publication of this article.",Non-OADS,/arxiv_data1/oa_pdf/35/f0/nihms-811010.PMC5025263.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/38/d8/2803.PMC5025265.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7a/f9/2804.PMC5025266.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9d/60/2807.PMC5025267.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/78/72/2811.PMC5025268.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/01/8d/2822.PMC5025269.pdf
"Microscopy image processing Images were processed with Photoshop CS6 (Adobe, San Jose, CA)  and Fiji (http://fiji.sc/wiki/index.php/Fiji).",OADS,/arxiv_data1/oa_pdf/01/8d/2822.PMC5025269.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/c4/2833.PMC5025270.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ed/6a/2844.PMC5025271.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/64/b6/2857.PMC5025272.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/89/08/2867.PMC5025273.pdf
"Filtered hits were com - bined with data from previously published findings using the BioGRID  API (http://thebiogrid.org; Stark et al., 2006) to find cointeractors be - tween all hits and identify interacting complexes.",OADS,/arxiv_data1/oa_pdf/89/08/2867.PMC5025273.pdf
"Image processing was performed in ImageJ (http://imagej.nih.gov/ ij/), including cropping and average/maximum intensity projections.",OADS,/arxiv_data1/oa_pdf/89/08/2867.PMC5025273.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ea/96/2879.PMC5025274.pdf
"2052 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/bb/dyw022.PMC5025336.pdf
"741 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/90/hyw062.PMC5025397.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/85/main.PMC5025458.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.10.003 2211-9132/Copyright ©2015.,Non-OADS,/arxiv_data1/oa_pdf/ea/85/main.PMC5025458.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 187 e189,Non-OADS,/arxiv_data1/oa_pdf/ea/85/main.PMC5025458.pdf
"Br Med J (Clin Res Ed) 283:1363 e1364, 1981 Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Kidney Res Clin Pract 35 (2016) 131 e132 http://dx.doi.org/10.1016/j.krcp.2016.08.003 2211-9132/Copyright ©2016.",Non-OADS,/arxiv_data1/oa_pdf/cd/ab/main.PMC5025459.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cd/ab/main.PMC5025459.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/6c/main.PMC5025461.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.05.005 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/36/6c/main.PMC5025461.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 176 e181,Non-OADS,/arxiv_data1/oa_pdf/36/6c/main.PMC5025461.pdf
Supplementary data Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.krcp.2016.05.005 .,OADS,/arxiv_data1/oa_pdf/36/6c/main.PMC5025461.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/ec/main.PMC5025462.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2015.09.003 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/dd/ec/main.PMC5025462.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 182 e186,Non-OADS,/arxiv_data1/oa_pdf/dd/ec/main.PMC5025462.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/05/main.PMC5025463.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.06.003 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/11/05/main.PMC5025463.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 165 e168,Non-OADS,/arxiv_data1/oa_pdf/11/05/main.PMC5025463.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/54/main.PMC5025464.pdf
"Am J Kidney Dis 67:243 e250, 2016 Available online 26 August 2016 DOI of original article: http://dx.doi.org/10.1016/j.krcp.2016.08.001 http://dx.doi.org/10.1016/j.krcp.2016.08.004 Letter and Reply / Kidney Res Clin Pract 35 (2016) 192 e193 193",Non-OADS,/arxiv_data1/oa_pdf/ac/54/main.PMC5025464.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Next generation sequencingCoverage and reimbursementFDA regulationIntellectual propertyPersonalized medicine Clinical genomics 1.,Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
http://dx.doi.org/10.1016/j.atg.2016.05.004 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"Initial medical policy and model coverage guidelines for clinical next generation sequencing in oncology, report and recom-mendations August http://www.cmtpnet.org/docs/resources/Full_Release_Version_ August_13__2015.pdf .",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
https://www.genomeweb.com/sequencing/cmtp-funded-effort- develop-evidence-standards-ngs-cancer-testing .,Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"http://www.rand.org/content/dam/rand/pubs/monograph_reports/ 2011/MR1269.pdf (Accessed September 12, 2012).",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"Home | Global Alliance for Genomics and Health, d. http://genomicsandhealth.org (Accessed August 31, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"MED-C - Molecular Evidence Development Consortium Inc., d. http://www.med-c.org (Accessed June 9, 2015).",OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"GenomeWeb https://www.genomeweb.com/clinical-genomics/tackling-vus- challenge-are-public-databases-solution-or-liability-labs (Accessed June 16, 2015) Rubenstein, W.S., Church, D.M., Maglott, D.R., 2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"SPOT/Dx Working Group, d. http://www.tapestrynetworks.com/initiatives/healthcare/ oncology-therapeutics-and-diagnostics-working-group.cfm (Accessed June 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
"Public workshop - optimizing FDA's regulatory oversight of next generation sequencing diagnostic tests public workshop, February 20. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ ucm427296.htm (Accessed May 20, 2015).",Non-OADS,/arxiv_data1/oa_pdf/c2/f2/main.PMC5025465.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/d8/main.PMC5025466.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.05.004 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/ee/d8/main.PMC5025466.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 142 e146,Non-OADS,/arxiv_data1/oa_pdf/ee/d8/main.PMC5025466.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c6/49/main.PMC5025467.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.07.001 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/c6/49/main.PMC5025467.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 152 e159,Non-OADS,/arxiv_data1/oa_pdf/c6/49/main.PMC5025467.pdf
"Carol Isaacson Barash Principal, Helix Health Advisors, United States E-mail address: cibarash@helixhealthadvisors.com .Applied & Translational Genomics 10 (2016) 1 http://dx.doi.org/10.1016/j.atg.2016.08.002 2212-0661/© 2016 Published by Elsevier B.V.",Non-OADS,/arxiv_data1/oa_pdf/80/89/main.PMC5025469.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/89/main.PMC5025469.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/eb/main.PMC5025470.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.07.003 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/05/eb/main.PMC5025470.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 133 e141,Non-OADS,/arxiv_data1/oa_pdf/05/eb/main.PMC5025470.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Gut microbiomeMetabolic modelingMicrobial communityData integrationBig Data Contents 1 .,Non-OADS,/arxiv_data1/oa_pdf/de/7b/main.PMC5025471.pdf
http://dx.doi.org/10.1016/j.atg.2016.02.001 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/7b/main.PMC5025471.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/7b/main.PMC5025471.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Kidney Res Clin Pract 35 (2016) 190 e191 http://dx.doi.org/10.1016/j.krcp.2016.04.003 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/ed/9c/main.PMC5025472.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ed/9c/main.PMC5025472.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5d/ee/main.PMC5025473.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.06.002 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/5d/ee/main.PMC5025473.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 169 e175,Non-OADS,/arxiv_data1/oa_pdf/5d/ee/main.PMC5025473.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/98/main.PMC5025474.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.07.002 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/25/98/main.PMC5025474.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 147 e151,Non-OADS,/arxiv_data1/oa_pdf/25/98/main.PMC5025474.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/45/4a/main.PMC5025479.pdf
Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect http://dx.doi.org/10.1016/j.krcp.2016.05.006 2211-9132/Copyright ©2016.,Non-OADS,/arxiv_data1/oa_pdf/45/4a/main.PMC5025479.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Kidney Res Clin Pract 35 (2016) 160 e164,Non-OADS,/arxiv_data1/oa_pdf/45/4a/main.PMC5025479.pdf
"The results do not change signiﬁcantlyfrom those presented in 1- and 2-year follow-ups, as shown in the assessment report.Acknowledgements The following urological surgeons provided expert clinical advice: Prof. Raj Persad (Consultant Urological Surgeon, North Bristol NHS Trust) Mr Gordon Muir (Consultant Urological Surgeon, King’s College Hospital NHS Found Trust) Mr Frank Keeley (Consultant Urological Surgeon, North Bristol NHS Trust) Mr Hashim Hashim (Consultant Urological Surgeon, North Bristol NHS Trust) Prof. Tom McNicholas (Consultant Urological Surgeon, East and North Herts NHS Trust) Mr Andrew Thorpe (Consultant Urological Surgeon, Freeman Hospital, Newcastle Hospitals NHS Found Trust) Mr Neil Barber (Consultant Urological Surgeon, Frimley Park Hospital NHS Found Trust) Prof. Mark Emberton (Professor of Interventional Oncology, Division of Surgery and Interventional Science, UCL and Clinical Director, Clinical Effectiveness Unit, Royal College of Surgeons ofEngland) Mr Mark Speakman (Consultant Urological Surgeon, Musgrove Park Hospital, Taunton & Somerset NHS Found Trust and President of BAUS) All clinical expert advice can be found here: https://www.nice.org.",Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
Clinical guideline 97. http://www.nice.org.uk/ guidance/cg97/resources/guidance-lower-urinary-tract-symptoms- pdf.,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
NICE 2014. http://www.nice.org.uk/guidance/ipg475 .,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
NICE 2003. https://www.nice.org.uk/ guidance/ipg17 .,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
NICE 2014.https://www.ni ce.org.uk/guidance/gid-m t241/documents/the- urolift-system-for-the-treatment-of-lower-urinary-tract-symptoms- secondary-to-benign-prostatic-hyperplasia-ﬁnal-scope2 .,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
http://www.crd.york.ac.uk/prospero/ .,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
http://hospital.blood.co.uk/media/27457/price_list_ 2015-16.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
http://www.isdscotland.org/Health-Topics/ Finance/Publications/2012-11-27/Costs_R040X_2012.xls .A c c e s - sed 26 Jan 2015.,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
https://www.gov.uk/government/publications/nhs- reference-costs-2012-to-2013 .,Non-OADS,/arxiv_data1/oa_pdf/f8/70/40258_2015_Article_218.PMC5025508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/af/main.PMC5025520.pdf
"Kidney Int81:442 e448, 2012 Available online 9 August 2016 http://dx.doi.org/10.1016/j.krcp.2016.08.001 Kidney Research and Clinical Practice journal homepage: http://www.krcp-ksn.com Contents lists available at ScienceDirect Kidney Res Clin Pract 35 (2016) 192 e193",Non-OADS,/arxiv_data1/oa_pdf/6b/af/main.PMC5025520.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowErratum Erratum: Treatment options for pediatric craniopharyngioma In the article titled, “Treatment options for pediatric craniopharyngioma”, which appeared in the pages S174-178,  supplement issue 6, vol.",Non-OADS,/arxiv_data1/oa_pdf/6f/ff/SNI-7-85.PMC5025905.pdf
Available	from:		http://www.fa.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/b9/ae/ABR-5-149.PMC5025910.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Do corticosteroids play a role in the management of traumatic  brain injury?",Non-OADS,/arxiv_data1/oa_pdf/68/2d/SNI-7-84.PMC5025911.pdf
"Surg  Neurol Int 2016;7:84. http://surgicalneurologyint.com/Do-corticosteroids-play-a-role-in-the-management- of-traumatic-brain-injury?/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/68/2d/SNI-7-84.PMC5025911.pdf
"Surgical Neurology International 2016, 7:84  http://www.surgicalneurologyint.com/content/7/1/84with severe TBI to placebo ( n = 80) versus a single bolus  of 100 mg dexamethasone ( n = 81) followed by a taper  regimen (100 mg per day between days 1 and 4, 16 mg  per day between days 5 and 7, and a taper of 12 mg, 8 mg,  and 4 mg for days 8, 9, and 10, respectively).",Non-OADS,/arxiv_data1/oa_pdf/68/2d/SNI-7-84.PMC5025911.pdf
"Surgical Neurology International 2016, 7:84  http://www.surgicalneurologyint.com/content/7/1/84of the enrolled patients were available for the 6‑month  follow‑up.",Non-OADS,/arxiv_data1/oa_pdf/68/2d/SNI-7-84.PMC5025911.pdf
"Surgical Neurology International 2016, 7:84  http://www.surgicalneurologyint.com/content/7/1/84REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/68/2d/SNI-7-84.PMC5025911.pdf
"Platelet‑rich plasma by C‑Punt preparation The authors prepared PRP from a volume of  blood (55 ml) according to the method of C‑punt; Biomed  Device, Modena, Itlay, (http://www.biomeddevice.it).",Non-OADS,/arxiv_data1/oa_pdf/6e/68/ABR-5-134.PMC5025913.pdf
"Coop, San Giuliano Milanese,  Italy, http://www.corios.it) was subjected to automatic  filtration and centrifugation cycles at 1200rpm per  10 minutes after which 40ml of the suspension was  extracted from the bag.",Non-OADS,/arxiv_data1/oa_pdf/6e/68/ABR-5-134.PMC5025913.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Image guidance in skull base tumor resection: A  synergistic  approach using intraoperative navigated angiosonography for  real‑time vessel visualization Francesco Prada1, Massimiliano Del Bene1, Francesco DiMeco1,2 1Department of Neurosurgery, Fondazione IRCCS Istituto Neurologico C. Besta, Milano, Italy, 2Department of Neurological Surgery, Johns Hopkins Medical  School, Baltimore, Maryland, USA E-mail: *Francesco Prada - francesco.prada@istituto-besta.it; Massimiliano Del Bene - macs.delbene@gmail.com; Francesco DiMeco - dimeco.f@istituto-besta.it   *Corresponding author Received: 31 January 16  Accepted: 21 July 16  Published: 13 September 16 Sir, We read with great interest the article by Parviz Dolati  et al .,[1] entitled “Multimodal navigated skull base tumor  resection using image-based vascular and cranial nerve  segmentation: A prospective pilot study.” The authors report their experience with image-based  preoperative vascular and neural element segmentation  with three-dimensional (3D) reconstruction for  intraoperative guidance in ten patients undergoing  surgery for skull base tumor resection.",Non-OADS,/arxiv_data1/oa_pdf/8d/78/SNI-7-82.PMC5025919.pdf
Surg Neurol Int 2016;7:82. http://surgicalneurologyint.com/Image-guidance-in-skull-base-tumor-resection:-A- synergistic-approach-using-intraoperative-navigated-angiosonography-for-real-time- vessel-visualization/,Non-OADS,/arxiv_data1/oa_pdf/8d/78/SNI-7-82.PMC5025919.pdf
"Surgical Neurology International 2016, 7:24  http://www.surgicalneurologyint.com/content/7/1/24preoperative MRI and intraoperative contrast enhanced  ultrasound (CEUS), obtaining a real-time navigated  angiosonography (N-ASG) [Figures 1 and 2].",Non-OADS,/arxiv_data1/oa_pdf/8d/78/SNI-7-82.PMC5025919.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article Metabolic syndrome and the hepatorenal reflex Michael D. Wider Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan, USA E‑mail: *Michael D. Wider ‑ mdwider@yahoo.com   *Corresponding author Received: 07 June 16  Accepted: 19 July 16  Published: 13 September 16 Abstract Insufficient hepatic O2 in animal and human studies has been shown to elicit  a hepatorenal reflex in response to increased hepatic adenosine, resulting in  stimulation of renal as well as muscle sympathetic nerve activity and activating  the renin angiotensin system.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surg Neurol Int 2016;7:83. http://surgicalneurologyint.com/Metabolic-syndrome-and-the-hepatorenal-reflex/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83nephropathy with proteinuria, cardiovascular  disease, obstructive sleep apnea, nonalcoholic fatty  liver disease (NAFLD), and nonalcoholic steatotic  hepatitis (NASH), polycystic ovary syndrome, and  increased risk of a number of cancers.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83pressure and improve insulin sensitivity and lipid levels  in MetS and T2DM.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83MetS would be expected to diminish transport as well as  lowering beta oxidation, resulting in lipid accumulation.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83in remission.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83The reduced contribution of low O2 gastric vein blood  to portal flow and the increased hepatic arterial flow  following gastrectomy would be expected to significantly  improve hepatic O2 delivery [ Figure  3].",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83of ACE inhibitors on insulin resistance and lipid profile in children with  metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83outflow in cirrhosis and ascites; direct evidence from intraneural recordings.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83of the clinically used low-dose pressor, norepinephrine.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83bariatric failure rates with the duodenal switch vs gastric bypass for morbid  obesity.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83222.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
"Surgical Neurology International 2016, 7:83  http://www.surgicalneurologyint.com/content/7/1/83HOPE Study Investigators.",Non-OADS,/arxiv_data1/oa_pdf/65/74/SNI-7-83.PMC5025922.pdf
http://hdl.handle.net/2066/935552012;11:29.,Non-OADS,/arxiv_data1/oa_pdf/da/ac/ABR-5-136.PMC5025926.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS632 Editor: Prof. Sergio Canavero,  MD (US FMGEMS) and Prof. Xiaoping Ren,  MDOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Head and Spinal Cord Transplantation a supplement to Surgical Neurology InternationalOriginal Article Spinal cord fusion with PEG‑GNRs (TexasPEG):  Neurophysiological recovery in 24 hours in rats C‑ Y oon Kim1,2,†, William K. A. Sikkema4,†, In‑Kyu Hwang1, Hanseul Oh2, Un Jeng Kim3,  Bae Hwan Lee3, James M. Tour4,5,6 1Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Korea, 2Department of Laboratory Animal Medicine, College of Veterinary  Medicine, Seoul National University, Seoul, Korea, 3Department of Physiology, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of  Medicine, Seoul, Korea, 4Department of Chemistry, 5The NanoCarbon Center, 6Department of Material Science and Nanoengineering, Rice University, Houston,  T exas, USA E‑mail:  C‑Yoon Kim ‑ vivavets@gmail.com; William K. A. Sikkema ‑ William.Sikkema@rice.edu; In‑Kyu Hwang ‑ weaver 0903@naver.com;   Hanseul Oh ‑ seul3198@snu.ac.kr; Un Jeng Kim ‑ mignon@yuhs.ac; *Bae Hwan Lee ‑ bhlee@yuhs.ac; *James M. T our ‑ T our@Rice.edu   *Corresponding author   †These authors equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/bf/e8/SNI-7-632.PMC5025948.pdf
"http://surgicalneurologyint.com/Spinal-cord-fusion-with-PEG-GNRs-(T exasPEG):- Neurophysiological-recovery-in-24-hours-in-rats/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/bf/e8/SNI-7-632.PMC5025948.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: Prof. Sergio Canavero,  MD (US FMGEMS) and Prof. Xiaoping Ren,  MDOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Head and Spinal Cord Transplantation a supplement to Surgical Neurology InternationalS629Original Article GEMINI: Initial behavioral results after full severance of the  cervical spinal cord in mice C‑ Y oon Kim1,2,†, Hanseul Oh2,†, In‑Kyu Hwang1, Ki‑Sung Hong1 1Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Korea, 2Department of Laboratory Animal Medicine, College of Veterinary  Medicine, Seoul National University, Seoul, Korea E‑mail: *C‑Yoon Kim ‑ vivavets@gmail.com; Hanseul Oh ‑ seul3198@snu.ac.kr; In‑Kyu Hwang ‑ weaver 0903@naver.com; Ki‑Sung Hong ‑ stemness@gmail.com   *Corresponding author   †These authors equally contributed to this work.",Non-OADS,/arxiv_data1/oa_pdf/88/a2/SNI-7-629.PMC5025949.pdf
"http://surgicalneurologyint.com/GEMINI:-Initial-behavioral-results-after-full- severance-of-the-cervical-spinal-cord-in-mice/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/88/a2/SNI-7-629.PMC5025949.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS607Abstract Background:  Ollier disease is a rare, nonfamilial disorder that primary affects the  long bones and cartilage of joints with multiple enchondromas.",Non-OADS,/arxiv_data1/oa_pdf/6a/e8/SNI-7-607.PMC5025950.pdf
"http://surgicalneurologyint.com/Ollier-disease-with-anaplastic-astrocytoma:-A- review-of-the-literature-and-a-unique-case/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/6a/e8/SNI-7-607.PMC5025950.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS612Abstract Background: Lymphomatoid granulomatosis is a rare disorder of the central  nervous system (CNS) with few cases being reported in literature.",Non-OADS,/arxiv_data1/oa_pdf/17/da/SNI-7-612.PMC5025951.pdf
"http://surgicalneurologyint.com/Lymphomatoid-granulomatosis-of-the-brain:-A- case-report/This is an open access article distributed under the terms of the Creative Commons  Attribution -NonCommercial -ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non -commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/17/da/SNI-7-612.PMC5025951.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS623 Editor: Prof. Sergio Canavero,  MD (US FMGEMS) and Prof. Xiaoping Ren,  MDOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Head and Spinal Cord Transplantation a supplement to Surgical Neurology InternationalEditorial HEAVEN: The Frankenstein effect Sergio Canavero, XiaoPing Ren, C. Y oon Kim HEAVEN/GEMINI International Collaborative Group, Turin, Italy E‑mail: *Sergio Canavero ‑ sercan@inwind.it; XiaoPing Ren ‑ chinarenxg@126.com; C. Yoon Kim ‑ vivavets@gmail.com   *Corresponding author Received: 28 July 16  Accepted: 29 July 16  Published: 13 September 16 Access this article online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.190472  Quick Response Code: Abstract The HEAVEN head transplant initiative needs human data concerning the acute  restoration of motor transmission after application of fusogens to the severed cord  in man.",Non-OADS,/arxiv_data1/oa_pdf/b4/45/SNI-7-623.PMC5025952.pdf
"http://surgicalneurologyint.com/HEAVEN:-The-Frankenstein-effect/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/b4/45/SNI-7-623.PMC5025952.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS591Abstract Background: Primary leptomeningeal melanocytic neoplasms of the central nervous  system are rare.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-7-591.PMC5025953.pdf
"http://surgicalneurologyint.com/Multifocal-melanocytoma-of-the-posterior-fossa- and-subcutaneous-scalp-in-the-absence-of-neurocutaneous-melanosis/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/21/b1/SNI-7-591.PMC5025953.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS603Abstract Background: Brain metastasis during pregnancy is a rare occurrence.",Non-OADS,/arxiv_data1/oa_pdf/01/76/SNI-7-603.PMC5025954.pdf
"http://surgicalneurologyint.com/Brain-metastases-from-breast-cancer-during- pregnancy/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/01/76/SNI-7-603.PMC5025954.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS617Abstract Background: Intraoperative neurophysiology, high magnification microscopes,  and ultrasonic aspirators are considered essential aid for the safe resection of  intramedullary spinal cord tumors (IMSCTs).",Non-OADS,/arxiv_data1/oa_pdf/e3/05/SNI-7-617.PMC5025955.pdf
"http://surgicalneurologyint.com/Management-and-outcomes-of-intramedullary-spinal-cord-tumors:-A-single-center-experience-from-a-developing-country/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and  build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/e3/05/SNI-7-617.PMC5025955.pdf
"Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology International © 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowS596Abstract Background:  Epithelioid hemangioendothelioma (EHE) is a rare sarcoma of  vascular origin, which is clinically and histologically intermediate between benign  hemangioma and angiosarcoma.",Non-OADS,/arxiv_data1/oa_pdf/41/48/SNI-7-596.PMC5025957.pdf
"http://surgicalneurologyint.com/Suprasellar-epithelioid-hemangioendothelioma:- Case-report-and-review-of-the-literature/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/41/48/SNI-7-596.PMC5025957.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowEditor: Prof. Sergio Canavero,  MD (US FMGEMS) and Prof. Xiaoping Ren,  MDOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Head and Spinal Cord Transplantation a supplement to Surgical Neurology InternationalS626Editorial Houston, GEMINI has landed: Spinal cord fusion achieved Sergio Canavero, Xiaoping Ren HEAVEN/GEMINI International Collaborative Group, Turin, Italy E‑mail: *Sergio Canavero ‑ sercan@inwind.it; Xiaoping Ren ‑ xren2@luc.edu   *Corresponding author Received: 01 September 16  Accepted: 01 September 16  Published: 13 September 16 In June 2013, the world was taken by storm by the  announcement that a full head (or body) transplant was  possible.",Non-OADS,/arxiv_data1/oa_pdf/b3/ca/SNI-7-626.PMC5025958.pdf
"http://surgicalneurologyint.com/Houston,-GEMINI-has-landed:-Spinal-cord-fusion- achieved/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/b3/ca/SNI-7-626.PMC5025958.pdf
"© 2016 Surgical Neurology International | Published by Wolters Kluwer ‑ MedknowEditor: Prof. Sergio Canavero,  MD (US FMGEMS) and Prof. Xiaoping Ren,  MDOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Head and Spinal Cord Transplantation a supplement to Surgical Neurology InternationalS637Case Report Accelerated recovery of sensorimotor function in a dog submitted  to quasi‑total transection of the cervical spinal cord and treated  with PEG C‑ Y oon Kim, In‑Kyu Hwang, Hana Kim, Se‑Woong Jang1, Hong Seog Kim1, Won‑ Y oung Lee2 Department of Stem Cell Biology, School of Medicine, Konkuk University, 1Liebe Animal Medical Center, Seoul, 2Department of Food Bioscience, College of  Biomedical and Health Science, Konkuk University, Chung‑ju, Korea E‑mail: *C‑Yoon Kim ‑ vivavets@gmail.com; In‑Kyu Hwang ‑ weaver0903@naver.com; Hana Kim ‑ flower216@nate.com; Se‑Woong Jang ‑ vivavet@naver.com;  Hong Seog Kim ‑ cypet@naver.com; Won‑Young Lee ‑ abseng@kku.ac.kr   Corresponding author Received: 07 August 16  Accepted: 31 August 16  Published: 13 September 16 Abstract Background: A case report on observing the recovery of sensory‑motor function  after cervical spinal cord transection.",Non-OADS,/arxiv_data1/oa_pdf/78/27/SNI-7-637.PMC5026027.pdf
"http://surgicalneurologyint.com/Accelerated-recovery-of-sensorimotor-function-in-a-dog- submitted-to-quasi-total-transection-of-the-cervical-spinal-cord-and-treated-with-PEG/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/78/27/SNI-7-637.PMC5026027.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/33/iew075.PMC5026046.pdf
The results were analyzed using Chromas (version 2.23)  software  (http://www.technelysium.com.au/chromas.html)  and compared with the reference sequences in the NCBI  (http://www.ncbi.nlm.nih.gov/) gene bank.,OADS,/arxiv_data1/oa_pdf/64/d6/IJO-64-508.PMC5026076.pdf
Bioinformatics analysis GJA3 amino‑acid sequences were retrieved from the Entrez  protein database and aligned using the ClustalW multiple  sequence alignment web servers (http://www.ebi.ac.uk/ clustalw/).,OADS,/arxiv_data1/oa_pdf/64/d6/IJO-64-508.PMC5026076.pdf
[6] The likely structure of the mutant Cx46 protein  was determined using MEMSAT from the PSIPRED server  (http://bioinf.cs.ucl.ac.uk/psipred/).,OADS,/arxiv_data1/oa_pdf/64/d6/IJO-64-508.PMC5026076.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1749–1758Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1749OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11293 1 comparison of pharmacist and public views and  experiences of community pharmacy medicines- related services in england ruth M rodgers shivaun M gammie ruey leng loo sarah A corlett Janet Krska Medway school of Pharmacy,   The Universities of greenwich and  Kent, chatham Maritime, UKBackground:  Services provided by community pharmacists designed to support people using  medicines are increasing.",Non-OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
"In England,  the Medicines Use Review (MUR) service was introduced in 2005 and by 2014/15, 3.2  million MURs were provided by 93.5% (10,916) of community pharmacies in England.1  This service aims to improve patients’ knowledge and use of medicines and help reduce correspondence: Janet Krska Medway school of Pharmacy,  The Universities of greenwich and Kent,  chatham Maritime, Kent Me4 4TB, UK Tel +44 1634 202950 Fax +44 01634 883827 email j.krska@kent.ac.u k Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Rodgers et al Running head recto: Pharmacist versus public views of pharmacy medicines-related services DOI: http://dx.doi.org/10.2147/PPA.S112931",Non-OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
"Available  from: http://www.nottingham.ac.uk/ ~pazmjb/nms/downloads/report/ index.html#2/ z. Accessed October 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
(Archived by WebCite® at  http://www.webcitation.org/6bydND1c L.) 11.,OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
Available from: http://onlinelibrary.wiley.com/ doi/10.1111/jphs.12121/abstract.,Non-OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/97/bd/ppa-10-1749.PMC5026175.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e8/36/ndt-12-2319.PMC5026176.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2319–2325Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2319OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11443 9 autistic traits in women with primary  dysmenorrhea: a case–control study harun T oy1 arzu hergüner2 Sevcan Şimşek1 sabri hergüner3 1Department of Obstetrics and  gynecology, Meram Faculty of  Medicine, Necmettin Erbakan  University, 2child and adolescent  Psychiatry clinic, Konya Training and  research hospital, 3Department of  child and adolescent Psychiatry,   Meram Faculty of Medicine,   Necmettin Erbakan University,   Konya, T urkeyObjectives:  Recent studies have shown that women with autism spectrum disorder have higher  rates of menstrual problems, including irregular menstrual cycles, unusually painful periods  (dysmenorrhea), and excessive menstrual bleeding.",Non-OADS,/arxiv_data1/oa_pdf/e8/36/ndt-12-2319.PMC5026176.pdf
"PD first occurs usually during adolescence after ovulatory cycles become estab - lished, and pain severity decreases with increasing age.2 The contributing risk  factors include younger age, low and high body mass index, earlier age at menar - che (AAM), smoking, prolonged or aberrant menstrual flow, family history of  dysmenorrhea, nulliparity, high caffeine intake, and a history of sexual abuse.1–3  It negatively affects daily life activities, academic performance, and socializing  with peers and is reported to be associated with psychiatric conditions such as  depression and anxiety.4 Autism spectrum disorder (ASD) is characterized by deficits in social commu - nication and social interaction across contexts, as well as restricted and repetitive  patterns of behavior, interests, or activities.5 According to the report of Autism and  Developmental Disabilities Monitoring Network, the current estimated prevalence of  ASD is 14.7/1,000 (one in 68) children aged 8 years.6 Males are approximately four  times more likely than females to receive the diagnosis.7 Although the underlying correspondence: harun Toy Department of Obstetrics and  gynecology, Meram Faculty of Medicine,  Necmettin Erbakan University, S Block  Fifth Floor, No 501, Post code 42090,  Meram, Konya, Turkey Tel +90 332 223 7863 email haruntoy@hotmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Toy et al Running head recto: Autistic traits and primary dysmenorrhea DOI: http://dx.doi.org/10.2147/NDT.S114439",Non-OADS,/arxiv_data1/oa_pdf/e8/36/ndt-12-2319.PMC5026176.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e8/36/ndt-12-2319.PMC5026176.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/36/ndt-12-2319.PMC5026176.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ab/59/ppa-10-1759.PMC5026177.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1759–1766Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1759OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10190 4 Psychometric properties of the Polish version  of the eight-item Morisky Medication Adherence  scale in hypertensive adults Beata Jankowska-Polanska1 izabella Uchmanowicz1 Anna chudiak1 Krzysztof Dudek2 Donald e Morisky3 Anna szymanska- chabowska4 1Department of clinical nursing,   Faculty of health science, Wroclaw  Medical University, Wroclaw,   Poland; 2Department of logistic  and Transport systems, Faculty of  Mechanical engineering, Wroclaw  University of T echnology, Wroclaw,   Poland; 3Department of community  health sciences, U clA Fielding  school of Public health, los Angeles,   cA, UsA; 4Department of internal  Medicine, Occupational Diseases  and hypertension, Wroclaw Medical  University, Wroclaw, PolandAbstract:  Low adherence to pharmacological treatment is often associated with poor blood  pressure control, but identification of nonadherent patients in outpatient settings is difficult.",Non-OADS,/arxiv_data1/oa_pdf/ab/59/ppa-10-1759.PMC5026177.pdf
"The prevalence of hypertension in European countries is about 60% higher than in the  USA or Canada.2 In Poland, hypertension is diagnosed in 29% of adult population,  and only 12% of patients are treated properly.3 Effective treatment of hypertension is based on lifestyle modification and long- term pharmacotherapy; however, about 40%–60% of patients with hypertension fail  to comply with the prescribed treatment4 and about 50% stop taking their drugs during  the first 12 months of treatment and 30% do not take them as prescribed.5 Poor blood correspondence: Beata Jankowska- Polanska Department of clinical nursing, Faculty  of health science, Wroclaw Medical  University, 5 Bartla street, Wroclaw  51-618, Poland Tel +48 71 784 1824 Fax +48 71 345 9324 email bianko@poczta.onet.p l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Jankowska-Polanska et al Running head recto: Polish version of the 8-item Morisky Medication Adherence Scale DOI: http://dx.doi.org/10.2147/PPA.S101904",Non-OADS,/arxiv_data1/oa_pdf/ab/59/ppa-10-1759.PMC5026177.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/ab/59/ppa-10-1759.PMC5026177.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7a/95/ott-9-5629.PMC5026178.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5629–5642OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5629Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9703 0 Clinical utility of 5-aminolevulinic acid HCl  to better visualize and more completely  remove gliomas Sameer H Halani1 D Cory Adamson1,2 1Department of Neurosurgery,   emory University School of Medicine,   Atlanta, GA, USA; 2Neurosurgery  Section, Atlanta vA Medical Center,   Decatur,  GA, USAAbstract:  Surgical resection is typically the first line of treatment for gliomas.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/ott-9-5629.PMC5026178.pdf
"Multiple studies  have demonstrated that the extent of resection is a recognized prognostic factor in HGGs Correspondence: D Cory Adamson emory University School of Medicine,  1365-B Clifton Rd, Ne, Suite 2200,  Atlanta, GA 30322, USA Tel +1 404 778 5770 email cory.adamson@emory.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Halani and Adamson Running head recto: Clinical utility of 5-ALA for glioma resection DOI: http://dx.doi.org/10.2147/OTT.S97030",Non-OADS,/arxiv_data1/oa_pdf/7a/95/ott-9-5629.PMC5026178.pdf
Available from: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/7a/95/ott-9-5629.PMC5026178.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/95/ott-9-5629.PMC5026178.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/95/ott-9-5629.PMC5026178.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/33/opth-10-1737.PMC5026179.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1737–1742Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1737Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10278 9 Optic nerve head topography and retinal  structural changes in eyes with macrodisks:  a comparative study with spectral domain  optical coherence tomography Zeynep Kayaarası Öztürker Kadir eltutar Belma Karini Sezin Özdogan Erkul Özen Ayrancı  Osmanbaşog ˇlu Pınar Sultan Ophthalmology Department, istanbul  research and Training hospital,   istanbul, T urkeyPurpose:  To compare optic nerve head parameters, the thicknesses of the peripapillary retinal  nerve fiber layer (pRNFL), the macular retinal nerve fiber layer (mRNFL), the ganglion cell  complex (GCC), and the ganglion cell–inner plexiform layer (GCIPL) in macrodisks and normal- sized healthy disks using spectral domain optical coherence tomography.",Non-OADS,/arxiv_data1/oa_pdf/84/33/opth-10-1737.PMC5026179.pdf
"Kocamustafapaşa,  Fatih, istanbul, Turkey Tel +90 212 669 4389 email zeynepkayaa@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Öztürker et al Running head recto: ONH topography and retinal structural changes in eyes with macrodisks DOI: http://dx.doi.org/10.2147/OPTH.S102789",Non-OADS,/arxiv_data1/oa_pdf/84/33/opth-10-1737.PMC5026179.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/84/33/opth-10-1737.PMC5026179.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/33/opth-10-1737.PMC5026179.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1403–1410Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1403ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11174 9 Reporting of adverse events related to dietary  supplements to a public health center by medical  staff: a survey of clinics and pharmacies Kazuki ide1 hiroshi Yamada1 Y ohei Kawasaki1 Marika noguchi1 Mamoru Kitagawa1 Tsuyoshi Chiba2 Y oshiyuki Kagawa3 Keizo Umegaki2 1Department of Drug evaluation &  informatics, graduate school of  Pharmaceutical sciences, University  of shizuoka, shizuoka, 2information  Center, national institutes of  Biomedical innovation, health and  nutrition, T okyo, 3Department of  Clinical Pharmaceutics, graduate  school of Pharmaceutical sciences,   University of shizuoka, shizuoka, JapanBackground:  Dietary supplements are used by .50% of the adult population in Japan, and  adverse events related to these products have been reported with their increased use.",Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
"Reliable methods for estimating causal relationships between  dietary supplements and adverse events have been developed.11 However, before such  relationships can be assessed, an efficient means to gather data – such as the MedWatch  system established by the US Food and Drug Administration – is essential.12,13 In Japan, there are three main avenues for reporting adverse events related to dietary  supplements: 1) manufacturers or retail stores; 2) the practical living information Correspondence: hiroshi Yamada Department of Drug evaluation &  informatics, graduate school of  Pharmaceutical sciences, University  of shizuoka, 52-1 Yada, suruga-ku,  shizuoka 422-8526, Japan Tel +81 54 264 5762 Fax +81 54 264 5762 email hyamada@u-shizuoka-ken.ac.j p Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Ide et al Running head recto: Reporting of adverse events related to dietary supplements DOI: http://dx.doi.org/10.2147/TCRM.S111749",Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
"Therapeutics and Clinical Risk Management 2016:12submit your manuscript | www.dovepress.co m Dove press Dove press 1404ide et al online network system ( http://www.kokusen.go.jp/pionet /);  and 3) local government public health centers.14 However,  manufacturers or retail stores often do not disclose detailed  information from consumers, and practical living informa - tion online network system reports include limited informa - tion, which makes it difficult to identify a cause-and-effect  relationship.14 Local government public health centers are  the formal points of contact for reporting adverse events  related to dietary supplements.",Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
"Available  from: https://kouseikyoku.mhlw.go.jp/tokaihokuriku/gyomu/gyomu/ hoken_kikan/shitei.htm l. Accessed May 25, 2016.",Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
Avail - able from: https://hfnet.nih.go.jp /.,Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/74/tcrm-12-1403.PMC5026180.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/c4/ott-9-5643.PMC5026181.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5643–5650OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5643Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11168 4 The association of PTEN  hypermethylation and  breast cancer: a meta-analysis shanshan luo Jiansi chen Xianwei Mo Department of gastrointestinal  surgery, T umor hospital of guangxi  Medical University, nanning, guangxi,   People’s republic of chinaObjective:  Phosphatase and tensin homolog ( PTEN ) deleted on chromosome 10, as a tumor  suppressor gene, is crucial  for the development of both familial and sporadic breast cancer  (BC).",Non-OADS,/arxiv_data1/oa_pdf/41/c4/ott-9-5643.PMC5026181.pdf
"Breast carcinogenesis is a stepwise accumulation of genetic changes including  point mutations, deletions, oncogene activation, or tumor suppressor inactivation.4 correspondence: shanshan luo Department of gastrointestinal  surgery, Tumor hospital of guangxi  Medical University, 71 hedi road,  nanning 530021, guangxi, People’s  republic of china email ssluomd98@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Luo et al Running head recto: Association of PTEN  hypermethylation and breast cancer DOI: http://dx.doi.org/10.2147/OTT.S111684",Non-OADS,/arxiv_data1/oa_pdf/41/c4/ott-9-5643.PMC5026181.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/41/c4/ott-9-5643.PMC5026181.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/c4/ott-9-5643.PMC5026181.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/49/ndt-12-2307.PMC5026182.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2307–2317Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2307OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10643 3 alexithymia, impulsiveness, and psychopathology  in nonsuicidal self-injured adolescents Michela gatta1 Francesco Dal santo1 alessio rago1 andrea spoto2 Pier antonio Battistella1 1childhood adolescence Family  Unit, Ulss 16 – Padua University,   2Department of general Psychology,   Padua University, Padova, italyIntroduction:  Nonsuicidal self-injury (NSSI) is a multifaceted phenomenon and a major  health issue among adolescents.",Non-OADS,/arxiv_data1/oa_pdf/4c/49/ndt-12-2307.PMC5026182.pdf
"A recent meta-analysis reported an  adjusted lifetime pooled prevalence of NSSI for adolescents of 17.2%,3 a figure very  similar to the findings of previous studies.4 It has been estimated that only about one  in eight self-harming adolescents in the community go to hospital.5 The methods  used to self-inflict injuries typically involve cutting or scratching the skin, though  other methods are used too.6 Cutting is generally done on the arms, but self-injurers correspondence: Michela gatta childhood adolescence Family Unit,  Ulss 16, Via colli 4   Padova 35143, italy Tel +39 049 8217 690 Fax +39 049 8217 708 email michela.gatta@unipd.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Gatta et al Running head recto: Alexithymia, impulsiveness, and psychopathology in NSSI adolescents DOI: http://dx.doi.org/10.2147/NDT.S106433",Non-OADS,/arxiv_data1/oa_pdf/4c/49/ndt-12-2307.PMC5026182.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4c/49/ndt-12-2307.PMC5026182.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/49/ndt-12-2307.PMC5026182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Patient Related Outcome Measures 2016:7 127–135Patient Related Outcome Measures Dovepress submit your manuscript | www.dovepress.com Dovepress 127 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S95593 Patient-reported symptom distress, and most  bothersome issues, before and during cancer  treatment Fangxin Hong1,2 Traci M Blonquist1 Barbara Halpenny3 Donna L Berry3,4 1Department of Biostatistics and  Computational Biology, Dana -Farber  Cancer Institute, Boston, MA,   USA;2Department of Biostatistics,   Harvard School of Public Health,  Boston, MA, USA;  3Department of  Nursing and Patient Care Services,  The Phyllis F .",Non-OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
"Investigators have documented the negative relation-ships between symptom distress and adults’ quality of life (QOL) both physically and psychologically before and during active medical cancer therapy, 2,3 postoperatively,4 Correspondence: Fangxin Hong Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health, 450 Brookline Avenue, mailstop CLSB 11007, Boston, MA 02115, USATel +1 617 632 3602Fax +1 617 632 2444Email fxhong@jimmy.harvard.eduJournal name: Patient Related Outcome Measures Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Hong et alRunning head recto: Patient-reported symptom distress and botherDOI: http://dx.doi.org/10.2147/PROM.S95593",Non-OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
"Patient Related Outcome Measures 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/patient-related-outcome-measures-journalPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/bb/prom-7-127.PMC5026183.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/86/opth-10-1759.PMC5026184.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1759–1765Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1759Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10308 4 Preservative-free bimatoprost 0.03% in patients  with primary open-angle glaucoma or ocular  hypertension in clinical practice lutz e Pillunat1 Peter eschstruth2 stefan häsemeyer3 Ulrich Thelen4 Christian Foja5 richard leaback6 stefan Pfennigsdorf7 1Department of Ophthalmology,   University hospital Carl gustav  Carus, Dresden, 2Ophthalmology  Practice, Kiel, 3eye Center  Kraichgau, Wiesloch, 4Department of  Ophthalmology, University of Münster,   Münster, 5Ophthalmology Practice,   leipzig, germany; 6allergan holdings  ltd., Marlow, UK; 7Ophthalmology  Practice, Polch, germanyBackground:  Intraocular pressure (IOP)-lowering medications for primary open-angle  glaucoma and ocular hypertension commonly contain preservatives that can cause ocular surface  damage in many patients.",Non-OADS,/arxiv_data1/oa_pdf/63/86/opth-10-1759.PMC5026184.pdf
"This number is expected to rise by 18.2% in 2020 and by 73.8%  in 2040, to 76.0 and 111.8 million people worldwide, respectively.Correspondence: lutz e Pillunat Department of Ophthalmology,  University hospital Carl gustav Carus  Fetscherstrasse 74, 01307 Dresden,  germany Tel +49 35 1458 3381 email augendirektion@uniklinikum- dresden.d e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Pillunat et al Running head recto: Efficacy and tolerability of switching to PF bimatoprost 0.03% DOI: http://dx.doi.org/10.2147/OPTH.S103084",Non-OADS,/arxiv_data1/oa_pdf/63/86/opth-10-1759.PMC5026184.pdf
Available from: http://emc.medicines.org.uk/medicine/8925/ SPC/Lumigan /.,Non-OADS,/arxiv_data1/oa_pdf/63/86/opth-10-1759.PMC5026184.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/63/86/opth-10-1759.PMC5026184.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/86/opth-10-1759.PMC5026184.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/59/opth-10-1743.PMC5026185.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1743–1748Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1743Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10948 6 successful conjunctival socket expansion in  anophthalmic patients until the age of 2 years: an  outpatient procedure rania assem el essawy sameh hassan abdelbaky Department of Ophthalmology,   Faculty of Medicine, Cairo University,   Cairo, egyptPurpose:  To report the results of a simple outpatient method for soft tissue socket expansion  in young children with congenital anophthalmos.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/opth-10-1743.PMC5026185.pdf
An abstract was published in the “AAPOS 2013 Meeting  Abstracts” ( http://www.jaapos.org/issue/S1091-8531(13) X0002- 3).,Non-OADS,/arxiv_data1/oa_pdf/ae/59/opth-10-1743.PMC5026185.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ae/59/opth-10-1743.PMC5026185.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/59/opth-10-1743.PMC5026185.pdf
(Cell Mol Gastroenterol Hepatol 2016;2:412 –428; http://dx.doi.org/ 10.1016/j.jcmgh.2016.04.003 ) Keywords: Acute Pancreatitis; Biliary Pancreatitis; Necroptosis; Apoptosis; Pancreatic Cell Death.,Non-OADS,/arxiv_data1/oa_pdf/4c/8e/main.PMC5026190.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/8e/main.PMC5026190.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2016.04.003,OADS,/arxiv_data1/oa_pdf/4c/8e/main.PMC5026190.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/1a/cia-11-1239.PMC5026212.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1239–1246Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1239OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10928 1 nutritional intervention in cognitively impaired  geriatric trauma patients: a feasibility study D eschbach1 T Kirchbichler1 T Wiesmann2 l Oberkircher1 C Bliemel1 s ruchholtz1 B Buecking1 1Center for Orthopedics and  Trauma surgery, 2Department  of Anaesthesiology and Critical  Care, University of Marburg,   Marburg, germanyBackground:  Most studies focusing on improving the nutritional status of geriatric trauma  patients exclude patients with cognitive impairment.",Non-OADS,/arxiv_data1/oa_pdf/f8/1a/cia-11-1239.PMC5026212.pdf
"Keywords:  malnutrition, perioperative nutrition management, elderly, cognitive impaired  geriatric trauma patients Introduction Owing to demographic changes, malnutrition is a continuing source of concern among  older people.1,2 Data show that up to 55% of elderly hospitalized patients and up to  58% of patients with a hip fracture are undernourished on admission.3–6 Perioperative  medical complications, perioperative periods of prolonged fasting while waiting for  surgical treatment, and preexisting dementia may also restrict nutritional intake in  the perioperative phase.7,8 It is estimated that ~30% of patients who sustain a hip Correspondence: D eschbach Center for Orthopedics and  Trauma surgery, University  of Marburg, Baldingerstrasse,  D-35033 Marburg, germany Tel +49 6421 586 3544 email eschbach@med.uni-marburg.d e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Eschbach et al Running head recto: Nutritional status of geriatric trauma patients DOI: http://dx.doi.org/10.2147/CIA.S109281",Non-OADS,/arxiv_data1/oa_pdf/f8/1a/cia-11-1239.PMC5026212.pdf
"Available from: http://www.aqua-institut.d e.   Accessed May 31, 2012.",Non-OADS,/arxiv_data1/oa_pdf/f8/1a/cia-11-1239.PMC5026212.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f8/1a/cia-11-1239.PMC5026212.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f8/1a/cia-11-1239.PMC5026212.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b3/19/opth-10-1749.PMC5026213.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1749–1757Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1749Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10850 9 Multimodal imaging and diagnosis of myopic  choroidal neovascularization in Caucasians Paolo Milani1 amedeo Massacesi1 stefania Moschini1 Marco setaccioli1 ennio Bulone1 gemma Tremolada1 stefano Ciaccia1 elena Mantovani1 Daniela Morale2 Fulvio Bergamini1 1Ophthalmology Department,   istituto auxologico, 2institute of  Mathematics, Universita’ degli studi  di Milano, Milan, italyPurpose:  To investigate myopic choroidal neovascularization (mCNV) by fluorescein angio­ graphy (FA), spectral­domain optical coherence tomography (SD­OCT), near­infrared (NIR)  reflectance, and autofluorescence (AF).",Non-OADS,/arxiv_data1/oa_pdf/b3/19/opth-10-1749.PMC5026213.pdf
"This “multimodal approach” is now widely employed  in highly specialized centers, especially to examine the retina when difficulties arise  in diagnosis or for study purposes.1Correspondence: Paolo Milani  Ophthalmology Department,  istituto auxologico italiano,  Via Mercalli 30, 20122 Milan, italy Tel +39 5821 8118 email dottpaolomilani@hotmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Milani et al Running head recto: Multimodal imaging of myopic CNV DOI: http://dx.doi.org/10.2147/OPTH.S108509",Non-OADS,/arxiv_data1/oa_pdf/b3/19/opth-10-1749.PMC5026213.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer ­reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b3/19/opth-10-1749.PMC5026213.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/19/opth-10-1749.PMC5026213.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 631–640Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  631 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S112626Use of preoperative gabapentin significantly  reduces postoperative opioid consumption:  a meta-analysis Sudha Arumugam1  Christine SM Lau1,2  Ronald S Chamberlain1–3 1Department of Surgery, Saint  Barnabas Medical Center, Livingston,   NJ, USA; 2Saint George’s University  School of Medicine, Grenada, West Indies;  3Department of Surgery,   Rutgers University, New Jersey Medical School, Newark, NJ, USAObjectives: Effective postoperative pain management is crucial in the care of surgical patients.",Non-OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
"5 While the majority of surgical patients recover and return  to a functional status, some patients are more likely to develop long-term opioid use Correspondence: Ronald S Chamberlain   Department of Surgery, Saint Barnabas  Medical Center, 94 Old Short Hills Road, Livingston, NJ 07039, USA Tel +1 973 322 5195   Fax +1 973 322 2471   Email rchamberlain@barnabashealth.orgJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Arumugam et alRunning head recto: Preoperative gabapentin decreases postoperative opioid requirementsDOI: http://dx.doi.org/10.2147/JPR.S112626",Non-OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
Available from: http://www.cdc.gov/nchs/fastats/.,OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 640 Arumugam et al,Non-OADS,/arxiv_data1/oa_pdf/0b/18/jpr-9-631.PMC5026214.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 445–456ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  445 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S107121Cost versus utility of aclidinium bromide 400 µg  plus formoterol fumarate dihydrate 12 µg  compared to aclidinium bromide 400 µg alone in  the management of moderate-to-severe COPD Mafalda Ramos1 John Haughney2 Nathaniel Henry3 Leandro Lindner4 Mark Lamotte1 1Real World Evidence, IMS Health,   Zaventem, Belgium; 2Academic  Primary Care Division of Applied  Health Sciences, University of Aberdeen, Aberdeen, Scotland,  3Health  Economics and Outcomes Research,  Real World Evidence, IMS Health,  London, UK;  4AstraZeneca,    Barcelona, SpainPurpose: Aclidinium–formoterol 400/12 µg is a long-acting muscarinic antagonist (LAMA) and  a long-acting β2-agonist in a fixed-dose combination used in the management of patients with  COPD.",Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
"Progressive dyspnea, chronic cough, Correspondence: Mafalda Ramos RWE, IMS Health, Corporate Village, Davos Building, 7 Da Vincilaan, Zaventem 1935, BelgiumTel +32 2 627 3285Fax:+32 2 646 7241Email mafalda.ramos@be.imshealth.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Ramos et alRunning head recto: Cost-effectiveness of aclidinium–formoterol versus aclidiniumDOI: http://dx.doi.org/10.2147/CEOR.S107121",Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.isdscotland.org/Health-Topics/General-Practice/GP-Consultations/Health-Conditions/COPD .,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.audit-scotland.gov.uk/docs/health/2007/nr_070816_managing_long_term.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01462942.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01437397.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.hscic.gov.uk/pubs/hse09trends.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 456 Ramos et al 22.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.nhstaysideadtc.scot.nhs.uk/ approved/bulletin/taypres/2014/Tayside%20Prescriber%20131%20-%20Respiratory%20Update%20%20COPD%20April%202014%20final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.nhsforthvalley.com/__documents/qi/ce_guideline_copd/nhsfvcopd-guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.bnf.org/products/bnf-online.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: https://www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.oecd.org/std .,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.isdscotland.org/Health-Topics/Finance/Scottish-National-Tariff.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK45886/pdf/Bookshelf_NBK45886.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from: https://www.cadth.ca/thiazide-diuretics-first-line-treatment-hyperten-sion-meta-analysis-and-economic-evaluation-0.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
Available from http://repub.eur.nl/pub/20172/Comparing%20the%20cost-effectiveness%20of%20a%20wide%20range%20of%20COPD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/ceor-8-445.PMC5026215.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/1c/dddt-10-2899.PMC5026216.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2899–2915Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2899Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11169 5 effects of an immunosuppressive treatment  on the rat prostate Marta grabowska1 Karolina Kędzierska2 Katarzyna Michałek3 Sylwia Słuczanowska- Głąbowska4 Maciej grabowski5 Małgorzata Piasecka1 Andrzej Kram6 iwona rotter7 Aleksandra Rył1 Maria Laszczyńska1 1Department of histology and  Developmental Biology, Pomeranian  Medical University, 2Department of  nephrology, Transplantology and  Internal Medicine, Pomeranian Medical  University, 3Department of Physiology,   Cytobiology and Proteomics, West  Pomeranian University of T echnology,   4Department of Physiology,   Pomeranian Medical University,   5Department of Microbiology  and Applied Biotechnology, West  Pomeranian University of T echnology,   6Department of Pathology,  West  Pomeranian Oncology Center,   7Department of Medical  Rehabilitation, Pomeranian Medical  University, Szczecin, PolandAbstract:  The aim of this study was to determine the influence of different combinations of  immunosuppressive drugs on the morphology, ultrastructure, and expression of proliferating  cell nuclear antigen and cytoskeleton proteins in the rat dorsolateral prostate.",Non-OADS,/arxiv_data1/oa_pdf/18/1c/dddt-10-2899.PMC5026216.pdf
"Many substances with immunosuppressive properties can be used together in  different combinations on account of their multidirectional effects.2 For this reason,  in clinical practice, immunosuppressive therapy in humans is based on multidrug  regimens.7,8 However, the bulk of the published studies focus on the impact of indi - vidual drugs on organs and tissues, despite the fact that these drugs may affect each  other’s metabolism.1,9–11correspondence: Marta grabowska Department of histology and  Developmental Biology, Pomeranian  Medical University, 48, Żołnierska Street,  71-210 Szczecin, Poland Tel +48 91 480 0908 email martag@pum.edu.p l Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Grabowska et al Running head recto: Immunosuppressants and the prostate DOI: http://dx.doi.org/10.2147/DDDT.S111695",Non-OADS,/arxiv_data1/oa_pdf/18/1c/dddt-10-2899.PMC5026216.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/18/1c/dddt-10-2899.PMC5026216.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/1c/dddt-10-2899.PMC5026216.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2016:10 119–138Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  119 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S89218Therapeutic efficacy of monthly subcutaneous  injection of daclizumab in relapsing multiple  sclerosis Stanley Cohan1,2,3 1Providence Multiple Sclerosis Center,   2Providence Brain and Spine institute,   3Providence Health & Services,   Portland, OR, USAAbstract:  Despite the availability of multiple disease-modifying therapies for relapsing multiple  sclerosis (MS), there remains a need for highly efficacious targeted therapy with a favorable  benefit–risk profile and attributes that encourage a high level of treatment adherence.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
"1 Relapses are transient and followed Correspondence: Stanley Cohan Providence Multiple Sclerosis Center, 9427 Sw Barnes Road, Portland, OR 97225, USATel +1 503 216 1150Fax +1 503 216 1170email Stanley.Cohan@providence.orgJournal name: Biologics: Targets and Therapy Article Designation: ReviewY ear: 2016V olume: 10Running head verso: CohanRunning head recto: Therapeutic efficacy of daclizumab for relapsing MSDOI: http://dx.doi.org/10.2147/BTT.S89218 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
Or use: http://youtu.be/TesJYGJeYeA,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
Avail- able from: http://www.msif.org/about-us/advocacy/atlas/.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
Available from: http://www.roche.com/media/store/releases/med-cor-2015-10-08.htm.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01462318.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01797965.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
"Biologics: Targets and Therapy 2016:10submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 138 Cohan 154.,Non-OADS,/arxiv_data1/oa_pdf/d0/ae/btt-10-119.PMC5026217.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2881–2897Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2881Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10619 6 Understanding cytoskeleton regulators in  glioblastoma multiforme for therapy design samaneh Masoumi,1,*  aditya harisankar,2,* aileen  gracias,3 Fabian Bachinger,1  T emesgen Fufa,1,4 gayathri  chandrasekar,5 Frank  gaunitz,4 Julian Walfridsson,2  satish s Kitambi1 1Department of Microbiology  T umor and cell Biology, 2center  for hematology and regenerative  Medicine, Department of Medicine,  3Department of neuroscience,  Karolinska institutet, solna, sweden;  4Department of neurosurgery,  University hospital, leipzig, germany;  5Department of Biosciences and  nutrition, Karolinska institutet, solna,  sweden *These authors contributed equally  to this workAbstract:  The cellular cytoskeleton forms the primary basis through which a cell governs the  changes in size, shape, migration, proliferation, and forms the primary means through which  the cells respond to their environment.",Non-OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
"GBM is one of the most aggressive brain tumors  with reduced life expectancy,3,4 often attributed to its high recurrence rate, even after  surgery and chemotherapy.4–6 The high recurrence rate of GBM is attributed to the  high infiltrative and invasive nature of the residual tumor cells.4 Current therapies  against GBM have not achieved a dramatic increase in prolonging lifespan due to  the difficulties posed by the location of the tumor, difficulties associated with drug  delivery, the blood–brain barrier, and tumor cells gaining resistance to chemo- or  radiotherapy.6–8 Current therapy includes surgery, use of a broad-spectrum alkylating  agent called temozolomide (TMZ) that is orally administered, and radiation therapy.6,7  The gene(s) or gene product(s) resulting in oncogenic transformation of cells are usu - ally components of signal transduction pathways that are involved in many diverse correspondence: satish s Kitambi Department of Microbiology Tumor and  cell Biology, Karolinska institutet, nobels  Vag 16, solna 17177, sweden email satish.kitambi@ki.s eJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Masoumi et al Running head recto: Cytoskeleton regulators in GBM DOI: http://dx.doi.org/10.2147/DDDT.S106196 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
Or use: http://youtu.be/3s9W7GoF-J gVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
Patient survival plots Survival curves were plotted for genes using patient survival  data sets available at TCGA database ( http://tcga-data.nci.,OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/60/dddt-10-2881.PMC5026218.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 463–475International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  463RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S10949 8 Factors associated with institutional delivery  service utilization in ethiopia Alemi Kebede1 Kalkidan Hassen2 Aderajew Nigussie  T eklehaymanot1 1Department of Population and Family  Health, 2College of Health Sciences,   Jimma University, ethiopiaBackground:  Most obstetric complications occur unpredictably during the time of delivery,  but they can be prevented with proper medical care in the health facilities.",Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
"It ensures safe birth,  reduces both actual and potential complications and maternal death, and increases the  survival of most mothers and newborns.4Correspondence: Aderajew Nigussie  Teklehaymanot Department of Population and Family  Health, College of Health Sciences, Old  Registrar Building, Room Number 5,  Jimma University, ethiopia Tel +251 912914777 email aderajewnu@gmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: Kebede et al Running head recto: Factors associated with institutional delivery service utilization in Ethiopia DOI: http://dx.doi.org/10.2147/IJWH.S109498",Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
Available from http://www.who.int/reproductivehealth/publications/ monitoring/maternal-mortality-2013/en /.,Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
Available from: http://www.unfpa.org/webdav/site/global/eng.,Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
"Available from: http://www.who.int/mediacentre/factsheets/ fs348/en/.world health Organizatio n. Accessed December 27, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/23/ijwh-8-463.PMC5026219.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/48/cia-11-1247.PMC5026220.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1247–1252Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1247OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10870 5 effect-site concentration of remifentanil for  preventing cough during emergence in elderly  patients undergoing nasal surgery: a comparison  with adult patients Ji Y oung Y oo1 Jong Yeop Kim1 hyun Jeong Kwak2 Dong Chul lee2 go Wun Kim1 sook Y oung lee1 Yun Jeong Chae1 1Department of Anaesthesiology and  Pain Medicine, Ajou University school  of Medicine, suwon, 2Department of  Anaesthesiology and Pain Medicine,   gachon University, gil Medical  Center, Incheon, KoreaPurpose:  Prevention of cough during emergence after nasal surgery is important for avoiding  surgical site bleeding.",Non-OADS,/arxiv_data1/oa_pdf/ed/48/cia-11-1247.PMC5026220.pdf
"Alongside medical  development, an increasing number of elderly patients undergo surgery and exhibit  a greater prevalence of cardiovascular disease than younger patients.2,3 Therefore,  the application of agents for cough suppression during emergence should be inves - tigated further.Correspondence: Yun Jeong Chae Department of Anaesthesiology and  Pain Medicine, Ajou University school  of Medicine, 164, Worldcup-ro,  Yeongtong-gu, suwon, 16499, Korea Tel +82 31 219 5576 Fax +82 31 219 5579 email yjchae06@hotmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y oo et al Running head recto: Remifentanil for smooth emergence in elderly patients DOI: http://dx.doi.org/10.2147/CIA.S108705",Non-OADS,/arxiv_data1/oa_pdf/ed/48/cia-11-1247.PMC5026220.pdf
"To minimize the  inaccuracy of the individual study, more than the minimum  six crossover points are required in this method.17Statistical analyses were performed using the Statistical  Package for Social Sciences (version 20.0 for Windows;  IBM Corporation, Armonk, NY, USA) and R for Windows  (version 3.0.1; The R Foundation for Statistical Computing;  https://www.r-project.or g).",Non-OADS,/arxiv_data1/oa_pdf/ed/48/cia-11-1247.PMC5026220.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ed/48/cia-11-1247.PMC5026220.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ed/48/cia-11-1247.PMC5026220.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 641–652Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  641 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S109038Thermal temporal summation and decay of   after-sensations in temporomandibular myofascial  pain patients with and without comorbid  fibromyalgia Malvin N Janal1 Karen G Raphael2 Dane B Cook3 David A Sirois2 Lena Nemelivsky2 Roland Staud4 1Epidemiology and Health Promotion,   2Oral and Maxillofacial Pathology,   Radiology, and Medicine, NYU  College of Dentistry, New Y ork,  NY,  3Department of Kinesiology,   University of Wisconsin, Madison, WI,   4Department of Medicine, University  of Florida College of Medicine,  Gainesville, FL, USAIntroduction: Chronic myofascial temporomandibular disorders (TMD) may have multiple  etiological and maintenance factors.",Non-OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
"One theory holds that pain results from a dysregulation of endogenous pain mechanisms, and this theory is par - tially supported by quantitative sensory testing studies showing that myofascial TMD patients have lower thresholds to noxious thermal and pressure stimuli than controls (hyperalgesia), as well as more painful responses to innocuous stimuli (allodynia), 1–7  higher levels of temporal summation (TS, participant reports increased painfulness of repeated stimuli, despite constant stimulus intensity) 6,8–10 and greater persistence Correspondence: Malvin N Janal Epidemiology and Health Promotion, NYU College of Dentistry, Suite 301,   380 Second Avenue, New York,   NY 10010, USAEmail mj62@nyu.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Janal et alRunning head recto: Central sensitization in TMD and FMDOI: http://dx.doi.org/10.2147/JPR.S109038",Non-OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 652 Janal et al 17.,Non-OADS,/arxiv_data1/oa_pdf/87/7d/jpr-9-641.PMC5026221.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/c7/msw125.PMC5026251.pdf
"1997 )a g a i n s tt h e database of 21 complete Rhodobacterales genomes ( supple mentary table S3 ,Supplementary Material online; downloaded from the NCBI FTP site at ftp://ftp.ncbi.nlm.nih.gov/genomes/ Bacteria/).",OADS,/arxiv_data1/oa_pdf/3d/c7/msw125.PMC5026251.pdf
S1–S3 and tables S1–S5 a r ea v a i l a b l ea t Molecular Biology and Evolution online (http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/3d/c7/msw125.PMC5026251.pdf
Multipl e sequence alignment and phy- logenetic tree ﬁles are available at http://goo.gl/bDhV8i and scri pt ﬁle created for this study is av ailable at https://github.com/ YanWangTF.,OADS,/arxiv_data1/oa_pdf/07/3f/msw126.PMC5026252.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/3f/msw126.PMC5026252.pdf
"For the Bayesian inference analysis, a total ofeight chains (two runs, each with three hot and one cold chain) were performed for 50 million generations and Tracer v1.5 (http://beast.bio.ed.ac.uk/Tracer, last accessedDecember 2, 2015) was used to confirm convergence of the Bayesian chains and the sufficiency of the default burnin value (25%).",OADS,/arxiv_data1/oa_pdf/07/3f/msw126.PMC5026252.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/29/msw127.PMC5026253.pdf
"Materials and Methods GWAS Summary Data for GWAS hit summary was downloaded from theNHGRI GWAS catalog (available at: http://www.genome.gov/gwastudies, accessed [February 15, 2015]) ( Welter et al.",OADS,/arxiv_data1/oa_pdf/28/29/msw127.PMC5026253.pdf
"To this end, we developed the program Forward Simulation (available at http://forwardsimulation.sourceforge.net), which is based on the Wright– Fisher model and allows to define distinct selection regimes for separate regions or sites of the simulated genome.",OADS,/arxiv_data1/oa_pdf/28/29/msw127.PMC5026253.pdf
"Exome Sequencing Data and MHC Region Genome-wide coding sequence v ariation data of about 6,500 human individuals were obtained from the Exome Variant Server (NHLBI GO Exome Sequencing Project (ESP6500 re-lease), Seattle, WA; http://evs.gs.washington.edu/EVS/; ac- cessed 11/2012) and parsed with custom scripts.",OADS,/arxiv_data1/oa_pdf/28/29/msw127.PMC5026253.pdf
"Disease associations for genes in the MHC region with the highest average frequency of pot entially deleterious variants were obtained from NHGRI GWAS catalog (see above) and the NIH Genetic Association Database (available at: http://geneticassociationdb.nih.gov, last accessed December 14, 2013) ( Becker et al.",OADS,/arxiv_data1/oa_pdf/28/29/msw127.PMC5026253.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/32/msw128.PMC5026254.pdf
"Finally, 808,943 DHSs wereused for the following analysis (the information about all tested DHSs and their corresponding AREs (including IDs and chromosome positions) can be downloadedfrom https://sourceforge.net/projects/acedhs/files/tested_ DHSs.xlsx.zip/download, last accessed July 13, 2016).",OADS,/arxiv_data1/oa_pdf/de/32/msw128.PMC5026254.pdf
"2011 )w e r ed o w n - loaded from UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgEncodeVocab?type ¼%22cell%22, with data re- leased before June 2012).",OADS,/arxiv_data1/oa_pdf/de/32/msw128.PMC5026254.pdf
The cell line activity of all tested DHSs can be downloaded from https://sourceforge.net/projects/acedhs/files/tested_DHSs_an d_cell_line_activity.xlsx.zip/ download.,OADS,/arxiv_data1/oa_pdf/de/32/msw128.PMC5026254.pdf
"The background set for local DHSs was the list of target genes to all local DHSs,whereas the background set for distal DHSs was the list of target genes to all distal DHSs (the target genes of all tested DHSs can be downloaded from https://sourceforge.net/projects/acedhs/files/tested_DHSs_and_target_genes.xlsx.zip/ download).",OADS,/arxiv_data1/oa_pdf/de/32/msw128.PMC5026254.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/e1/msw129.PMC5026255.pdf
"Precipitation data during the 21 years from 1981 to 2001 were retrieved from the Abdus Salam International Center forTheoretical Physics, Italy (ICTP, https://www.ictp.it, last accessed January 5, 2015).",OADS,/arxiv_data1/oa_pdf/eb/e1/msw129.PMC5026255.pdf
"Validation of the Called SNPs To examine the accuracy of our SNPs, we first compared the SNPs identified here with those from Build 143 of the sheep dbSNP database in the National Center for BiotechnologyInformation (NCBI; http://www.ncbi.nlm.nih.gov/SNP, last accessed November 12, 2015).",OADS,/arxiv_data1/oa_pdf/eb/e1/msw129.PMC5026255.pdf
"musimon ,O.a.polii,a n d C.ibex), using the software TreeBeST v1.9.2 (http://treesoft.sourceforge.net/treebest.shtml, lastaccessed August 6, 2013).",OADS,/arxiv_data1/oa_pdf/eb/e1/msw129.PMC5026255.pdf
"We also positioned the candidate genes on known KEGG pathways (http://www.kegg.jp, last accessed October 16, 2015) and Reactome pathways (http://www.reac tome.org, last accessed October 16, 2015).",OADS,/arxiv_data1/oa_pdf/eb/e1/msw129.PMC5026255.pdf
"The functions ofthe candidate genes were consu lted based on the annotations in the NCBI (http://www.ncbi.nlm.nih.gov, last accessed October 2, 2015) and Ensembl (http://www.ensembl.org,last accessed October 2, 2015) databases.",OADS,/arxiv_data1/oa_pdf/eb/e1/msw129.PMC5026255.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/8e/msw132.PMC5026256.pdf
Supplementary Material Supplementary figures S1–S10 and tables S1–S8 are available atMolecular Biology and Evolution online (http://www.mbe.,OADS,/arxiv_data1/oa_pdf/c2/8e/msw132.PMC5026256.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/f3/msw151.PMC5026260.pdf
"In order to ensure reproducibility of our results, we have made these scripts available on GitHub at https://github.com/petebio/Intron_coevolution togetherwith detailed usage instructions.",Non-OADS,/arxiv_data1/oa_pdf/58/f3/msw151.PMC5026260.pdf
Available from:https://cran.r-project.org/web/packages/dynamicTreeCut/index.,OADS,/arxiv_data1/oa_pdf/58/f3/msw151.PMC5026260.pdf
Availa ble from: http://qvalue.princeton.,Non-OADS,/arxiv_data1/oa_pdf/58/f3/msw151.PMC5026260.pdf
"edu/, http://github.com/jdstorey/qvalue.",Non-OADS,/arxiv_data1/oa_pdf/58/f3/msw151.PMC5026260.pdf
"This is an Open Access article distribut ed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/4.0/), which permits non-commercial re- use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
Materials and Methods Identification of Paralog/Ortholog Groups of Plant NBS-Encoding Genes The genome sequences and the annotations of 75 plants were downloaded from Phytozome (http://phytozome.jgi.,OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
"The annotated proteins of each genome were searched against a model of the NBS domain (Pfam PF00931) to identify NBS-encoding candidates by hmmer3.0 (http://hmmer.janelia.org/, last accessed August 7, 2016) with an E- v a l u ec u t - o f fo f1 0 /C04(Yue et al.",OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
"All the functional Rgenes in PRGdb (http://prgdb.crg.eu/, last accessed August 7, 2016) weremapped into the families using BLAST and used as the refer- ence gene of the family to which they matched ( Sanseverino et al.",OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
NBS sequences were aligned using MUSCLE ( Edgar 2004 ) and manually modified in GeneDoc (http://www.nrbsc.,OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
The pair- wise proportions of synonymous ( Ps) and nonsynonymous (Pn) differences were calculated by SNAP (http://www.hiv.,OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
"All the statistics analyses including descrip- tive analysis, t-test, and linear regression, were performed using the R package (https://www.r-project.org/, last accessed August 7, 2016).",OADS,/arxiv_data1/oa_pdf/09/0e/msw154.PMC5026261.pdf
"288 http://tah.sagepub.com Ther Adv Hematol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Therapeutic Advances in Hematology Introduction Multiple myeloma (MM) is a mature B-cell malignancy characterized by monoclonal expan-sion of plasma cells in the bone marrow leading to bone destruction and marrow failure and accom-panied by excessive production of monoclonal immunoglobulins (Igs) that produce an ‘M spike’ on serum protein electrophoresis [Raab et  al.,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"H Einsele and M Schreder http://tah.sagepub.com 289 other agents, antibody-based immunotherapy is  employed in tailored regimens for patients with advanced disease.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"Therapeutic Advances in Hematology 7(5) 290 http://tah.sagepub.com fragment of an antibody related to elotuzumab  effectively redirected NK and T cells to secrete cytokines, degranulate and exhibit cytotoxic activity in response to MM cell lines and primary human myeloma cells in vitro.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"H Einsele and M Schreder http://tah.sagepub.com 291 signaling-regulated kinase (ERK), implicated in  NK cell activation and cytotoxicity [Collins et al.",OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
Therapeutic Advances in Hematology 7(5) 292 http://tah.sagepub.com Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
H Einsele and M Schreder http://tah.sagepub.com 293 Clinical study (NCT identifier) Patient population Treatment groups Dose levels/ regimenResults Reference   Admin.,OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
Therapeutic Advances in Hematology 7(5) 294 http://tah.sagepub.com (Figure 2).,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
H Einsele and M Schreder http://tah.sagepub.com 295 was not analyzed in this study.,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
Therapeutic Advances in Hematology 7(5) 296 http://tah.sagepub.com elotuzumab was consistent across doses and did  not appear to be dose-dependent.,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
H Einsele and M Schreder http://tah.sagepub.com 297 et al.,OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"Therapeutic Advances in Hematology 7(5) 298 http://tah.sagepub.com Infusion reactions were noted in only five patients  (7%) receiving elotuzumab, but were all of mild to moderate intensity (grade 1–2) and managea-ble.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"H Einsele and M Schreder http://tah.sagepub.com 299 References Ayed, A., Chang, L. and Moreb, J.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"Therapeutic Advances in Hematology 7(5) 300 http://tah.sagepub.com Liu, Y., Szmania, S. and van Rhee, F. (2014) Profile  of elotuzumab and its potential in the treatment of multiple myeloma.",Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
H Einsele and M Schreder http://tah.sagepub.com 301 therapeutic target in multiple myeloma.,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
Visit SAGE journals online  http://tah.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/9d/ec/10.1177_2040620716657993.PMC5026292.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in any medium, pro- vided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/0d/fiw180.PMC5026301.pdf
A prominent example for such special- ized resources is CAZY ( http://www.cazy.org/ ) (Cantarel et al.,OADS,/arxiv_data1/oa_pdf/31/0d/fiw180.PMC5026301.pdf
bThe Universal Protein Resource Knowledgebase ( http://www.uniprot.org ).,OADS,/arxiv_data1/oa_pdf/31/0d/fiw180.PMC5026301.pdf
"dThe National Center of Biotechnology Information ( http://www.ncbi.nlm.nih.gov ), as of 19 February 2013. eBiologically non-redundant, annotation partially curated by experts.",OADS,/arxiv_data1/oa_pdf/31/0d/fiw180.PMC5026301.pdf
"In addition, MetaProteomeAnalyzer software is a tool that features four freely available DB search algorithms (X!Tandem, OMSSA, Crux, InsPect), and is also highly suitable for comprehen- sive analysis and visualization of metaproteomic datasets (https://code.google.com/archive/p/meta-proteome-analyzer/ ) (Muthet al.2015).Data storage and visualization For several reasons, data storage is a major issue in metapro- teomics.",OADS,/arxiv_data1/oa_pdf/31/0d/fiw180.PMC5026301.pdf
Available at: http://www.unaids.org/en/regionscountries/countries/southafrica.,Non-OADS,/arxiv_data1/oa_pdf/bf/63/qai-73-154.PMC5026386.pdf
Available at: http://www.unaids.org/sites/ default/ ﬁles/en/media/unaids/contentassets/documents/unaidspublication/ 2014/UNAIDS_Gap_report_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/63/qai-73-154.PMC5026386.pdf
Available at: https://extranet.who.int/sree/Reports?op=Replet&name= %2FWHO_HQ_Reports% 2FG2%2FPROD%2FEXT%2FTBCountry Proﬁle&ISO2=ZA&LAN=EN&outtype=html.,OADS,/arxiv_data1/oa_pdf/bf/63/qai-73-154.PMC5026386.pdf
Available at: http://www.who.int/hiv/ pub/progressreports/update2013/en/.,Non-OADS,/arxiv_data1/oa_pdf/bf/63/qai-73-154.PMC5026386.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1600969/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/2c/1600969.PMC5026419.pdf
"T. W. Kirkman, Statistics to use (1996), August 2015; http://www.physics.csbsju.edu/stats/.39.",OADS,/arxiv_data1/oa_pdf/bf/2c/1600969.PMC5026419.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1600823/DC1table S1.,Non-OADS,/arxiv_data1/oa_pdf/c6/af/1600823.PMC5026420.pdf
"Bioinformatic analyses were performed at the sciCORE (http://scicore.unibas.ch/) scientific computing core facility at the University of Basel, with supportfrom the SIB Swiss Institute of Bioinformatics.",OADS,/arxiv_data1/oa_pdf/c6/af/1600823.PMC5026420.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1601072/DC1Supplementary Informationfig.,Non-OADS,/arxiv_data1/oa_pdf/34/6f/1601072.PMC5026421.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1501814/DC1Supplementary calculationsfig.,Non-OADS,/arxiv_data1/oa_pdf/2d/c3/1501814.PMC5026422.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1501499/DC1 section S1.1.,Non-OADS,/arxiv_data1/oa_pdf/90/6f/1501499.PMC5026423.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/9/e1600932/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/4a/1600932.PMC5026424.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/50/iew076.PMC5026474.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
Contigs pre-senting similarity to TRP genes were further assembled using Cap3(http://pbil.univ-lyon1.fr/cap3.php).,OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"Open reading frames (ORFs)were searched and translated to amino acid sequences usingExPASy (http://www.expasy.org/translate/), and Blastx on theGenbank non-redundant database (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to verify their annotation.",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"For CpTRPA5 and its splice forms, transmembrane domains were predicted fromtranslated sequences using TMHMM 2.0 (http://www.cbs.dtu.dk/ services/TMHMM/) and TMPred (http://www.ch.embnet.org/soft ware/TMPRED_form.html) ( Hofmann and Stoffel 1993 ).",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"For the candidateCpTRPA5_F1117 splice form, which was predicted to lack trans- membrane segments, we predicted the tertiary structure of the re-lated polypeptide using the Proteus structure prediction server 2.0(http://www.proteus2.ca/proteus2/).",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"To perform 3D-representa-tion, Rastop 2.2 was used (available for the public domain athttp://www.geneinfinity.org/rastop/).",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"Phylogenetic Investigation of CpTRPs TRP sequences of Rattus norvegicus Berkenhout, Caenorhabditis elegans Maupas and Drosophila melanogaster Meigen were down- loaded from their proper genome browsers (http://rgd.mcw.edu/;http://www.wormbase.org/; http://flybase.org/).",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"In addition to C. pomonella TRP sequences, TRP sequences were searched in two other lepidopteran species (the silk moth Bombyx mori L. and the monarch butterfly Danaus plexippus L.), as well as in the insects Apis mellifera L.,Tribolium castaneum Herbst and Acyrthosiphon pisum Harris using NCBI-blast (http://blast.ncbi.nlm.nih.gov/ Blast.cgi) with the amino acid sequences of D. melanogaster TRPs as a query.",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
The 131 amino acid sequences were aligned using MAFFT version 7 (http://mafft.cbrc.jp/alignment/server/) ( Katoh and Toh 2010 )a n da neighbor-joining tree was built using the BioNJ algorithm as im-plemented in SeaView v.4 ( Gouy et al.,OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"Thermodynamic features were checkedby OligoEvaluator (Sygma Genosys, http://www.oligoevaluator.com),and putative oligodimerization was checked by OligoAnalyzer 3.1(Integrated DNA Technologies, http://eu.idtdna.com/calc/analyzer).Primer melting temperatures were est imated using the salt-adjusted al- gorithm on the OligoCalc website (ww.basic.northwestern.edu/biotools/OligoCalc.html).",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
Alignment of amplicon sequences from RACE-PCR amplifications wasperformed using Multalin (http://multalin.toulouse.inra.fr/multalin/)(Corpet 1988 ).,OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"The 5 0and 30sequenced regions were assembled with existing contig data to generate a partial CDS-template of 1677 bp.Despite being partial, this sequence was checked using the online toolORF Finder (http://www.ncbi.nlm.nih.gov/gorf/orfig.cgi).",OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
The five genome scaffolds and the four transcriptsthat matched our RACE-PCR templa te are available for download and inspection at https://www.researchgate.net (DOI: 10.13140/RG.2.1.3056.8726).,OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
Graphical intron/exon representationof splice forms was done using the online tool Exon-Intron GraphicMaker version 4 (http://wormweb.org/exonintron).,OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"Among proposed 3D-models (Protein Database, http://www.rcsb.org/pdb/home/home.do) the model 1N11.pdb re-lated with the D34-region of a human ankyrin was chosen.",Non-OADS,/arxiv_data1/oa_pdf/df/50/iew072.PMC5026476.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/f1/iew071.PMC5026477.pdf
Acknowledgments This study was supported by project number GA15-09038S of the Czech Science Foundation (https://gacr.cz/en/).,Non-OADS,/arxiv_data1/oa_pdf/c3/e1/iew070.PMC5026478.pdf
"In fact, the genomic data areexpanding at an unprecedented rate for more and more insect spe-cies of different orders and families relying on this technique (http://www.entsoc.org/press-releases/entomologists-launch-5000-insect-genome-project-i5).",Non-OADS,/arxiv_data1/oa_pdf/ae/73/iew079.PMC5026479.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/73/iew079.PMC5026479.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
"2009 ) (http://www.mothur.org/) for preprocessing, identifying operationaltaxonomic units (OTUs), taxonomic assignment, and communitystructure comparisons.",OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
These trimming processes were completed using RDPInitial Process (http://pyro.cme.msu.edu).,OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
"To assign the phylotypes of the tagged sequences, the trimmed reads were clus-tered using UCLUST program (http://www.drive5.com/uclust/).",OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
Venn diagram generated with the online program athttp://bioinfogp.cnb.csic.es/tools/venny/index.html was used tocompare the distribution of OTUs in the four termites.,OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
Cladogramwas constructed with the METAGENassist tool (http://www.metagenassist.ca/METAGENassist/faces/Upload View.jsp2).,OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
"To probe the microbial metabolic and functional pathways in the microbiota, the OTUs were automati-cally taxonomy-to-phenotype mapped using approximately 20 dif-ferent phenotypic categories in METAGENassist (http://www.metagenassist.ca/METAGE Nassist/faces/Home.jsp).",OADS,/arxiv_data1/oa_pdf/96/68/iew081.PMC5026480.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/e7/iew087.PMC5026481.pdf
In: Programa Nacional de Combate /C18as Moscas-das-Frutas – Dispon /C19ıvel em: http://www.agricultura.gov.br/comunicacao/noticias/2015/ 09/ministra-anuncia-rs-128-milhoes-para-combate-as-moscas-das-frutas (accessed 26 November 2015).,Non-OADS,/arxiv_data1/oa_pdf/9c/e7/iew087.PMC5026481.pdf
"R Foundation for Statistical Computing, Vienna, Austria.ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/9c/e7/iew087.PMC5026481.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/24/iew083.PMC5026482.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Major depressive disorderDifferent age at onsetMagnetic resonance imaging Grey matter volume 1.,Non-OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.0162213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
Voxel-based morphometry All primary DICOM images were converted into NIfTI format using the MRIconvert software ( http://lcni.uoregon.edu/downloads/ mriconvert/mriconvert-and-mcverter ).,OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
"All the structural data were an- alyzed using the VBM8 toolbox ( http://dbm.neuro.uni-jena.de/vbm )i n the statistic parametric mapping software package (SPM8, http:// www.",OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
"Multiple comparisons were corrected by using the Monte Carlo simulation-based Alphasim program, which is implemented in the REST toolbox ( http://restfmri.net/forum/REST_V1.8 ).",OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
All results were visualized usingxjview8.0 software ( http://www.alivelearn.net/xjview8/ ).,OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
Mean values of GMV were extracted using the REX toolbox(http://gablab.mit.edu/downloads/rex.m ).,OADS,/arxiv_data1/oa_pdf/e0/39/main.PMC5026687.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1d/46/main.PMC5026688.pdf
Most current concerns about antibiotic resistance focus on infections in hospitalContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2016.07.001 0011-393X/ &2016.,Non-OADS,/arxiv_data1/oa_pdf/1d/46/main.PMC5026688.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).This study was presented as a poster at the South Central Association of Clinical Microbiologists, April 19, 2014, Cincinnati, Ohio as well as the 114th General Meeting of American Society for Microbiology, May 20, 2014, Boston, Massachussets.",Non-OADS,/arxiv_data1/oa_pdf/1d/46/main.PMC5026688.pdf
"Antibiotic Resistance Threats in the United States, 2013, US Department of Health and HumanServices, CDC accessed website on October 29, 2015 at http://www.cdc.gov/ drugresistance/pdf/ar-threats-2013-508.pdf .",Non-OADS,/arxiv_data1/oa_pdf/1d/46/main.PMC5026688.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/ec/main.PMC5026689.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.08.035 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/ec/main.PMC5026689.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/51/main.PMC5026690.pdf
MRI  brain  showed  a  2.2  ×  1.3  ×  1.1  cm  nodular http://dx.doi.org/10.1016/j.ijscr.2016.08.022 2210-2612/© 2016  The  Authors.,OADS,/arxiv_data1/oa_pdf/f1/51/main.PMC5026690.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC5026691.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.08.015 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC5026691.pdf
"Avail- able, https://www.nice.org.uk/guidance/cg74 (accessed 06.05.16).",Non-OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC5026691.pdf
"(10) (2013), http://dx.doi.org/10.1002/ 14651858.CD010075.pub2 .",Non-OADS,/arxiv_data1/oa_pdf/7a/54/main.PMC5026691.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/60/main.PMC5026692.pdf
Contents lists available at ScienceDirect Respiratory Medicine Case Reports journal homepage: www.elsevier.c om/locate/rmcr http://dx.doi.org/10.1016/j.rmcr.2016.09.001 2213-0071/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/60/main.PMC5026692.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Respiratory Medicine Case Reports 19 (2016) 118 e120,Non-OADS,/arxiv_data1/oa_pdf/7d/60/main.PMC5026692.pdf
[8]http://evs.nci.nih.gov .,Non-OADS,/arxiv_data1/oa_pdf/7d/60/main.PMC5026692.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/43/main.PMC5026693.pdf
http://dx.doi.org/10.1016/j.nicl.2016.08.0172213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/43/main.PMC5026693.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/43/main.PMC5026693.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 12823080 .,Non-OADS,/arxiv_data1/oa_pdf/c4/43/main.PMC5026693.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/06/49/main.PMC5026705.pdf
Five  years  later  the  patient  had  a  chest  X-ray  as  part  of  a  preop- erative  evaluation for an  unrelated  and  elective  surgical  procedure and  was  found  to  have  signiﬁcant  deviation  of  the  mediastinal  tra- http://dx.doi.org/10.1016/j.ijscr.2016.08.036 2210-2612/© 2016  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/06/49/main.PMC5026705.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2016) 7, 839–850 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2016.08.007 2090-1232 /C2112016 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/bf/bd/main.PMC5026708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/bd/main.PMC5026708.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/bd/main.PMC5026708.pdf
"The sequence data were aligned and compared with the known nucleotide sequences in the Gen-Bank database using BLASTn ( http://www.ncbi.nlm.nih.gov/ BLAST ), to identify the bacterial strains.",OADS,/arxiv_data1/oa_pdf/bf/bd/main.PMC5026708.pdf
The surface area of activated carbon makes the material suitable for many processes: metal extraction from industrial wasteReceived: 31 January 2016 Revised: 26 May 2016 Accepted: 5 September 2016 Heliyon 2 (2016) e00155 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Although the major part Article No~e00155 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
It is Article No~e00155 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
BJH Micropore volume Average pore diameter (°C) (h) (%) (%) (m2/g) (m2/g) (%) (cm3/g) (cm3/g) (%) (nm) 400 2 3.9 8.90 52.13 4.82 9.25 0.0358 0.0017 4.71 2.749 4 4.2 8.98 37.52 4.08 10.87 0.0348 0.0013 3.80 3.711 600 2 4.4 23.11 370.49 296.39 80.00 0.1948 0.1381 70.14 1.594 4 4.0 23.97 367.25 298.97 81.41 0.1928 0.1389 72.03 1.576 800 2 4.8 30.53 435.09 366.69 85.02 0.2314 0.1728 74.68 1.582 4 5.4 29.92 436.51 371.10 77.38 0.2285 0.1736 75.95 1.571 Article No~e00155 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
BJH Micropore volume Average pore diameter (°C) (h) (%) (%) (m2/g) (m2/g) (%) (cm3/g) (cm3/g) (%) (nm) 400 2 3.6 9.10 72.97 8.15 11.17 0.0391 0.0016 4.17 2.144 4 3.5 10.11 134.56 17.76 13.20 0.0689 0.0038 5.59 2.048 8 3.9 11.11 181.78 62.00 34.10 0.0933 0.0257 27.60 2.054 600 2 4.7 13.33 376.70 304.74 80.90 0.1948 0.1425 73.17 1.546 4 5.0 25.03 389.96 336.69 86.34 0.1987 0.1563 78.66 1.5398 5.2 27.25 410.06 326.02 79.50 0.2186 0.1570 71.81 1.547 800 2 10.6 66.77 905.02 544.36 55.13 0.5488 0.2538 46.24 1.794 4 25.4 89.88 1034.07 570.09 63.23 0.6129 0.2596 42.35 1.779 Article No~e00155 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
SEM of a sample activated at 800 °C during 4 h. Article No~e00155 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
"Wate, Physico-chemical and surface characterization of adsorbent prepared from groundnut shell by ZnCl2 Article No~e00155 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
"Suhas Carrott, C. Laginhas, S. Roman, Phenol removal onto novel activated carbons made from lignocellulosic Article No~e00155 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
Article No~e00155 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00155 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/f5/main.PMC5026709.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/8e/hepatmon-16-07-37534.PMC5026730.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs204/en/index.html .2.,Non-OADS,/arxiv_data1/oa_pdf/7a/8e/hepatmon-16-07-37534.PMC5026730.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)OPRM1 A118G and opioid antagonists H Ziauddeen et al 2657 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/e6/7d/npp201660a.PMC5026731.pdf
"Intracranial volume included the ventricles and was determined by computing the Jacobian determinant of the linear registration to acommon target (Montreal Neurological Institute template13, ICBM 2009c Nonlinear Symmetric template; http://www.bic.",OADS,/arxiv_data1/oa_pdf/2a/41/npp201664a.PMC5026732.pdf
Using intracranial volume inferred from a linear registration gives an unbiased estimate of head size and has been implementedin recent large-scale analyses (http://enigma.ini.usc.edu/).,OADS,/arxiv_data1/oa_pdf/2a/41/npp201664a.PMC5026732.pdf
Available at: http://www.cdc.gov/media/releases/2014/p0327-aut ism-spectrum-disorder.html (last date accessed 28 January 2016).,OADS,/arxiv_data1/oa_pdf/2a/41/npp201664a.PMC5026732.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)Subcortical structure in autism spectrum disorder M Schuetze et al 2637 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/2a/41/npp201664a.PMC5026732.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies the paper on the Neuropsychopharmacology website (http://www.nature.com/npp)LSD and emotion processing PC Dolder et al 2646 Neuropsychopharmacology",Non-OADS,/arxiv_data1/oa_pdf/d0/ad/npp201682a.PMC5026740.pdf
"Swedish Environmental Protection Agency Report 6639, July 2015.Available at https://www.naturvardsverket.se/Documents/publikationer6400/978-91- 620-6639-0.pdf?pid =14226 (accessed 5 October 2015).",Non-OADS,/arxiv_data1/oa_pdf/95/72/hdy201644a.PMC5026756.pdf
Available from the Swedish Government at http://www.regerin- gen.se (accessed September 2015).,Non-OADS,/arxiv_data1/oa_pdf/95/72/hdy201644a.PMC5026756.pdf
Available from the Swedish Government at http://www.regeringen.se (accessed September 2015).,Non-OADS,/arxiv_data1/oa_pdf/95/72/hdy201644a.PMC5026756.pdf
Available at http://ec.europa.eu/ archives/commission_2010-2014/potocnik/media/pdf/Swedish%20wolves.pdf (accessed 5 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/95/72/hdy201644a.PMC5026756.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Heredity website (http://www.nature.com/hdy)Metapopulation Neof Fennoscandian wolves LL a i k r e et al 289 Heredity",Non-OADS,/arxiv_data1/oa_pdf/95/72/hdy201644a.PMC5026756.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/8e/ircmj-18-07-23194.PMC5026765.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/0f/ircmj-18-07-27893.PMC5026766.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/bf/ircmj-18-07-29541.PMC5026782.pdf
"5, 610 –611 http://dx.doi.org/10.1080/21505594.2016.1162371",Non-OADS,/arxiv_data1/oa_pdf/73/56/kvir-07-05-1162371.PMC5026792.pdf
"Virulence 2016:7(2):98 –109; PMID:26670824; http://dx.doi.org/10.1080/21505594.2015.1131381 [2] Pujhari S, Kryworuchko M, Zakhartchouk AN.",Non-OADS,/arxiv_data1/oa_pdf/73/56/kvir-07-05-1162371.PMC5026792.pdf
"Virus Res 2014; 194:138-44; PMID:25304692; http://dx.doi.org/10.1016/j.virusres.2014.09.017 [3] Pujhari S, Baig TT, Zakhartchouk AN.",OADS,/arxiv_data1/oa_pdf/73/56/kvir-07-05-1162371.PMC5026792.pdf
BiomedRes Int 2014; 2014:160505; PMID:24511529; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/56/kvir-07-05-1162371.PMC5026792.pdf
Virology 2015; 484:136-45; PMID:26093497; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/56/kvir-07-05-1162371.PMC5026792.pdf
Virulence 2016; 7 (5): 527–535; http://dx.doi.org/10.1080/21505594.2016.1152442 © 2016 Shubhada Bopegamage.,Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"5, 495 –497 http://dx.doi.org/10.1080/21505594.2016.1175701",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Ped Rev 1978; 19: 183-91; http://dx.doi.org/10.1542/pir.19-6-183 [3] Chapman NM, Kim KS.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Infect Dis 2003; 187:1552-61; PMID:12721935; http://dx.doi.org/10.1086/ 374877 [7] Kim KS, Tracy SM, Tapprich W, Bailey J, Lee CK, Kim K, Barry WH, Chapman NM.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Virol 2005; 79:7024-41; PMID:15890942; http://dx.doi.org/10.1128/ JVI.79.11.7024-7041.2005 [8] Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R. Recent progress in understanding coxsackievirus replica- tion, dissemination, and pathogenesis.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Virology 2015;484:288-04; PMID:26142496; http://dx.doi.org/10.1016/j.virol.2015.06.006 [9] Tracy S, Gauntt C. Group B Coxsackievirus virulence.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Med Virol 2002; 68:544-57; PMID:12376963; http://dx.doi.org/10.1002/jmv.10236 [11] Chapman N, Tracy S, Gauntt C. Immunology of the Cox- sackieviruses, In Molecular Biology of Picornavirus.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
World J Virol 2012; 1:91-107;PMID:24175214; http://dx.doi.org/10.5501/wjv.v1.i3.91 [14] Gauntt CJ.,OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Curr Top Microbiol Immunol1997; 223:259-82; PMID:9294933 [15] Melchers WJ, Zoll J, van Kuppeveld F J, Swanink CM, Galama JMD.Thereisnoevidenceforpersistententerovirusinfections inchronicmedicalconditionsinhumans.RevMedVirol1994;4:235-43;http://dx.doi.org/10.1002/rmv.1980040402 [16] Muir P, Archard LC.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Med Virol 1997; 52:206-14; PMID:9179770; http://dx.doi.org/10.1002/(SICI)1096-9071(199706)52:2%3c206::AID-JMV15%3e3.0.CO;2-I [18] Bopegamage S, Kovacova J, Vargova A, Motusova J, Pet- rovicova A, Benkovicova M, Gomolcak P, Bakkers J, vanKuppeveld F, Melchers WJG, Galama JM.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
J Gen Virol 2000; 81:2755-62; PMID:11038389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Infect Dis 1995; 171:1131-38; PMID:7751687; http://dx.doi.org/10.1093/infdis/171.5.1131 [23] Tracy S, Drescher KM, Chapman N, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero JR, Leser JS.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Virol 76; 2002:12097-111; PMID:12414951; http://dx.doi.org/10.1128/JVI.76.23.12097-12111.2002 [24] Newton AH, Cardani A, Braciale TJ The host immune response in respiratory virus infection:balancing virusclearance and immunopathology.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"2016. http://dx.doi.org/10.1007/s00281-016-0558-0 [25] Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
Viruses 2011; 3:920-940; PMID:21994762; http://dx.doi.org/10.3390/v3060920 [26] Hawkes AR.,Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Aust J Exp Biol Med Sci 1964; 42:465-82; PMID:14202187;http://dx.doi.org/10.1038/icb.1964.44 [27] Cardosa MJ, Port ﬁeld JS, Gordon S. Complement recep- tor mediates enhanced ﬂavivirus replication in macro- phages.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Exp Med 1983; 158:258-63; PMID:6864163; http://dx.doi.org/10.1084/jem.158.1.258 [28] Sauter P, Hober D. Mechanisms and results of the anti- body-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"PMID:19399964; http://dx.doi.org/10.1016/j.micinf.2009.01.005 [29] Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S. Secondary enterovirus infection in the murine model of mycarditis.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Emerging Infect Dis 2010; 16:1023-24; PMID:20507764; http://dx.doi.org/10.3201/eid1606.100453 [32] Girn J, Kavoosi M, Chantler J. Enhancement of Coxsacie- virus B3 infection by antibody to a different Coxsackievi- rus strain.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"J Gen Virol 2002; 83:351-58; PMID:11807228; http://dx.doi.org/10.1099/0022-1317-83-2-351 [33] Horwitz MS, Ilie A, Fine C, Rodriguez E, Sarvetnick N Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Virol-ogy 2003; 314:510-20; PMID:14554080; http://dx.doi.org/ 10.1016/S0042-6822(03)00462-8 [34] Kishimoto C, Kurokawa M, Ochiai H Antibody-mediated immune enhancement in Coxsackievirus B3 myocarditis.J Mol Cell Cardiol 2002; 34:1227-38; PMID:12392896; http://dx.doi.org/10.1006/jmcc.2002.2087 [35] Takada A, Kawaoka Y. Antibody-dependent enhance- ment of viral infection: molecular mechanisms and in vivo implications.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"Rev Med Virol 2003; 13:387-398; PMID:14625886; http://dx.doi.org/10.1002/rmv.405 [36] Bopegamage S, Precechtelova J, Marosova L, Stipalova D, Sojka M, Borsanyiova M, Gomolcak P, Berakova K, Galama J.",OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
"FEMS Immunol and Med Microbiol 2012: 64:184- 190; http://dx.doi.org/10.1111/j.1574-695X.2011.00886.x [37] Elmastour F, Ja €ıdane H, Aguech-oueslati L, Ben Kahla M, Aouni M, Gharbi J, Sane F, Hober D. Immunoglobulin G-dependent enhancement of the infection with Cox- sackievirus B4 in a murine system.",Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
Virulence 2016; 7(5):527-535; http://dx.doi.org/ 10.1080/21505594.2016.,Non-OADS,/arxiv_data1/oa_pdf/fa/b5/kvir-07-05-1175701.PMC5026793.pdf
Nat Cell Biol 2016; 18(4):371-81; PMID:26974661; http://dx.doi.org/10.1038/ncb3326.,OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
"18, 2381 –2382 http://dx.doi.org/10.1080/15384101.2016.1194138",Non-OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
"Cell Stem Cell 2011; 9(6):504-16; PMID:22136926; http://dx.doi.org/ 10.1016/j.stem.2011.11.012 [2] Di Tullio A, Manh TPV, Schubert A, Castellano G, Ma/C14nsson R, Graf T. CCAAT/enhancer binding protein a(C/EBP a)-induced transdifferen- tiation of pre-B cells into macrophage s involves no overt retrodifferen- tiation.",Non-OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
"Cell 2008; 133(2):250-64; PMID:18423197; http://dx.doi.org/ 10.1016/j.cell.2008.03.028 [4] Di Stefano B, Sardina JL, van Oevelen C, Collombet S, Kallin EM, Vicent GP, Lu J, Thieffry D, Beato M, Graf T. C/EBP apoises B cells for rapid reprogramming into induced pluripotent stem cells.",Non-OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
"Nature 2014; 506(7487):235-9; PMID:24336202; http://dx.doi.org/10.1038/ nature12885 [5] Di Stefano B, Collombet S, Jakobsen JS, Wierer M, Sardina JL, Lackner A, Stadhouders R, Segura-Morales C, Francesconi M, Limone F, et al.",OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
C/EBP acreates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4.Nat Cell Biol 2016; 18(4):371-81; PMID:26974661; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
"Nat Biotech 2015; 33(7):761-8; PMID:26098450; http://dx.doi.org/10.1038/nbt.3247 [ 7 ] Y eM ,Z h a n gH ,Y a n gH ,K o c h eR ,S t a b e rP B ,C u s a nM ,L e v a n t i n i E, Welner RS, Bach CS, Zhang J, et a l. Hematopoietic differentia- tion is required for initiation o f acute myeloid leukemia.",Non-OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
Cell Stem Cell 2015; 17(5):611-23; PMID:26412561; http://dx.doi.org/10.1016/j.stem.2015.08.0112382 J. L. SARDINA ET AL.,OADS,/arxiv_data1/oa_pdf/fe/db/kccy-15-18-1194138.PMC5026819.pdf
"Epidemic situation of notifiable diseases in 2014, http://www.moh.gov.cn/jkj/s3578/201502/847c041a3bac4- c3e844f17309be0cabd.shtml (accessed 16 February 2016).178 International Journal of STD & AIDS 28(2)",Non-OADS,/arxiv_data1/oa_pdf/09/58/10.1177_0956462416638224.PMC5026914.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Christine C Johnson, MD,  Department  of Sports Medicine and Shoulder Surgery, Hospital for Special  Surgery, 535 E 70th St, New York, NY 10021,  United States.",Non-OADS,/arxiv_data1/oa_pdf/77/98/WJO-7-519.PMC5027006.pdf
Information about activity levels and the rate of return Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.519World J Orthop  2016 September 18; 7(9): 519-526 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/77/98/WJO-7-519.PMC5027006.pdf
wjgnet.com/ 2218-5836 /full/v7/i9/519.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/98/WJO-7-519.PMC5027006.pdf
"Available from: URL: http://www.dartmouthatlas.org 36 Ponce BA , Oladeji LO, Rogers ME, Menendez ME.",Non-OADS,/arxiv_data1/oa_pdf/77/98/WJO-7-519.PMC5027006.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/77/98/WJO-7-519.PMC5027006.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dr. Bivas Biswas, Assistant Professor,   Department of Medical Oncology, Dr.B.R.A.I.R.C.H, All India  Institute of Medical Sciences, Ansari Nagar, New Delhi 110029,  India.",Non-OADS,/arxiv_data1/oa_pdf/24/b0/WJO-7-527.PMC5027007.pdf
Novel targeted therapies Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.527World J Orthop  2016 September 18; 7(9): 527-538 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/24/b0/WJO-7-527.PMC5027007.pdf
wjgnet.com/ 2218-5836 /full/v7/i9/527.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/24/b0/WJO-7-527.PMC5027007.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/24/b0/WJO-7-527.PMC5027007.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Shawn Nguyen, DO,  Department of  Orthopaedic Surgery, Riverside University Health Sciences,  26520 Cactus Ave., Moreno Valley, CA 92555,  United States.",Non-OADS,/arxiv_data1/oa_pdf/81/8f/WJO-7-539.PMC5027008.pdf
wjgnet.com/ 2218-5836 /full/v7/i9/539.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/8f/WJO-7-539.PMC5027008.pdf
Casting may be performed to Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.539World J Orthop  2016 September 18; 7(9): 539-545 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/81/8f/WJO-7-539.PMC5027008.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/81/8f/WJO-7-539.PMC5027008.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Lazaros A Poultsides, MD, MSc, PhD,   Department of Orthopaedic Surgery, Division of Adult Recon - struction and Joint Replacement, Hospital for Special Surgery,  Weill Medical College of Cornell University, 535 East 70th Street,  New York, NY 10021, United States.",Non-OADS,/arxiv_data1/oa_pdf/68/d6/WJO-7-546.PMC5027009.pdf
Published by Baishideng Publishing  Group Inc. All rights reserved.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.546World J Orthop  2016 September 18; 7(9): 546-552 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/68/d6/WJO-7-546.PMC5027009.pdf
World J Orthop   2016; 7(9): 546-552  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/68/d6/WJO-7-546.PMC5027009.pdf
"com/ 2218-5836 /full/v7/i9/546.htm  DOI: http://dx.doi.org/10.5312/ wjo.v7.i9.546 INTRODUCTION Periprosthetic hip and knee infections: Trends,  diagnosis, classification and treatment  Total joint arthroplasty (TJA) is a very useful tool in  the hands of orthopaedic surgeons, as it can relieve  symptoms and significantly improve the quality of life in  patients with end-stage arthritis of the hip and the knee.",Non-OADS,/arxiv_data1/oa_pdf/68/d6/WJO-7-546.PMC5027009.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/68/d6/WJO-7-546.PMC5027009.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Anuj Singla, MD,  Department of Orthopedic  Surgery, University of Virginia, P .O.",Non-OADS,/arxiv_data1/oa_pdf/4b/e1/WJO-7-553.PMC5027010.pdf
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.553World J Orthop  2016 September 18; 7(9): 553-560 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/4b/e1/WJO-7-553.PMC5027010.pdf
World J Orthop  2016; 7(9): 553-560   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v7/ i9/553.htm  DOI: http://dx.doi.org/10.5312/wjo.v7.i9.,Non-OADS,/arxiv_data1/oa_pdf/4b/e1/WJO-7-553.PMC5027010.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/4b/e1/WJO-7-553.PMC5027010.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Evdokia Billis, Assistant Professor  in  Physiotherapy, Department of Physical Therapy, Technological  Educational Institute of Western Greece, Psaron 6, 25100 Aigion,  Greece.",Non-OADS,/arxiv_data1/oa_pdf/35/a5/WJO-7-561.PMC5027011.pdf
These were  then given to 30 British PTs assessing their level of Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.561World J Orthop  2016 September 18; 7(9): 561-569 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/35/a5/WJO-7-561.PMC5027011.pdf
wjgnet.com/ 2218-5836 /full/v7/i9/ 561.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/a5/WJO-7-561.PMC5027011.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/35/a5/WJO-7-561.PMC5027011.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to:  Fikri M Abu-Zidan, MD, FACS, FRCS,  PhD, DipApplStats, Professor,  Department of Surgery, College  of Medicine and Health Sciences, UAE University, PO Box  17666, Al Ain, United Arab Emirates.",Non-OADS,/arxiv_data1/oa_pdf/33/f3/WJO-7-570.PMC5027012.pdf
Cases  injured at home were young ( P < 0.0001) with an  associated higher incidence of females ( P < 0.0001).Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.570World J Orthop  2016 September 18; 7(9): 570-576 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/33/f3/WJO-7-570.PMC5027012.pdf
World J Orthop   2016; 7(9): 570-576  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/33/f3/WJO-7-570.PMC5027012.pdf
com/ 2218-5836 /full/v7/i9/ 570.htm  DOI: http://dx.doi.org/10.5312/ wjo.v7.i9.,Non-OADS,/arxiv_data1/oa_pdf/33/f3/WJO-7-570.PMC5027012.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/33/f3/WJO-7-570.PMC5027012.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Georgios I Drosos, MD, PhD, Associate Professor  of Orthopaedics, Department of Orthopaedic Surgery,   Democritus University of Thrace, University General Hospital  of Alexandroupolis, St. Niarhos Street 1, Dragana, 68100 Alexan­ droupolis, Greece.",Non-OADS,/arxiv_data1/oa_pdf/f5/b3/WJO-7-577.PMC5027013.pdf
"The most impor - tant screening tool for osteoporosis risk was the Osteo - porosis Self-assessment Tool, which had an AUC of  0.643, a sensitivity of 77%, and a specificity of 46%,  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.577World J Orthop  2016 September 18; 7(9): 577-583 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f5/b3/WJO-7-577.PMC5027013.pdf
wjgnet.com/ 2218 ­5836 /full/v7/i9/ 577.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/b3/WJO-7-577.PMC5027013.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f5/b3/WJO-7-577.PMC5027013.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ran Schwarzkopf, MD, MSc,  Division  of Adult Reconstruction, Department of Orthoapedic Surgery,  New York University Langone Medical Center, Hospital for Joint  Diseases, 301 E 17th Street, New York, NY 10003,  United States.",Non-OADS,/arxiv_data1/oa_pdf/be/56/WJO-7-584.PMC5027014.pdf
"The most commonly  reported complications with TKA included infection, Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.584World J Orthop  2016 September 18; 7(9): 584-591 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/be/56/WJO-7-584.PMC5027014.pdf
World J Orthop  2016; 7(9): 584-591  Available from:  URL:  http://www.wjgnet.com/ 2218-5836 /full/v7/i9/584.htm   DOI: http://dx.doi.org/10.5312/wjo.v7.i9.584 INTRODUCTION Post-traumatic arthritis (PTA) refers to structural damage  following an injury to an articulating joint[1].,Non-OADS,/arxiv_data1/oa_pdf/be/56/WJO-7-584.PMC5027014.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/be/56/WJO-7-584.PMC5027014.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Berardo Di Matteo, MD,  Ⅰ Orthopaedic  and Traumatologic Clinic - Biomechanics and Technology Inno - vation Laboratory, Rizzoli Orthopaedic Institute, Via Pupilli n. 1,  40136 Bologna, Italy.",Non-OADS,/arxiv_data1/oa_pdf/26/70/WJO-7-592.PMC5027015.pdf
Both studies on ACL repair  were case series.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.592World J Orthop  2016 September 18; 7(9): 592-603 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/26/70/WJO-7-592.PMC5027015.pdf
"World J Orthop  2016; 7(9): 592-603   Available from: URL:  http://www.wjgnet.com/ 2218-5836 /full/ v7/i9/592.htm  DOI: http://dx.doi.org/10.5312/wjo.v7.i9.592 INTRODUCTION Anterior cruciate ligament (ACL) injuries are among  the most common conditions treated in everyday ortho­ paedic practice, with an increasing incidence in the past  years due to a concurrent increase of sports activities  among the general population[1,2].",Non-OADS,/arxiv_data1/oa_pdf/26/70/WJO-7-592.PMC5027015.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/26/70/WJO-7-592.PMC5027015.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Rob Paulus Augustinus Janssen, MD,  PhD, Department of Sports Medicine and Orthopaedic Surgery,  Máxima Medical Center, Postbus 90052, 5600PD, Eindhoven,  The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/ca/19/WJO-7-604.PMC5027016.pdf
Tourniquet time  Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.604World J Orthop  2016 September 18; 7(9): 604-617 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/ca/19/WJO-7-604.PMC5027016.pdf
World J Orthop  2016;  7(9): 604-617  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/ca/19/WJO-7-604.PMC5027016.pdf
com/ 2218-5836 /full/v7/i9/604.htm  DOI: http://dx.doi.org/ 10.53 12/wjo.v7.i9.604 INTRODUCTION Vascular complications after anterior cruciate ligament  (ACL) reconstructions cause serious morbidity and  potential mortality[1].,Non-OADS,/arxiv_data1/oa_pdf/ca/19/WJO-7-604.PMC5027016.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/ca/19/WJO-7-604.PMC5027016.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Mohamed Sukeik, MD, MRCSEd, PGA,  Specialist Registrar  in Trauma and Orthopaedics, Department  of Trauma and Orthopaedics, Queens Hospital, Rom Valley Way,  Romford RM7 0AG,  United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/cf/ef/WJO-7-618.PMC5027017.pdf
World J Orthop  2016; 7(9): 618-622  Available  from: URL:  http://www.wjgnet.com/ 2218-5836 /full/v7/i9/618.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.618World J Orthop  2016 September 18; 7(9): 618-622 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/cf/ef/WJO-7-618.PMC5027017.pdf
"Compartment syndrome following TKR htm  DOI: http://dx.doi.org/10.5312/wjo.v7.i9.618 INTRODUCTION Compartment syndrome is a serious condition that occurs  due to elevation of interstitial pressure in closed fascial  compartments resulting in microvascular compromise,  myoneuronal function impairment and soft tissue necrosis.",Non-OADS,/arxiv_data1/oa_pdf/cf/ef/WJO-7-618.PMC5027017.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cf/ef/WJO-7-618.PMC5027017.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Ewout S Veltman, MD,  Department of  Surgery, St. Antonius Ziekenhuis, Koekoekslaan 1, 3435 CM  Nieuwegein, the Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/e0/e5/WJO-7-623.PMC5027018.pdf
Sub -Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5312/wjo.v7.i9.623World J Orthop  2016 September 18; 7(9): 623-627 ISSN 2218-5836 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/e0/e5/WJO-7-623.PMC5027018.pdf
wjgnet.com/ 2218-5836 /full/v7/i9/623.htm  DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/e5/WJO-7-623.PMC5027018.pdf
"© 2016 Baishideng Publishing Group Inc. All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/e0/e5/WJO-7-623.PMC5027018.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Yoshihito Ohhara, MD,  Department  of Medical Oncology, Hokkaido University Graduate School  of Medicine, North 15, West 7, Kita-ku, Sapporo, Hokkaido  060-8638, Japan.",Non-OADS,/arxiv_data1/oa_pdf/5d/8f/WJGO-8-642.PMC5027019.pdf
Improvements of cytotoxic and biologic agents have Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.642World J Gastrointest Oncol   2016 September 15; 8(9): 642-655 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/5d/8f/WJGO-8-642.PMC5027019.pdf
World J Gastrointest Oncol  2016; 8(9): 642-655   Available from: URL: http://www.wjgnet.com/1948-5204/full/v8/ i9/642.htm  DOI: http://dx.doi.org/10.4251/wjgo.v8.i9.,Non-OADS,/arxiv_data1/oa_pdf/5d/8f/WJGO-8-642.PMC5027019.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/5d/8f/WJGO-8-642.PMC5027019.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Kazuya Matsumoto, MD, PhD, Depart - ment of Gastroenterology, Tottori University Hospital, 86 Nishi- cho, Yonago 683-8504, Japan.",Non-OADS,/arxiv_data1/oa_pdf/fd/71/WJGO-8-656.PMC5027020.pdf
"matsumot@med.tottori-u.ac.j p Telephone:  +81-859-386527 Received:  July 27, 2015 Peer-review started:  August 21, 2015 First decision:  October 21, 2015 Revised:  November 29, 2015 Accepted:  July 28, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.656World J Gastrointest Oncol   2016 September 15; 8(9): 656-662 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/fd/71/WJGO-8-656.PMC5027020.pdf
World J  Gastrointest Oncol  2016; 8(9): 656-662  Available from: URL:  http://www.wjgnet.com/1948-5204/full/v8/i9/656.htm  DOI: http:// dx.doi.org/10.4251/wjgo.v8.i9.,Non-OADS,/arxiv_data1/oa_pdf/fd/71/WJGO-8-656.PMC5027020.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/fd/71/WJGO-8-656.PMC5027020.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Reina Ohba, MD, PhD,  Department of  Gastroenterology, Akita University Graduate School of Medicine,  1-1-1 Hondo, Akita 010-8543,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/WJGO-8-663.PMC5027021.pdf
"reina@doc.med.akita-u.ac.jp Telephone:  +81-18-8846573 Fax:  +81-18-8017501 Received:  March 23, 2016 Peer­review started: March 24, 2016 First decision:  May 23, 2016 Revised:  June 8, 2016 Accepted:  July 14, 2016 Article in press:  July 18, 2016 Published online:  September 15, 2016 Abstract Helicobacter pylori  (H. pylori ) infection was thought to  be the main cause of gastric cancer, and its eradication  showed improvement in gastric inflammation and dec­Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.663World J Gastrointest Oncol   2016 September 15; 8(9): 663-672 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/WJGO-8-663.PMC5027021.pdf
wjgnet.com/1948-5204/full/v8/i9/663.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/7a/WJGO-8-663.PMC5027021.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/bd/7a/WJGO-8-663.PMC5027021.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Jin-Bo Gao, Associate Professor,   Department of Gastrointestinal Surgery, Union Hospital,  Tongji Medical College, Huazhong University of Science and  Technology, 1277 Jiefang Avenue, Wuhan 430022, Hubei  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/7f/84/WJGO-8-673.PMC5027022.pdf
World J Gastrointest Oncol  2016; 8(9): 673-681   Available from: URL: http://www.wjgnet.com/1948-5204/full/v8/ i9/673.htm  DOI: http://dx.doi.org/10.4251/wjgo.v8.i9.,Non-OADS,/arxiv_data1/oa_pdf/7f/84/WJGO-8-673.PMC5027022.pdf
673Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.673World J Gastrointest Oncol   2016 September 15; 8(9): 673-681 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/7f/84/WJGO-8-673.PMC5027022.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/7f/84/WJGO-8-673.PMC5027022.pdf
wjgnet.com/1948-5204/full/v8/i9/682.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/e5/WJGO-8-682.PMC5027023.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Alberto Zaniboni, MD,  Department of  Medical Oncology, Poliambulanza Foundation, via Bissolati 57,  25124 Brescia, Italy.",Non-OADS,/arxiv_data1/oa_pdf/9f/e5/WJGO-8-682.PMC5027023.pdf
"zanib@numerica.it Telephone:  +39-30-3515553 Fax:  +39-30-3518270 Received:  March 26, 2016 Peer-review started:  March 27, 2016 First decision:  May 17, 2016 Revised:  June 7, 2016 Accepted:  July 14, 2016 Article in press:  July 18, 2016 Published online:  September 15, 2016Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.682World J Gastrointest Oncol   2016 September 15; 8(9): 682-687 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9f/e5/WJGO-8-682.PMC5027023.pdf
"Available from: URL: https://www.nccn.org/professionals/ physician_gls/pdf/pancreatic.pdf 4 Burris HA , Moore MJ, Andersen J, Green MR, Rothenberg ML,  Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P,  Nelson R, Dorr FA, Stephens CD, V on Hoff DD.",Non-OADS,/arxiv_data1/oa_pdf/9f/e5/WJGO-8-682.PMC5027023.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/9f/e5/WJGO-8-682.PMC5027023.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Neil Vyas, MD,  Department of Internal  Medicine, Elmhurst Hospital Center, 79-01 Broadway, Elmhurst,  NY 11373, United States.",Non-OADS,/arxiv_data1/oa_pdf/54/e1/WJGO-8-688.PMC5027024.pdf
Stage Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.688World J Gastrointest Oncol   2016 September 15; 8(9): 688-694 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/54/e1/WJGO-8-688.PMC5027024.pdf
World J Gastrointest Oncol  2016; 8(9): 688-694   Available from: URL: http://www.wjgnet.com/1948-5204/full/v8/ i9/688.htm  DOI: http://dx.doi.org/10.4251/wjgo.v8.i9.,Non-OADS,/arxiv_data1/oa_pdf/54/e1/WJGO-8-688.PMC5027024.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/54/e1/WJGO-8-688.PMC5027024.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Esin Kabul Gürbulak, MD,  Department  of General Surgery, Şişli Etfal Training and Research Hospital,  Halaskargazi Cad, Etfal Sk, Şişli 34371, Istanbul,  Turkey.",Non-OADS,/arxiv_data1/oa_pdf/0b/34/WJGO-8-695.PMC5027025.pdf
Patients  were divided into two groups according to the interval Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.695World J Gastrointest Oncol   2016 September 15; 8(9): 695-706 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/0b/34/WJGO-8-695.PMC5027025.pdf
World J Gastrointest Oncol  2016; 8(9): 695-706  Available  from: URL: http://www.wjgnet.com/1948-5204/full/v8/i9/695.htm   DOI: http://dx.doi.org/10.4251/wjgo.v8.i9.,Non-OADS,/arxiv_data1/oa_pdf/0b/34/WJGO-8-695.PMC5027025.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/0b/34/WJGO-8-695.PMC5027025.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Shinji Morita, MD,  Department of  Surgical Oncology, National Cancer Center Hospital, 5-1-1  Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.",Non-OADS,/arxiv_data1/oa_pdf/b6/07/WJGO-8-707.PMC5027026.pdf
"CONCLUSION For patients with apparent PAN metastasis, a D3  gastrectomy is typically  planned if a few courses of Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4251/wjgo.v8.i9.707World J Gastrointest Oncol   2016 September 15; 8(9): 707-714 ISSN 1948-5204 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b6/07/WJGO-8-707.PMC5027026.pdf
World J Gastrointest Oncol  2016;  8(9): 707-714  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/b6/07/WJGO-8-707.PMC5027026.pdf
com/1948-5204/full/v8/i9/707.htm  DOI: http://dx.doi.org/10.4251/ wjgo.v8.i9.,Non-OADS,/arxiv_data1/oa_pdf/b6/07/WJGO-8-707.PMC5027026.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b6/07/WJGO-8-707.PMC5027026.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/f8/aapm-06-03-36344.PMC5027128.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/c8/ircmj-18-07-29800.PMC5027129.pdf
Available from: http://www.who.int/tb/publications/global_ report/gtbr12_main.pdf .,OADS,/arxiv_data1/oa_pdf/68/c8/ircmj-18-07-29800.PMC5027129.pdf
Available from: http://tuberkuloz.thsk.,Non-OADS,/arxiv_data1/oa_pdf/68/c8/ircmj-18-07-29800.PMC5027129.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/3a/ircmj-18-07-34449.PMC5027131.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/0d/ircmj-18-07-34135.PMC5027132.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f1/58/ircmj-18-07-33998.PMC5027133.pdf
"2, 103~112, June , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.2.103  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received April 0 8, 2016, Received in revised form April 15, 2016, Accepted April 1 8, 2016    † Corresponding Author : Hee Woong  Kang, East Sea Fisheries Research Institute, NIFS,  Gangneung 25435, Korea .",Non-OADS,/arxiv_data1/oa_pdf/22/57/DR-20-103.PMC5027215.pdf
http://www.fishbase.org (version  02/2014).,Non-OADS,/arxiv_data1/oa_pdf/22/57/DR-20-103.PMC5027215.pdf
"2, 123~130, June , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.2.123  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received April 25, 2016, Received in revised form May 06, 2016, Accepted May 12, 2016    † Corresponding Author : Haekwon Kim, Dept .",Non-OADS,/arxiv_data1/oa_pdf/6a/df/DR-20-123.PMC5027217.pdf
"2, 131~140, June , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.2.131  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received May 05, 2016, Received in revised form May 0 8, 2016, Accepted May 1 5, 2016    † Corresponding Author : Young -Don Lee , Marine Science  Institute, Jeju National University , Jeju 63333 , Korea.",Non-OADS,/arxiv_data1/oa_pdf/7e/75/DR-20-131.PMC5027218.pdf
"2, 141~147, June , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.2.141  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received  May 20, 2016, Received in revised form May 28, 2016, Accepted June 07, 2016   † Corresponding Author : Young -Don Lee , Marine Science  Institute, Jeju National University , Jeju 63333 , Korea.",Non-OADS,/arxiv_data1/oa_pdf/04/99/DR-20-141.PMC5027219.pdf
"2, 149~155, June , 2016    http://dx.doi.org/10.12717/DR.201 6.20.2.149  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received May 28, 2016, Received in revised form June 05, 2016, Accepted June 12, 2016    † Corresponding Author : Yong  Pil Cheon, Division of Development and Physiology, Department of Biology, Institute for Basic Sciences,  Sungshin  Women’s University, Seoul 136 -742, Republic of Korea .",Non-OADS,/arxiv_data1/oa_pdf/ed/9e/DR-20-149.PMC5027220.pdf
"2, 157~162, June , 201 6  <Short communication>   http://dx.doi.org/10.12717/DR.201 6.20.2.157  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received May 05, 2016, Received in revised form May 11, 2016, Accepted May 25, 2016    † Corresponding Author : Jong -Man Yoon , Dept .",Non-OADS,/arxiv_data1/oa_pdf/20/cb/DR-20-157.PMC5027221.pdf
"2, 163~169, June , 201 6  <Short communication>   http://dx.doi.org/10.12717/DR.201 6.20.2.163  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received May 18, 2016, Received in revised form May 29, 2016, Accepted June 09, 2016    † Corresponding Author : Kyung -Soon Park , Dept .",Non-OADS,/arxiv_data1/oa_pdf/db/e5/DR-20-163.PMC5027222.pdf
"2, 171~177, June , 201 6  <Short communication>   http://dx.doi.org/10.12717/DR.201 6.20.2.171  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received 2016, Received in revised form 201 6, Accepted 201 6   † Corresponding Author : Kyung -Soon Park, Dept.",Non-OADS,/arxiv_data1/oa_pdf/3d/ef/DR-20-171.PMC5027223.pdf
"2, 73~85, June , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.2.073  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received March  20, 2016, Received in revised form March  27, 2016, Accepted April  01, 2016   † Corresponding Author : In-Seok Park , Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime  and Ocean  University,  727 Taejong -ro, Yeong do -gu, Busan 606 -791, Korea .",Non-OADS,/arxiv_data1/oa_pdf/67/95/DR-20-73.PMC5027224.pdf
"2, 87~101, June , 201 6    http://dx.doi.org/10.12717/DR.201 6.20.2.087  ISSN 2465 -9525  (Print)   ISSN 2 465-9541  (Online)     Manuscript received April  01, 2016, Received in revised form April  06, 2016, Accepted April  10, 2016   † Corresponding Author : Jae Min Park, Gyeongsangbuk -do Native Fish Business Center, Uiseong  37366 , Korea.",Non-OADS,/arxiv_data1/oa_pdf/63/a0/DR-20-87.PMC5027225.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"The increasing number of cases with infections related to antibiotic-resistant bacterial strains and biofilmPhage therapy against Enterococcus faecalis Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"No significant effect in extracted toothmodel(108) E. faecalis Human dental roots Single phage Substantial reduction in bacterial cell viability(109) The phage therapy here involves either use of single phages or phage cocktails or combination treatments where phages are used along with antibiotics or previous clinical treatments.Phage therapy against Enterococcus faecalis Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"Both the bioﬁlms are 2 weeks old.Phage therapy against Enterococcus faecalis Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"The Calgary Bioﬁlm Device: new technology for rapidPhage therapy against Enterococcus faecalis Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"Curr Opin Biotechnol 2011;22: 449 /C155.Phage therapy against Enterococcus faecalis Citation: Journal of Oral Microbiology 2016, 8: 32157 - http://dx.doi.org/10.3402/jom.v8.32157 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/99/3f/JOM-8-32157.PMC5027333.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"gene expression in root caries lesions Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"gene expression in root caries lesions Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"gene expression in root caries lesions Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"gene expression in root caries lesions Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"gene expression in root caries lesions Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"12 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"gene expression in root caries lesions Citation: Journal of Oral Microbiology 2016, 8: 32383 - http://dx.doi.org/10.3402/jom.v8.32383 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/79/55/JOM-8-32383.PMC5027334.pdf
"Nucleosome samples were separated by native acrylamide gels, visualized using a GE Typhoon9410 variable mode imager, and the relative intensities of different nucleosome species were obtained using ImageJ (http://imagej.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/e2/9e/gkw406.PMC5027475.pdf
"Samples (3 /H9262l) were separated by SDS-PAGE (18% acrylamide), visualized us- ingaGETyphoon9410variablemodeimager,andquanti-fied using ImageJ ( http://imagej.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/e2/9e/gkw406.PMC5027475.pdf
Only interactions with a STRING score of at least 0.7 were further analyzed using Cytoscape(http://www.cytoscape.org/ )(56).,OADS,/arxiv_data1/oa_pdf/8c/14/gkw442.PMC5027479.pdf
"The colocal- ization of red-green spots was determined by calculatingthe distances between spots of one color to their mutual closest neighboring spot of the other color using R soft- ware (http://www.r-project.org ), with distances below 360 nmconsideredascolocalized.Thepercentageofcolocalizedspots was calculated by dividing the number of colocalized redspotsbythetotalnumberofredspots ×100.Todiscrim- inate between specific and random colocalization for eachcell,thecenterpositionsofthegreenspotswereshiftedsuc- cessively in the x-axis from 0 to ±12 pixels relative to the othercolorandthenumberofcolocalizedspotsbetweentheshifted and the original image was calculated at each shift positionasbefore.Thevalueswherethedecayofcolocaliza- tion reached a plateau (shifts of 8–12 pixels) were averagedtoestimaterandomness.Thisway,aspecificdegreeofcolo- calization was calculated by subtracting the random value from theoriginal colocalization value.",OADS,/arxiv_data1/oa_pdf/0d/22/gkw511.PMC5027490.pdf
"NucleicAcidsResearch,2016,Vol.44,No.16 7925 using R software ( http://www.r-project.org ).",OADS,/arxiv_data1/oa_pdf/0d/22/gkw511.PMC5027490.pdf
The sequencing bam files were downloaded from the Cancer Genomics Hub ( https://cghub.ucsc.edu/ ).,OADS,/arxiv_data1/oa_pdf/eb/9c/gkw520.PMC5027494.pdf
EQP is freely available for download at https://github.com/ Novartis/EQP-cluster .,OADS,/arxiv_data1/oa_pdf/85/f2/gkw538.PMC5027495.pdf
"Nat.Methods ,7, http://www.nature.com/nmeth/journal/v7/n10/pdf/nmeth.f.313.pdf .47.",OADS,/arxiv_data1/oa_pdf/56/e3/gkw547.PMC5027498.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/75/ircmj-18-07-21731.PMC5027627.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/3c/ircmj-18-07-21964.PMC5027628.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/a1/afw077.PMC5027637.pdf
"World Health Organization, 2012. http://apps.who.int/iris/bitstream/ 10665/75263/1/9789241564458_eng.pdf?ua=1 (21 April 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d0/a1/afw077.PMC5027637.pdf
nationalarchives.gov.uk/20160105160709/ ;http://www.ons.,Non-OADS,/arxiv_data1/oa_pdf/d0/a1/afw077.PMC5027637.pdf
"Alzheimer ’s Society, 2014. https://www.alzheimers.org.uk/site/scripts/documents_info.",Non-OADS,/arxiv_data1/oa_pdf/d0/a1/afw077.PMC5027637.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/81/afw091.PMC5027640.pdf
"Vienna, Austria.ISBN 3-900051-07-0, URL http://www.R-project.org/ ].",Non-OADS,/arxiv_data1/oa_pdf/6c/81/afw091.PMC5027640.pdf
"2013, 26 June 15.Available from: http://www.nice.org.uk/article/pmg9/ resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf .",Non-OADS,/arxiv_data1/oa_pdf/6c/81/afw091.PMC5027640.pdf
33.HTA —11/15/13: Evaluating the effectiveness and cost effectiveness of dementia care mapping (DCM) to enableperson-centred care for people with dementia and theircarers: a UK cluster randomised controlled trial in carehomes (DCM EPIC trial) [cited 2015 21 December 2015].Available from: http://www.nets.nihr.ac.uk/projects/hta/ 111513 .,Non-OADS,/arxiv_data1/oa_pdf/6c/81/afw091.PMC5027640.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/81/afw091.PMC5027640.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/fd/ircmj-18-07-25050.PMC5027670.pdf
Available from: http://www.unisdr.org/2005/wcdr/intergover/ofﬁcial-doc/L- docs/Hyogo-framework-for-action-english.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8f/fd/ircmj-18-07-25050.PMC5027670.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/21/ircmj-18-07-35167.PMC5027671.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/ec/ircmj-18-07-35460.PMC5027672.pdf
"The identi ﬁed variants and other patient data were deposited in the LOVD database (http://databases.lovd.nl/shared/genes/AICDA) (variant ID: AICDA_000004; individual IDs: 00058568, 00058569, 00058570,00058572, 00058573, 00058574 and 00058575).",OADS,/arxiv_data1/oa_pdf/60/0f/ejhg201637a.PMC5027683.pdf
"In parallel, a segregation analysis of polymorphisms in a 2-Mb region encompassing the p.(Met139Thr) was executed in the 32 carriers included in the above mentioned clinical and epidemiological sample collections in addition to the SISu data set (Supplementary Table 2) by utilizing PLINK (v. 1.07, http://pngu.mgh.harvard.edu/purcell/plink/).13Next, according to the observed haplotype blocks, a total of 80 markers located in a 1.1-Mb region surrounding the p.(Met139Thr) were screened for a putative shared allele, carried on in the comprehensive group of 32 carriers (Supplementary Table 3).",OADS,/arxiv_data1/oa_pdf/60/0f/ejhg201637a.PMC5027683.pdf
Teemu Kuulasmaa and Markku Laakso are thank ed for kindly sharing the genetic data and geographic origin of p.(Met139Thr) c arriers included in the METSIM study (http://www.nationalbiobanks.,Non-OADS,/arxiv_data1/oa_pdf/60/0f/ejhg201637a.PMC5027683.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Enrichment of a HIGM2- causing mutation in Finland LT r o t t a et al 1478 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/60/0f/ejhg201637a.PMC5027683.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Deﬁning the sub-nucleolar role of PHF6 MM Todd et al 1459 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/6c/e4/ejhg201640a.PMC5027685.pdf
"All possible causative variants have been deposited into the appropriate gene- speciﬁc databases (https://grenada.lumc.nl/LOVD2/mendelian_genes (Patient ID 0064817), PMM2 (Patient ID 0064818) or http://databases.lovd.nl/shared/ variants (SPG7), 00054866 (GOSR2), 00054867 (SCN8A), 00054869 (C10orf2), 00054870 (KCNC3), 00054871& 00054875 (OPA1), 00054872 (GBA2),00054873 (FA2H), 00054874 (KIAA0196), 00054876 (TH), 00054877 and00054878 (KIF1A), and 00054879 (LRRK2).",Non-OADS,/arxiv_data1/oa_pdf/b9/77/ejhg201642a.PMC5027687.pdf
"9 5 4 C0 SPG7 c.1454_1462del p.(Arg485_Glu487del)170.0015 (All) 6 6 —— — c.1529C 4T p.(Ala510Val)180.004 (All) 45 0 0 1.000 C65 c.1756G 4T p.(Glu586*) Absent 0 0 —— — TH c.772G4A p.(Glu258Lys)50.005 (SA) 46 1 0 0.669 C55 VCP c.278G4A p.(Arg93His)50.000015 (Eu) 1 0 0.12 0.991 C0 Abbreviations: EA, European American (from EVS (Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: http://evs.gs.wa shington.edu/EVS/) May 2015); AA, African American (from EVS); All, EA and AA (from EVS); Eu, European (from ExAC (Exome Aggregation Consortium (ExAC), Cambridge, MA (URL: http://exac.broad institute.org) 11 May 2015); SA, South Asian (from ExAC); Af, African (from ExAC).Gene names are according to the HUGO Gene Nomenclature Committee (HGNC) and variant nomenclature is according to the Human Genome Variation Society ( HGVS) guidelines.",Non-OADS,/arxiv_data1/oa_pdf/b9/77/ejhg201642a.PMC5027687.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Gene panel ﬁltering of ataxia and HSP exomes B Pv a nd eW a r r e n b u r g et al 1466 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/b9/77/ejhg201642a.PMC5027687.pdf
"MATERIALS AND METHODS Sample and target population Potential participants, both men and women with a partner and in the reproductive age, were recruited online by a survey research sampling company (Survey Sampling International, SSI; http://www.surveysampling.com) inMarch 2014.",Non-OADS,/arxiv_data1/oa_pdf/58/81/ejhg201643a.PMC5027688.pdf
org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Users ’views towards population-based expanded PCS MP l a n t i n g a et al 1423 European Journal of Human Genetics,Non-OADS,/arxiv_data1/oa_pdf/58/81/ejhg201643a.PMC5027688.pdf
"Genetic variants have been submitted to the ClinVar database (http://www.ncbi.nlm.nih.gov/clinvar/; accession numbers SCV000262600, SCV000262601,SCV000262602, SCV000262603, SCV000262604 and SCV000262605).",Non-OADS,/arxiv_data1/oa_pdf/87/ed/ejhg201644a.PMC5027689.pdf
"Genes linked to colorectal cancer (CRC) predisposition by the present report and previous evidence are shaded in gray (adapted from KEGG database, http://www.genome.jp/kegg/pathway.html).The FA DNA repair pathway in CRC predisposition C Esteban-Jurado et al 1502 European Journal of Human Genetics",OADS,/arxiv_data1/oa_pdf/87/ed/ejhg201644a.PMC5027689.pdf
"On the other hand, the identi ﬁed missense variants comply with several criteria to be potentially deleterious and two ofthem (those in BRCA2 andFANCE ) that fall in protein domains where pathogenic mutations have been previously reported in FA or familial breast and ovarian cancer patients in the ClinVar database orthe FA mutation database (http://www.rockefeller.edu/fanconi/).",Non-OADS,/arxiv_data1/oa_pdf/87/ed/ejhg201644a.PMC5027689.pdf
"In addition, when comparing with a publically available genetic variation control data set (Exome Aggregation Consortium), wedetected a clear enrichment for putative loss-of-function variants in these FA DNA damage repair pathway genes in our familial CRC cohort, when considering nonsense, canonical splice site, frame-shift and missense variants with a likely pathogenicity prediction(CADD415, Combined Annotation Dependent Depletion, CADD, http://cadd.gs.washington.edu/) and a genotype frequency o0.01% (6/40, 15% vs2546/60 706, 4.2%; χ 2test, uncorrected for multiple testing P-value =0.0025), or only nonsense, canonical splice site and frameshift with a genotype frequency o0.01% (3/40, 7.5% vs306- /60 706, 0.5%; χ2test, uncorrected for multiple testing P-value o0.0001).",Non-OADS,/arxiv_data1/oa_pdf/87/ed/ejhg201644a.PMC5027689.pdf
"To view a copy of this license,visit http://creativecommons.o rg/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)The FA DNA repair pathway in CRC predisposition CE s t e b a n - J u r a d o et al 1505 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/87/ed/ejhg201644a.PMC5027689.pdf
Loss-of-function mutations in the maternally expressed CDKN1C gene account for 5% of sporadic and up to 50% of familial BWS cases (Table 1) (for mutations see: http://databases.lovd.nl/shared/genes/CDKN1C).,Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"After clinical re-evaluation testing other tissues might be considered to exclude tissue-speci ﬁc mosaicism.MOLECULAR GENETIC TESTING METHODS Several techniques have been implemented in the moleculardiagnostic testing algorithm of both SRS and BWS, and as theﬁrst EMQN pilot schemes for SRS and BWS in 2014 showed (http://www.imprinting-di sorders.eu/wp-content/uploads/ 2015/07/EMQN-SRS-Summary-Report.pdf; http://www.imprinting- disorders.eu/wp-content/uplo ads/2015/07/EMQN-BWS-Summary- Report.pdf), different methods (Table 2) are suitable for diagnosticanalysis.",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"Several MS-MLPA Kits arecommercially available from MRC Holland (Amsterdam, Netherlands;http://www.mrc-holland.com).",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"In case of sequencing genes (eg, CDKN1C ), the appropriate guidelines (eg, of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (2015) 48or the Association for Clinical Genetic Sciences49(http://www.acgs.uk.com/media/774853/ evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_- _ﬁnalpdf.pdf) should be followed.",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"In general, the format of the reports has to correspond to general guidelines of reporting molecular genetic results according to Inter- national and the National Regulators (eg, from the Association for Clinical Genetic Science (Part of the British Society for GeneticMedicine; http://www.acgs.uk.com/me dia/949852/acgs_general_genetic_ laboratory_reporting_recommendations_2015.pdf).",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"The nomenclature of genomic mutations has to be inaccordance with the suggestions of the HGVS (http://www.hgvs.org/ mutnomen/), /C15applied methods and statement on the limitations and sensitivities including detection of mosaicism.",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"Appropriate references should be given, if commercial kits are used, the kit version has to be mentioned (eg, ME030-C3; http://www.mrc-holland.com), /C15the precise result description, /C15interpretation of diagnostic testing results (see above), /C15statement whether the clinical diagnosis is con ﬁrmed or not, /C15statement on the signi ﬁcance of the molecular results for the clinical management: for SRS, the certainty of the molecular genetic diagnosis aids medical management and precludes further investiga-tions for short stature.",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
Available from http://www.acgs.uk.com/media/774853/evaluation_and_ reporting_of_sequence_variants_bpgs_june_2013_-_ ﬁnalpdf.pdf.,OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Molecular genetic testing for 11p15 imprinting disorders KE g g e r m a n n et al 1387 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/b4/de/ejhg201645a.PMC5027690.pdf
"9, 2406 –2412 http://dx.doi.org/10.1080/21645515.2016.1179412",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
Lancet Infect Dis 2012; 12:136-41;PMID:22030330; http://dx.doi.org/10.1016/S1473-3099(11)70253-5 [2] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Pediatr Infect Dis J 2005; 24:481-8; PMID:15933555; http://dx.doi.org/10.1097/01.inf.0000164763.55558.71 [5] Phua KB, Emmanuel SC, Goh P, Quak SH, Lee BW, Han HH, Ward RL, Bernstein DI, De Vos B, Bock HL.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"PediatrInfect Dis J 2005; 24:807-16; PMID:16148848; http://dx.doi.org/ 10.1097/01.inf.0000178294.13954.a1 [8] Vesikari T, Karvonen A, Korhonen T, Espo M, Lebacq E, Forster J, Zepp F, Delem A, De Vos B.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Vaccine 2004; 22:2836-42; PMID:15246619; http://dx.doi.org/10.1016/j.vaccine.2004.01.044 [9] Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Ef ﬁcacy of human rotavirus vaccine against rotavirus gastroenteritis during the ﬁrst 2 years of life in European infants: randomised, double-blind controlled study.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Lancet 2007; 370:1757-63; PMID:18037080; http://dx.doi.org/10.1016/S0140-6736(07)61744-9 [10] Vesikari T, Karvonen A, Puustinen L, Zeng SQ, Szakal ED, Delem A, De Vos B. Ef ﬁcacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Pediatr Infect Dis J 2004; 23:937-43; PMID:15602194; http://dx.doi.org/10.1097/ 01.inf.0000141722.10130.50[11] Linhares AC, Velazquez FR, Perez-Schael I, Saez-Llorens X, Abate H, Espinoza F, Lopez P, Macias-Parra M, Ortega-Barria E, Rivera-Medina DM, et al.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Lancet 2008; 371:1181-9;PMID:18395579; http://dx.doi.org/10.1016/S0140-6736(08)60524-3 [12] Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, Chimpeni P, Victor JC, Steele AD, Bouckenooghe A, et al.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Vaccine 2013; 31:2253-9; PMID:23499605; http://dx.doi.org/10.1016/j.vaccine.2013.03.001 [14] Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"N Engl J Med2010; 362:289-98; PMID:20107214; http://dx.doi.org/10.1056/ NEJMoa0904797 [15] Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, Teoh YL, Tang H, Boudville I, et al.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Vaccine 2009; 27:5936-41; PMID:19679216; http://dx.doi.org/10.1016/j.vaccine.2009.07.098 [16] Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, et al.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"BMC Infect Dis 2012; 12:213; PMID:22974466; http://dx.doi.org/10.1186/1471- 2334-12-213 [17] Phua KB, Lim FS, Lau YL, Nelson EA, Huang LM, Quak SH, Lee BW, van Doorn LJ, Teoh YL, Tang H, et al.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Vaccine 2012; 30:4552-7;PMID:22497874; http://dx.doi.org/10.1016/j.vaccine.2012.03.030 [18] Bresee JS, Hummelman E, Nelson EA, Glass RI.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"J Infect Dis 2005; 192 Suppl 1:S1-5; PMID:16088790; http://dx.doi.org/10.1086/431515 [19] Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, Jaffar S, Gomara MI, Gray JJ, Brown DW, et al.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"NEngl J Med 2011; 365:337-46; PMID:21793745; http://dx.doi.org/ 10.1056/NEJMoa1006261 [20] Phua KB, Tee N, Tan N, Ramakrishnan G, Teoh YL, Bock H, Liu Y.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
A hospital-based surveillance of rotavirus gastroenteritis in children.Pediatr Infect Dis J 2013; 32:e426-31; PMID:23958814; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
Hum Vaccin Immunother 2014; 10:11-8; PMID:24013441; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Lancet 2009; 373:1543-9; PMID:19303633; http://dx.doi.org/10.1016/S0140-6736(09)60317-2 [23] Cunliffe NA, Ngwira BM, Dove W, Thindwa BD, Turner AM, Broadhead RL, Molyneux ME, Hart CA.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
Scand J Infect Dis 2010; 42:142-7; PMID:19916900; http://dx.doi.org/10.3109/00365540903380495HUMAN VACCINES & IMMUNOTHERAPEUTICS 2411,Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Scand J Infect Dis 1990; 22:269-78; PMID:2164706; http://dx.doi.org/10.3109/ 00365549009027047 [26] Armah GE, Kapikian AZ, Vesikari T, Cunliffe N, Jacobson RM, Burlington DB, Ruiz LP, Jr. Ef ﬁcacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghanawith the ﬁrst dose administered during the neonatal period.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"J Infect Dis 2013; 208:423-31; PMID:23599316; http://dx.doi.org/ 10.1093/infdis/jit174 [27] Vesikari T, Karvonen A, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Pediatr Infect Dis J 2006; 25:118-22; PMID:16462287; http://dx.doi.org/10.1097/01.inf.0000199288.98370.71 [28] Danchin M, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice F A ,C l i f f o r dV ,C o w l e yD ,B u t t e r yJ P ,B i n e sJ E .P h a s eIt r i a lo fRV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"Vaccine 2013; 31:2610-6; PMID:23597719; http://dx.doi.org/ 10.1016/j.vaccine.2013.04.008[29] Fischer TK, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, Molbak K, Sommerfelt H. Protective immunity after naturalrotavirus infection: a community cohort study of newborn childrenin Guinea-Bissau, West Africa.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"J Infect Dis 2002; 186:593-7; PMID:12195345; http://dx.doi.org/10.1086/342294 [30] Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM.",OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"N Engl J Med 1996; 335:1022-8; PMID:8793926; http://dx.doi.org/10.1056/NEJM199610033351404 [31] Steele AD, Alexander JJ, Hay IT.",Non-OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
Scand J Infect Dis 1990; 22:259-67; PMID:2371542; http://dx.doi.org/ 10.3109/003655490090270462412 A. D. STEELE ET AL.,OADS,/arxiv_data1/oa_pdf/87/10/khvi-12-09-1179412.PMC5027698.pdf
"9, 2422 –2440 http://dx.doi.org/10.1080/21645515.2016.1174356",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Lancet 2013; 381:1405-16; PMID:23582727; http://dx.doi.org/10.1016/S0140-6736(13)60222-6 [2] Rudan I, O ’Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Luk /C20si/C19c I, Fischer Walker CL, Black RE, et al.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"J Glob Health 2013; 3:010401; PMID:23826505;http://dx.doi.org/10.7189/jogh.03.010101 [3] Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, et al.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Lancet 2012; 379:2151-61; PMID:22579125; http://dx.doi.org/10.1016/S0140-6736(12)60560-12436 R. DEANTONIO ET AL.,OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
PLoS One 2015; 10:e0116380; PMID:25635911; http://dx.doi.org/ 10.1371/journal.pone.0116380 [5] WHO.,OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs331/en/.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Available at: http://www.who.int/whr/1998/en/whr98_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Lancet 2005; 365:1147-52;PMID:15794969; http://dx.doi.org/10.1016/S0140-6736(05)71877-8 [8] Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global esti- mate of the incidence of clinical pneumonia among children under ﬁve years of age.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Lancet Infect Dis 2002; 2:25-32; PMID:11892493; http://dx.doi.org/10.1016/S1473-3099(01)00170-0 [10] Zar HJ, Madhi SA.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Pediatr Pulmonol 2014; 49:430-4; PMID:24610581; http://dx.doi.org/10.1002/ppul.23030 [12] Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Bull WorldHealth Organ 2008; 86:408-16; PMID:18545744; http://dx.doi.org/ 10.2471/BLT.07.048769 [13] Wardlaw T, White Johansson E, Hodge M. Pneumonia: the forgot- ten killer of children.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Available at: http://www.childinfo.org/ ﬁles/ Pneumonia_The_Forgotten_Killer_of_Children.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"J Glob Health 2013; 3:010402; PMID:23826506; http://dx.doi.org/10.7189/jogh.03.010402 [16] Church J, Maitland K. Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review.BMC Med 2014; 12:31; PMID:24548672; http://dx.doi.org/10.1186/ 1741-7015-12-31 [17] Ashraf H, Chisti MJ, Alam NH.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Thorax 2002; 57:1-24; PMID:11809978; http://dx.doi.org/10.1136/thorax.57.1.1 [19] Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O ’Brien KL.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"PLoS Med 2010; 7:pii:e1000348; http://dx.doi.org/10.1371/journal.pmed.1000348 [20] Lassi ZS, Das JK, Haider SW, Salam RA, Qazi SA, Bhutta ZA.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Thorax 2013; 68:1052-6; PMID:23956020; http://dx.doi.org/10.1136/thoraxjnl-2013-204247[22] Madhi SA, De Wals P, Grijalva CG, Grimwood K, Grossman R, Ish- iwada N, Lee PI, Nascimento-Carvalho C, Nohynek H, O ’Brien KL, et al.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Pediatr Infect Dis J 2013; 32:e119-27; PMID:23099423; http://dx.doi.org/10.1097/INF.0b013e318271f369 [23] United Nations Industrial Development Organization.,OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Available at: https://www.unido.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Int J InfectDis 2012; 16:e5-15; PMID:22056731; http://dx.doi.org/10.1016/j.ijid.2011.09.013 [25] Roca A, Sigauque B, Quinto L, Morais L, Berenguera A, Corachan M, Rib /C19o JL, Naniche D, Bassat Q, Sacoor Ch, et al.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Vaccine 2010; 28:4851-7; PMID:20392430; http://dx.doi.org/10.1016/j.vaccine.2010.03.060 [26] Campbell JD, Kotloff KL, Sow SO, Tapia M, Keita MM, Keita T, Diallo S, Hormazabal JC, Murray P, Levine MM.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Pediatr Infect Dis J 2004; 23:642-9; PMID:15247603; http://dx.doi.org/10.1097/01.inf.0000130951.85974.79 [27] Campbell JD, Sow SO, Levine MM, Kotloff KL.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"J Trop Pediatr 2004; 50:158-63; PMID:15233192; http://dx.doi.org/10.1093/tropej/50.3.158 [28] Tornheim JA, Manya AS, Oyando N, Kabaka S, Breiman RF, Feikin DR.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"The epidemiology of hospitalized pneumonia in rural Kenya: the potential of surveillance data in setting public health priorities.Int J Infect Dis 2007; 11:536-43; PMID:17537660; http://dx.doi.org/ 10.1016/j.ijid.2007.03.006 [29] O ’Callaghan-Gordo C, Bassat Q, Morais L, Diez-Padrisa N, MacHevo S, Nhampossa T, Nhalungo D, Sanz S, Quint /C19o L, Alonso PL, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Pediatr Infect Dis J 2011; 30:39-44; PMID:20805786; http://dx.doi.org/10.1097/INF.0b013e3181f232fe [30] Usen S, Adegbola R, Mulholland K, Jaffar S, Hilton S, Oparaugo A, Omosigho C, Lahai G, Corrah T, Palmer A, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Pediatr Infect Dis J 1998; 17:23-8; PMID:9469390; http://dx.doi.org/ 10.1097/00006454-199801000-00006 [31] Enwere G, Cheung YB, Zaman SMA, Akano A, Oluwalana C, Brown O, Vaughan A, Adegbola R, Greenwood B, Cutts F. Epide- miology and clinical features of pneumonia according to radio- graphic ﬁndings in Gambian children.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Trop Med Int Health 2007; 12:1377-85; PMID:18045264; http://dx.doi.org/10.1111/j.1365-3156.2007.01922.x [32] Brooks WA, Breiman RF, Goswami D, Hossain A, Alam K, Saha SK, Nahar K, Nasrin D, Ahmed N, El Arifeen S, et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Pediatr Infect Dis J 2010; 29:216-21; PMID:20190613;http://dx.doi.org/10.1097/INF.0b013e3181bc23fd [34] Awasthi S, Pande VK.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Clin Infect Dis 2009; 48 Suppl 2:S103-13; PMID:19191605; http://dx.doi.org/10.1086/596543HUMAN VACCINES & IMMUNOTHERAPEUTICS 2437,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
J Clin Virol 2010; 49:94-9; PMID:20728404; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Vaccine 2007; 25:6837-41; PMID:17714837; http://dx.doi.org/10.1016/j.vaccine.2007.07.039 [39] Hildenwall H, Nantanda R, Tumwine JK, Petzold M, Pariyo G, Tomson G, Peterson S. Care-seeking in the development of severe community acquired pneumonia in Ugandan children.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Ann Trop Paediatr 2009; 29:281-9; PMID:19941751; http://dx.doi.org/10.1179/027249309X12547917869005 [40] Delport SD, Brisley T. Aetiology and outcome of severe commu- nity-acquired pneumonia in children admitted to a paediatric intensive care unit.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"The etiology of pneu- monia in malnourished and well-nourished Gambian children.Pediatr Infect Dis J 1994; 13:975-82; PMID:7845751; http://dx.doi.org/10.1097/00006454-199411000-00008 [42] Johnson A-W, Osinusi K, Aderele WI, Gbadero DA, Olaleye OD, Adeyemi-Doro FAB.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"J Natl Med Assoc 2008; 100:370-85; PMID:18481475; http://dx.doi.org/10.1016/S0027-9684(15)31269-4 [43] Zhao R, Zheng Y, Deng Q, Wang H, Chen Q, Deng J.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"DiagnMicrobiol Infect Dis 2005; 52:7-14; PMID:15878436; http://dx.doi.org/10.1016/j.diagmicrobio.2005.01.005 [45] Zhang Q, Guo Z, MacDonald NE.",OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Vaccine preventable community- acquired pneumonia in hospitalized children in Northwest China.Pediatr Infect Dis J 2011; 30:7-10; PMID:20625346; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Clin Infect Dis 2009; 48:S82-9; PMID:19191623; http://dx.doi.org/10.1086/596485 [47] Agarwal J, Awasthi S, Rajput A, Tiwari M, Jain A. Atypical bacterial pathogens in community-acquired pneumonia in children: a hospi-tal-based study.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
"Trop Doct 2009; 39:109-11; PMID:19299299; http://dx.doi.org/10.1258/td.2008.080248 [48] Batuwanthudawe R, Karunarathne K, Dassanayake M, De Silva S, Lalitha MK, Thomas K, Steinhoff M, Abeysinghe N. Surveillance ofinvasive pneumococcal disease in Colombo, Sri Lanka.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
Clin Infect Dis 2009; 48:S136-40; PMID:19191609; http://dx.doi.org/10.1086/596492 [49] Thomas K. Prospective multicentre hospital surveillance of strepto- coccus pneumoniae disease in India.,Non-OADS,/arxiv_data1/oa_pdf/ea/f1/khvi-12-09-1174356.PMC5027706.pdf
